concept,description,size,link
MDG_0000000001,Infant mortality rate (probability of dying between birth and age 1 per 1000 live births),5531.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1
MDG_0000000003,Adolescent birth rate (per 1000 women aged 15-19 years),177.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4669
MDG_0000000005,Contraceptive prevalence (%),256.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=5
MDG_0000000006,Unmet need for family planning (%),197.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=6
MDG_0000000007,Under-five mortality rate (probability of dying by age 5 per 1000 live births),5531.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=7
MDG_0000000010,Median availability of selected generic medicines (%) - Public,36.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=10
MDG_0000000011,Median consumer price ratio of selected generic medicines - Public,20.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=11
MDG_0000000012,Antiretroviral therapy coverage among people with advanced HIV infection (%),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=12
MDG_0000000013,Children aged <5 years sleeping under insecticide-treated nets (%),460.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=13
MDG_0000000014,Children aged <5 years with fever who received treatment with any antimalarial (%),56.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=14
MDG_0000000015,Prevalence of condom use by adults during higher-risk sex (15-49) (%),75.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=15
MDG_0000000016,Deaths due to malaria (per 100 000 population),111.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=16
MDG_0000000017,Deaths due to tuberculosis among HIV-negative people (per 100 000 population),3462.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=17
MDG_0000000018,Deaths due to tuberculosis among HIV-positive people (per 100 000 population),12.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=17
MDG_0000000019,Prevalence of HIV among adults aged >=15 years (per 100 000 population),12.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=19
MDG_0000000020,Incidence of tuberculosis (per 100 000 population per year),3462.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=20
MDG_0000000021,Population aged 15-24 years with comprehensive correct knowledge of HIV/AIDS (%),88.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=21
MDG_0000000022,Tuberculosis detection rate under DOTS (%),36.0,
MDG_0000000023,Prevalence of tuberculosis (per 100 000 population),5062.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=23
MDG_0000000024,Tuberculosis treatment success under DOTS (%),36.0,
MDG_0000000025,Births attended by skilled health personnel (%),182.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=25
MDG_0000000026,Maternal mortality ratio (per 100 000 live births),585.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=26
MDG_0000000027,Children aged <5 years stunted (%),1912.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=72
MDG_0000000028,Population below minimum level of dietary energy consumption,0.0,
LIFE_0000000029,nMx - age-specific death rate between ages x and x+n,123796.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=29
LIFE_0000000030,nqx - probability of dying between ages x and x+n,123796.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=30
LIFE_0000000031,lx - number of people left alive at age x,123796.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=31
LIFE_0000000032,ndx - number of people dying between ages x and x+n,123796.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=32
LIFE_0000000033,nLx - person-years lived between ages x and x+n,123796.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=33
LIFE_0000000034,Tx - person-years lived above age x,123796.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=34
LIFE_0000000035,ex - expectation of life at age x,123796.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=35
GBD_0000000036,Number of deaths,1.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3365
GBD_0000000037,GBD - population,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=
GBD_0000000038,GBD - crude death rate,5.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3367
WHS3_40,Cholera - number of reported cases,114.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=42
WHS3_41,Diphtheria - number of reported cases,7099.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=43
WHS3_42,Japanese encephalitis - number of reported cases,1052.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=44
WHS3_43,Pertussis - number of reported cases,7098.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=45
WHS3_45,Leprosy - number of reported cases,2196.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=47
WHS3_46,Total tetanus - number of reported cases,6930.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=48
WHS3_47,Meningitis - number of reported cases,1550.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=49
WHS3_48,Malaria - number of reported confirmed cases,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4635
WHS3_49,Poliomyelitis - number of reported cases,997.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=51
WHS3_50,Yellow fever - number of reported cases,3113.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=52
WHS3_51,H5N1 influenza - number of reported cases,28.0,
WHS3_52,Plague - number of reported cases,34.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=54
WHS3_53,Mumps - number of reported cases,2298.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=55
WHS3_54,Number of reported cases of tuberculosis (DOTS),188.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=56
WHS3_55,Congenital Rubella Syndrome - number of reported cases,2181.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=57
WHS3_56,Neonatal tetanus - number of reported cases,6479.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=58
WHS3_57,Rubella - number of reported cases,2963.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=59
MORT_58,Mortality - deaths (country),0.0,
MORT_59,Mortality - population (country),0.0,
MORT_61,Mortality - crude death rate per 100 000 population,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=41
WHS3_62,Measles - number of reported cases,7633.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=60
MORT_63,Mortality - live births (country),0.0,
WHOSIS_000001,Life expectancy at birth (years),9486.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=65
WHOSIS_000002,Healthy life expectancy (HALE) at birth (years),2856.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=66
WHOSIS_000003,Neonatal mortality rate (per 1000 live births),5531.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=67
WHOSIS_000004,Adult mortality rate (probability of dying between 15 and 60 years per 1000 population),9690.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=64
WHOSIS_000005,Low-birth-weight newborns (%),226.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=76
WHOSIS_000006,Infants exclusively breastfed for the first six months of life (%),511.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=130
GBD_76,GBD - Disability-adjusted life years (DALYS),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=158
GBD_77,GBD - Years of life lost (YLL),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=159
GBD_78,GBD - Years lost due to disability (YLD),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=160
WHOSIS_000008,Children aged <5 years underweight (%),1966.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=27
WHOSIS_000013,Prevalence of current tobacco use among adolescents (13-15 years) (%),344.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=129
WHOSIS_000009,Children aged <5 years overweight (%),1740.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=74
WHOSIS_000010,Adults aged &#8805; 20 years who are obese (%),612.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2389
WHOSIS_000011,Alcohol consumption among adults aged &#8805; 15 years (litres of pure alcohol per person per year),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=462
WHOSIS_000012,Prevalence of smoking any tobacco product among adults (&#8805;15 years) (%),702.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=128
WHS9_85,Literacy rate among adults aged >= 15 years (%),142.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=77
WHS9_86,Population (in thousands) total,208.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=113
WHS9_87,Net primary school enrolment ratio (%),2926.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=99
WHS9_88,Population median age (years),377.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=116
WHS9_89,Population proportion under 15 (%),194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=118
WHS9_90,Population living on <$1 (PPP int. $) a day (%),127.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=115
WHS9_91,Civil registration coverage of births (%),381.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=83
WHS9_92,Population proportion over 60 (%),194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=117
WHS9_93,Gross national income per capita (PPP int. $),4260.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=94
WHS9_94,Civil registration coverage of causes of deaths (%),122.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=84
WHS9_95,Total fertility rate (per woman),183.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=123
WHS9_96,Population living in urban areas (%),2101.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=114
WHS9_97,Annual population growth rate (%),12.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=79
WHS4_99,Antiretroviral therapy coverage among HIV-infected pregnant women for PMTCT (%),11.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=82
WHS4_100,Diphtheria tetanus toxoid and pertussis (DTP3) immunization coverage among 1-year-olds (%),6967.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=88
WHS6_101,Median availability of selected generic medicines (%) - Private,38.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=10
WHS6_102,Hospital beds (per 10 000 population),1607.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=97
WHS7_103,Private prepaid plans as a percentage of private expenditure on health,3533.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=120
WHS7_104,Per capita government expenditure on health at average exchange rate (US$),4015.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=109
WHS7_105,Per capita total expenditure on health (PPP int. $),4015.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=110
WHS4_106,Children aged < 5 years with pneumonia symptoms taken to a healthcare provider (%),273.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4737
WHS4_107,Children aged <5 years with diarrhoea receiving ORT (%),199.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=71
WHS7_108,Per capita government expenditure on health (PPP int. $),4015.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=108
WHS8_110,Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%),6839.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2
WHS4_111,Antenatal care coverage - at least one visit (%),168.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=81
WHS7_113,General government expenditure on health as a percentage of total government expenditure,4010.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=93
WHS4_115,Births by caesarean section (%),176.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=68
WHS6_116,Median consumer price ratio of selected generic medicines - Private,32.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=11
WHS4_117,Hepatitis B (HepB3) immunization coverage among 1-year-olds (%),3488.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=95
WHS7_120,External resources for health as a percentage of total expenditure on health,3460.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=91
WHS5_122,Population using improved drinking-water sources (%),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=8
WHS6_123,Number of dentistry personnel,275.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=101
WHS4_124,Children aged 6-59 months who received vitamin A supplementation (%),149.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=69
WHS6_125,Physicians density (per 10 000 population),289.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=112
WHS2_126,Distribution of years of life lost by major cause group,1032.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=90
WHS6_127,Number of nursing and midwifery personnel,281.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=102
WHS4_128,Neonates protected at birth against neonatal tetanus (PAB) (%),3897.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=98
WHS4_129,Hib (Hib3) immunization coverage among 1-year-olds (%),2641.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=96
WHS2_131,Age-standardized NCD mortality rate  (per 100 000 population),118812.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=78
WHS7_134,Social security expenditure on health as a percentage of general government expenditure on health,3625.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=121
WHS6_136,Number of physicians,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=104
WHS2_138,Deaths due to HIV/AIDS (per 100 000 population),248.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=86
WHS7_139,Out-of-pocket expenditure as a percentage of private expenditure on health,4015.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=107
WHS6_140,Number of community health workers,60.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=100
WHS7_143,Total expenditure on health as a percentage of gross domestic product,4015.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=122
WHS6_144,Dentistry personnel density (per 10 000 population),275.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=87
WHS7_147,Private expenditure on health as a percentage of total expenditure on health,4015.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=119
WHS6_148,Nursing and midwifery personnel density (per 10 000 population),281.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=105
WHS7_149,General government expenditure on health as a percentage of total expenditure on health,4015.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=92
WHS6_150,Community health workers density (per 10 000 population),58.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=85
WHS2_152,Deaths due to malaria (per 100 000 population),10.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=16
WHS4_154,Antenatal care coverage - at least four visits (%),148.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=80
WHS2_155,Distribution of causes of death among children aged <5 years (%),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=89
WHS7_156,Per capita total expenditure on health at average exchange rate (US$),4015.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=111
WHS6_157,Number of other health service providers,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=103
WHS5_158,Population using improved sanitation facilities (%),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=9
WHS6_159,Other health service providers density (per 10 000 population),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=106
WHS2_160,Age-standardized mortality rate by cause (per 100 000 population) - Cancer,12.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=78
WHS2_161,Age-standardized mortality rate by cause (per 100 000 population) - Cardiovascular,12.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=78
WHS2_162,Age-standardized mortality rate by cause (per 100 000 population) - Injuries,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=78
WHS2_163,Age-standardized mortality rate by cause (per 100 000 population) - Noncommunicable,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=78
WHS2_164,Distribution of causes of death among children aged <5 years (%) - Malaria,2192.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=89
WHS2_165,Distribution of causes of death among children aged <5 years (%) - Pneumonia,2192.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=89
WHS2_166,Distribution of causes of death among children aged <5 years (%) - Injuries,2192.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=89
WHS2_167,Distribution of causes of death among children aged <5 years (%) - Diarrhoea,2192.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=89
WHS2_168,Distribution of causes of death among children aged <5 years (%) - Measles,2192.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=89
WHS2_169,Distribution of causes of death among children aged <5 years (%) - Causes arising in the perinatal period,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=89
WHS2_170,Distribution of causes of death among children aged <5 years (%) - HIV/AIDS,2192.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=89
WHS2_171,Distribution of causes of death among children aged <5 years (%) - Other diseases,2192.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=89
WHS2_172,Distribution of years of life lost by broader causes (%) - Communicable,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=90
WHS2_173,Distribution of years of life lost by broader causes (%) - Noncommunicable,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=90
WHS2_174,Distribution of years of life lost by broader causes (%) - Injuries,205.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=90
WAS_0000000001,Access to improved drinking water sources,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=8
WAS_0000000002,Access to improved sanitation,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=9
ODA_1,"Donor commitments (Million, constant 2009 US$)",245.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3253
ODA_2,"Commitments to recipient countries (Million, constant 2009 US$)",1295.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3253
ODA_3,"Donor disbursements (Million, constant 2009 US$)",233.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3252
ODA_4,"Disbursements to recipient countries (Million, constant 2009 US$)",1295.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3252
GBD_PREV,Prevalence (in thousands),0.0,
GBD_INC,Incidence (in thousands),0.0,
GBD_DTHRT,"Death rates  (per 100,000)",0.0,
GBD_DALYRT,"DALY rates (per 100,000)",0.0,
GBD_DALYRTAGE,"Age-standardized DALYs (per 100,000)",1376.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=157
TOBACCO_0000000186,Monitor,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=339
TOBACCO_0000000187,Protect from tobacco smoke,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=341
TOBACCO_0000000188,Offer help to quit tobacco use,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=343
TOBACCO_0000000189,Warn about the dangers of tobacco,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1221
TOBACCO_0000000190,Enforce bans on tobacco advertising,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=373
TOBACCO_0000000191,Raise taxes on tobacco,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=374
TOBACCO_0000000192,Prevalence of smoking any tobacco product among persons aged >= 15 years,1815.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=346
TOBACCO_0000000193,Daily smoking of any tobacco product (age-standardized rate),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=347
TOBACCO_0000000194,Current smoking of cigarettes (age-standardized rate),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=348
TOBACCO_0000000195,Daily smoking of cigarettes (age-standardized rate),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=356
TOBACCO_0000000196,Health-care facilities (national legislation),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1232
TOBACCO_0000000197,Education facilities except universities (national legislation),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1233
TOBACCO_0000000198,Universities (national legislation),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1234
TOBACCO_0000000199,Government facilities (national legislation),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1235
TOBACCO_0000000200,Indoor offices (national legislation),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1236
TOBACCO_0000000201,Restaurants (national legislation),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1329
TOBACCO_0000000202,Pubs and bars (national legislation),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1238
TOBACCO_0000000203,Public transport (national legislation),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1239
TOBACCO_0000000204,All other indoor public places (national legislation),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1240
TOBACCO_0000000205,Number of places smoke-free (national legislation),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1312
TOBACCO_0000000206,Compliance with regulations on smoke-free environments (national legislation),0.0,
TOBACCO_0000000207,Subnational smoke-free legislation authority exists,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1241
TOBACCO_0000000208,Comprehensive bans in place subnationally,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1242
TOBACCO_0000000209,Fines for violations,386.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1324
TOBACCO_0000000210,Fines on the establishment,386.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1325
TOBACCO_0000000211,Fines on the patron,386.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1326
TOBACCO_0000000212,Dedicated funds for enforcement,386.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1323
TOBACCO_0000000213,Citizen complaints and investigations,386.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1322
CHOLERA_0000000001,Number of reported cases of cholera,2480.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=42
CHOLERA_0000000002,Number of reported deaths from cholera,2377.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2446
CHOLERA_0000000003,Cholera case fatality rate,2366.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2445
MALARIA_15034,Total microscopy examined,0.0,
MALARIA_15035,Total microscopy positive,0.0,
MALARIA_15043,Suspected malaria cases,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4633
MALARIA_15049,Malaria outpatient cases,1813.0,
MALARIA_15065,Number of reported presumed and confirmed malaria cases,0.0,
MALARIA_16201,Number of health facility reports received per year (Outpatient),0.0,
MALARIA_16202,Number of health facilities (Outpatient),0.0,
MALARIA_16203,Number of reports expected per health facility per year (Outpatient),0.0,
MALARIA_16205,Number of Admin 2 reports received per year (Outpatient),0.0,
MALARIA_16206,Number of Admin 2 units (Outpatient),0.0,
MALARIA_16207,Number of reports expected per Admin 2 per year (Outpatient),0.0,
MALARIA_16210,Cases at community level (presumed and confirmed),0.0,
MALARIA_16227,Number of malaria cases treated with ACT in public facilities,0.0,
MALARIA_16228,Number of RDTs delivered (public facilities and community),0.0,
MALARIA_16263,Number of malaria cases treated with ACT (Community level),0.0,
MALARIA_16270,Number of health facility reports received per year (Inpatient),0.0,
MALARIA_16271,Number of health facilities (Inpatient),0.0,
MALARIA_16272,Number of reports expected per health facility per year (Inpatient),0.0,
MALARIA_16273,Number of Admin 2 reports received per year (Inpatient),0.0,
MALARIA_16274,Number of Admin 2 units (Inpatient),0.0,
MALARIA_16275,Number of reports expected per Admin 2 per year (Inpatient),0.0,
MALARIA_40105,Imported cases,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4637
MALARIA_15029,All-cause outpatient cases,1022.0,
MALARIA_15030,All-cause inpatient cases,433.0,
MALARIA_15031,All-cause inpatient deaths,488.0,
MALARIA_15056,Malaria inpatient cases,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4640
MALARIA_15059,Malaria attributed deaths,763.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2967
MALARIA_16231,All-cause deaths (including malaria death) (Vital registration),0.0,
MALARIA_16232,Malaria deaths (including confirmed deaths) (Vital registration),0.0,
MALARIA_15032,Total RDT examined,0.0,
MALARIA_15033,Total RDT positive,0.0,
MALARIA_15036,Number of P. falciparum,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4641
MALARIA_15037,Number of P. vivax,0.0,
MALARIA_15040,Number of mixed infections,274.0,
MALARIA_15063,RDT Positive cases at community level,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4639
MALARIA_15095,Microscopy slides/RDTs examined,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4634
MALARIA_15096,Microscopy slides/RDTs positive,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=50
MALARIA_16209,RDT tested at community level,0.0,
MALARIA_16211,Examined (by microscopy and RDT)(Active case detection),0.0,
MALARIA_16212,Positive (by microscopy and RDT)(Active case detection),0.0,
MALARIA_16229,Number of P. falciparum (RDT test),0.0,
MALARIA_16230,Number of other plamodium species (RDT test),0.0,
MALARIA_15077,ANC first attendance,0.0,
MALARIA_15079,IPT 1st dose,0.0,
MALARIA_15080,IPT 2nd dose,0.0,
MALARIA_15116,Total number of conventional Insecticide Treated Nets (ITNs) + LLINS sold or delivered,0.0,
MALARIA_15117,Total number of Long Lasting Insecticide Treated Nets (LLINs) sold or delivered,0.0,
MALARIA_16223,Number distributed through mass campaign,0.0,
MALARIA_16224,Number distributed through ANC,0.0,
MALARIA_16225,Number distributed through EPI,0.0,
MALARIA_16226,Number distributed through other channels,0.0,
MALARIA_20126,Number of conventional insecticide-treated nets (ITNs) sold or delivered,307.0,
MALARIA_15130,Spraying cycle,0.0,
MALARIA_15136,Number of households sprayed at least once,185.0,
MALARIA_15137,Number of households targeted for spraying,300.0,
MALARIA_15138,Number people targeted for protection by IRS,0.0,
MALARIA_15139,Number of people protected by IRS,0.0,
MALARIA_16221,Number of houses or structures targeted,0.0,
MALARIA_16222,Number of houses or structures sprayed at least once,0.0,
MALARIA_20129,Insecticide used,0.0,
MALARIA_15150,Number of ACT only treatment doses received (public facilities and community),306.0,
MALARIA_16261,Number of ACT only treatment doses received (public facilities only),0.0,
MALARIA_16262,Total number of ACT treatment courses distributed,0.0,
MALARIA_20132,Total number of 1st line treatment course distributed,0.0,
MALARIA_16234,Programme Management (PM),0.0,
MALARIA_16235,"Entomology and vector control (ITN, IRS, others)",0.0,
MALARIA_16236,"Surveillance, Monitoring and Evaluation (SME)",0.0,
MALARIA_16237,Diagnosis and case manangement (incl. IPT),0.0,
MALARIA_16238,Communications and Advocacy (CAD),0.0,
MALARIA_16239,Training,0.0,
MALARIA_15283,Government health budget (USD),276.0,
MALARIA_15284,Government budget for malaria (USD),331.0,
MALARIA_15287,Contributions from the Global Fund (USD),229.0,
MALARIA_15288,Contributions from the Wolrdbank (USD),154.0,
MALARIA_15309,European Union (USD),108.0,
MALARIA_15310,Gov. expenditure on malaria (USD),295.0,
MALARIA_16233,"Other (NGOs, foundations,etc)",0.0,
MALARIA_16240,Others,0.0,
MALARIA_16264,WHO,0.0,
MALARIA_16265,UNICEF,0.0,
MALARIA_16266,Other UN agencies,0.0,
MALARIA_16267,PMI,0.0,
MALARIA_16268,Other bilaterals,0.0,
MALARIA_16252,High endemic or risk areas ( RMI > 1),0.0,
MALARIA_16253,Low endemic or epidemic-prone areas ( RMI < 1),0.0,
MALARIA_16254,Malaria-free areas (no indigenous transmission),0.0,
MALARIA_30514,Household Net Possession - Percentage with at least one (Any type of mosquito net ),0.0,
MALARIA_30515,Household Net Possession - Percentage with more than one (Any type of mosquito net ),3.0,
MALARIA_30516,Household Net Possession - Average number of nets per household (Any type of mosquito net ),3.0,
MALARIA_30517,Household Net Possession - Percentage with at least one (Ever treated mosquito net ),53.0,
MALARIA_30518,Household Net Possession - Percentage with more than one (Ever treated mosquito net ),3.0,
MALARIA_30519,Household Net Possession - Average number of ever treated nets per household (Ever treated mosquito net ),3.0,
MALARIA_30520,Household Net Possession - Percentage with at least one (Insecticide treated mosquito nets (ITNs) ),0.0,
MALARIA_30521,Household Net Possession - Percentage with more than one (Insecticide treated mosquito nets (ITNs) ),3.0,
MALARIA_30522,Household Net Possession - Average number of ITNs per household (Insecticide treated mosquito nets (ITNs) ),3.0,
MALARIA_30523,Household Net Possession - (Number of households ),0.0,
MALARIA_30526,IPT and Anti-malarial Treatment - Percentage who took 2+ doses SP/Fansidar,79.0,
MALARIA_30532,Prompt Treatment - Percentage who took antimalarial drugs (Among children under age five with fever),0.0,
MALARIA_30533,Prompt Treatment - Percentage who took antimalarial drugs same or next day (Among children under age five with fever),0.0,
MALARIA_30535,Children with fever - Percentage of children who took drug: SP/ Fansidar,0.0,
MALARIA_30536,Children with fever - Percentage of children who took drug: Chloroquine,0.0,
MALARIA_30539,Children with fever - Percentage of children who took drug: Combination with artemisinin,30.0,
MALARIA_30541,Children with fever - Percentage of children who took drug the same or next day: SP/ Fansidar,41.0,
MALARIA_30542,Children with fever - Percentage of children who took drug the same or next day: Chloroquine,35.0,
MALARIA_30545,Children with fever - Percentage of children who took drug the same or next day: Combination with artemisinin,12.0,
MALARIA_30548,Use of mosquito nets - Percentage of under 5 who slept under any net last night,0.0,
MALARIA_30549,Use of mosquito nets - Percentage of under 5 who slept under an ever treated net last night,0.0,
MALARIA_30550,Use of mosquito nets - Percentage of under 5 who slept under an ITN last night,0.0,
MALARIA_30555,Use of mosquito nets - Number of children under 5,0.0,
MALARIA_30556,Use of mosquito nets - Percentage of all women age 15-49 who Slept under any net last night,3.0,
MALARIA_30557,Use of mosquito nets - Percentage of all women age 15-49 who Slept under an ever treated net last night,3.0,
MALARIA_30558,Use of mosquito nets - Percentage of all women age 15-49 who Slept under an ITN last night,3.0,
MALARIA_30559,Use of mosquito nets - Number of pregnant women,0.0,
MALARIA_30560,Use of mosquito nets - Percentage of pregnant women age 15-49 who Slept under any net last night,0.0,
MALARIA_30561,Use of mosquito nets - Percentage of pregnant women age 15-49 who Slept under an ever treated net last night,0.0,
MALARIA_30562,Use of mosquito nets - Percentage of pregnant women age 15-49 who Slept under an ITN last night,0.0,
MALARIA_15279,Population,0.0,
TB_c_tsr,Treatment success rate (new smear-positive cases),0.0,
TB_e_mort_exc_tbhiv_100k,"Mortality of TB cases (all forms, excluding HIV) per 100 000 population",0.0,
TB_e_mort_exc_tbhiv_num_save,"Number of deaths from TB (all forms, excluding HIV)",0.0,
TOBACCO_0000000337,Current smoking of any tobacco product (crude rate),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=358
TOBACCO_0000000338,Daily smoking of any tobacco product (crude rate),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=360
TOBACCO_0000000339,Current smoking of cigarettes (crude rate),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=361
TOBACCO_0000000340,Daily smoking of cigarettes (crude rate),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=363
TOBACCO_0000000341,Current users of any smokeless tobacco product (crude rate),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=364
TOBACCO_0000000342,Daily users of any smokeless tobacco product (crude rate),579.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=365
TOBACCO_0000000343,Ever users of any smokeless tobacco product (crude rate),0.0,
TOBACCO_0000000344,Prevalence of current tobacco use among adolescents aged 13-15 years,606.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1298
TOBACCO_0000000345,Current smokers of cigarettes (youth rate),1158.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1297
TOBACCO_0000000346,Exposure to smoke at home,1158.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1300
TOBACCO_0000000347,Exposure to smoke outside home,1158.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1301
TOBACCO_0000000348,Jurisdiction name,0.0,
TOBACCO_0000000349,Number of people covered by subnational legislation,0.0,
TOBACCO_0000000350,Proportion of national population covered by subnational legislation,0.0,
TOBACCO_0000000351,Number of places smoke-free (subnational legislation),0.0,
TOBACCO_0000000352,Health-care facilities (subnational legislation),0.0,
TOBACCO_0000000353,"Education facilities, except universities (subnational legislation)",0.0,
TOBACCO_0000000354,Universities (subnational legislation),0.0,
TOBACCO_0000000355,Government facilities  (subnational legislation),0.0,
TOBACCO_0000000356,Indoor offices (subnational legislation),0.0,
TOBACCO_0000000357,Restaurants (subnational legislation),0.0,
TOBACCO_0000000358,Pubs and bars (subnational legislation),0.0,
TOBACCO_0000000359,Public transport (subnational legislation),0.0,
TOBACCO_0000000360,All other indoor public places (subnational legislation),0.0,
TOBACCO_0000000361,Access to a toll-free quit line,386.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1288
TOBACCO_0000000362,Smoking cessation support is available in hospitals,386.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1243
TOBACCO_0000000363,Smoking cessation support is available in health clinics or other primary care facilities,386.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1263
TOBACCO_0000000364,Smoking cessation support is available in offices of health professionals,386.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1262
TOBACCO_0000000365,Smoking cessation support is available in the community,386.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1319
TOBACCO_0000000366,Smoking cessation support is available in other settings,386.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1261
TOBACCO_0000000367,Nicotine replacement therapy - legally sold,386.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1309
TOBACCO_0000000368,Nicotine replacement therapy - place available,386.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1260
TOBACCO_0000000369,Bupropion - legally sold,386.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1259
TOBACCO_0000000370,Bupropion - place available,386.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1258
TOBACCO_0000000371,Varenicline - legally sold,386.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1256
TOBACCO_0000000372,Varenicline - place available,386.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1257
TOBACCO_0000000373,Ban on deceitful terms on cigarette packaging,0.0,
TOBACCO_0000000374,Percentage of principal display area mandated to be covered by health warnings - front and back of cigarette packaging,0.0,
TOBACCO_0000000375,Percentage of principal display area mandated to be covered by health warnings - front of cigarette packaging,0.0,
TOBACCO_0000000376,Percentage of principal display area mandated to be covered by health warnings - back of cigarette packaging,0.0,
TOBACCO_0000000377,Specific health warnings are mandated for cigarette packaging,0.0,
TOBACCO_0000000378,Number of health warnings approved by the law for cigarette packaging,0.0,
TOBACCO_0000000379,Health warnings appear on each cigarette package and any outside packaging and labelling used in the retail sale,0.0,
TOBACCO_0000000380,Health warnings on cigarette packaging describe the harmful effects of tobacco use on health,0.0,
TOBACCO_0000000381,"Font style, font size and colour of health warnings are mandated for cigarette packaging",0.0,
TOBACCO_0000000382,Health warnings on cigarette packaging must be rotated,0.0,
TOBACCO_0000000383,Health warnings on cigarette packaging must be written in the principal language(s) of the country,0.0,
TOBACCO_0000000384,Health warnings on cigarette packaging must include a photograph or graphic,0.0,
TOBACCO_0000000385,Ban on deceitful terms on other smoked tobacco packaging,0.0,
TOBACCO_0000000386,Percentage of principal display area mandated to be covered by health warnings - front and back of other smoked tobacco packaging,386.0,
TOBACCO_0000000387,Percentage of principal display area mandated to be covered by health warnings - front of other smoked tobacco packaging,386.0,
TOBACCO_0000000388,Specific health warnings are mandated for other smoked tobacco packaging,386.0,
TOBACCO_0000000389,Number of health warnings approved by the law for other smoked tobacco packaging,386.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1269
TOBACCO_0000000390,Health warnings on other smoked tobacco packaging must be rotated,386.0,
TOBACCO_0000000391,Percentage of principal display area mandated to be covered by health warnings - back of other smoked tobacco packaging,386.0,
TOBACCO_0000000392,Health warnings appear on each other smoked tobacco package and any outside packaging and labelling used in the retail sale,386.0,
TOBACCO_0000000393,Health warnings on other smoked tobacco packaging describe the harmful effects of tobacco use on health,386.0,
TOBACCO_0000000394,"Font style, font size and colour of health warnings are mandated for other smoked tobacco packaging",386.0,
TOBACCO_0000000395,Health warnings on other smoked tobacco packaging must be written in the principal language(s) of the country,386.0,
TOBACCO_0000000396,Health warnings on other smoked tobacco packaging must include a photograph or graphic,386.0,
TOBACCO_0000000397,Ban on deceitful terms on smokeless tobacco packaging,0.0,
TOBACCO_0000000398,Percentage of principal display area mandated to be covered by health warnings - front and back of smokeless tobacco packaging,0.0,
TOBACCO_0000000399,Percentage of principal display area mandated to be covered by health warnings - front of smokeless tobacco packaging,0.0,
TOBACCO_0000000400,Percentage of principal display area mandated to be covered by health warnings - back of smokeless tobacco packaging,0.0,
TOBACCO_0000000401,Specific health warnings are mandated for smokeless tobacco packaging,0.0,
TOBACCO_0000000402,Number of health warnings approved by the law for smokeless tobacco packaging,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1280
TOBACCO_0000000403,Health warnings appear on each smokeless tobacco package and any outside packaging and labelling used in the retail sale,0.0,
TOBACCO_0000000404,Health warnings on smokeless tobacco packaging describe the harmful effects of tobacco use on health,0.0,
TOBACCO_0000000405,"Font style, font size and colour of health warnings are mandated for smokeless tobacco packaging",0.0,
TOBACCO_0000000406,Health warnings on smokeless tobacco packaging must be rotated,0.0,
TOBACCO_0000000407,Most sold brand of bidis - price in US$ at official exchange rates,0.0,
TOBACCO_0000000408,Cheapest brand of bidis - currency reported,0.0,
TOBACCO_0000000409,Cheapest brand of bidis - price in currency reported,0.0,
TOBACCO_0000000410,Cheapest brand of bidis - price in US$ at official exchange rates,0.0,
TOBACCO_0000000411,Health warnings on smokeless tobacco packaging must be written in the principal language(s) of the country,0.0,
TOBACCO_0000000412,Health warnings on smokeless tobacco packaging must include a photograph or graphic,0.0,
TOBACCO_0000000413,Billboard and outdoor advertising,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1292
TOBACCO_0000000414,International magazines and newspapers,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1304
TOBACCO_0000000415,International television and radio,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1305
TOBACCO_0000000416,Internet,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1306
TOBACCO_0000000417,Local magazines and newspapers,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1307
TOBACCO_0000000418,National television and radio,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1313
TOBACCO_0000000419,Point of sale,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1315
TOBACCO_0000000420,"Subnational bans on tobacco advertising, promotion and sponsorship",0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1318
TOBACCO_0000000421,Compliance with bans on direct advertising,0.0,
TOBACCO_0000000422,Appearance of tobacco products in TV and/or films,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1291
TOBACCO_0000000423,Brand name of non-tobacco products used for tobacco product,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1293
TOBACCO_0000000424,Free distribution in mail or through other means,0.0,
TOBACCO_0000000425,Non-tobacco products identified with tobacco brand names,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1310
TOBACCO_0000000426,Promotional discounts,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1316
TOBACCO_0000000427,Sponsored events,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1317
TOBACCO_0000000428,Compliance with bans on promotion and sponsorship,0.0,
TOBACCO_0000000429,Most sold brand of cigarettes - currency reported,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=376
TOBACCO_0000000430,Most sold brand of cigarettes - price in currency reported,0.0,
TOBACCO_0000000431,Most sold brand of cigarettes - price in US$ at official exchange rates,0.0,
TOBACCO_0000000432,Cheapest brand of cigarettes - currency reported,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=379
TOBACCO_0000000433,Cheapest brand of cigarettes - price in currency reported,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=380
TOBACCO_0000000434,Cheapest brand of cigarettes - price in US$ at official exchange rates,0.0,
TOBACCO_0000000435,Most sold brand of bidis - currency reported,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=382
TOBACCO_0000000436,Most sold brand of bidis - price in currency reported,0.0,
TOBACCO_0000000437,Most sold brand of cigarettes - taxes as a % of price - ad valorem excise,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=386
TOBACCO_0000000438,Most sold brand of cigarettes - taxes as a % of price - import duties,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=387
TOBACCO_0000000439,Most sold brand of cigarettes - taxes as a % of price - specific excise,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=385
TOBACCO_0000000440,Most sold brand of cigarettes - taxes as a % of price - total tax,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1223
TOBACCO_0000000441,Cheapest brand of cigarettes - taxes as a % of price - ad valorem excise,0.0,
TOBACCO_0000000442,Cheapest brand of cigarettes - taxes as a % of price - import duties,0.0,
TOBACCO_0000000443,Cheapest brand of cigarettes - taxes as a % of price - specific excise,0.0,
TOBACCO_0000000444,Cheapest brand of cigarettes - taxes as a % of price - total tax,0.0,
TOBACCO_0000000445,Most sold brand of bidis - taxes as a % of price - ad valorem excise,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1225
TOBACCO_0000000446,Most sold brand of bidis - taxes as a % of price - import duties,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1226
TOBACCO_0000000447,Most sold brand of bidis - taxes as a % of price - specific excise,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1224
TOBACCO_0000000448,Most sold brand of bidis - taxes as a % of price - total tax,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1231
TOBACCO_0000000449,Cheapest brand of bidis - taxes as a % of price - ad valorem excise,0.0,
TOBACCO_0000000450,Cheapest brand of bidis - taxes as a % of price - import duties,0.0,
TOBACCO_0000000451,Cheapest brand of bidis - taxes as a % of price - specific excise,0.0,
TOBACCO_0000000452,Cheapest brand of bidis - taxes as a % of price - total tax,0.0,
TOBACCO_0000000453,Government objectives on tobacco control exist,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1303
TOBACCO_0000000454,National agency for tobacco control exists,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1308
TOBACCO_0000000455,Number of full-time equivalent staff in national agency,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1311
TOBACCO_0000000456,Annual budget for tobacco control in currency reported,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1289
TOBACCO_0000000457,Reported currency,0.0,
TOBACCO_0000000458,Annual budget for tobacco control in US$ at official exchange rate,0.0,
TOBACCO_0000000459,Budget year,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1294
RS_193,Income level,181.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=193
RS_194,Number of registered vehicles,179.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=194
RS_196,Estimated number of road traffic deaths,179.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=196
RS_198,Estimated road traffic death rate (per 100 000 population),197.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=198
RS_204,Existence of a national drink-driving law,179.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=204
RS_208,Attribution of road traffic deaths to alcohol (%),179.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=208
RS_209,Existence of a national seat-belt law,179.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=209
RS_210,Applicability of seat-belt law to all occupants,179.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=210
RS_213,Existence of a national child-restraint law,179.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=213
RS_214,Existence of national speed limits,179.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=214
RS_215,Adaptation of national speed limit at a local level,179.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=215
RS_216,Specification of national speed law by vehicle type,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=216
RS_218,Existence of a national motorcycle helmet law,179.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=218
RS_221,Applicability of national motorcycle helmet law to all road types,179.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=221
RS_222,Applicability of national motorcycle helmet law to all engine types,179.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=222
RS_223,Requirement of motorcycle helmet use to adhere to standard,179.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=223
RS_224,Motorcycle helmet wearing rate (%),179.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=224
RS_225,Existence of a road safety lead agency,179.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=225
RS_228,Existence of a national road safety strategy,179.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=228
RS_229,Availability of funding for national road safety strategy,179.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=229
RS_231,Existence of a national policy on walking and cycling,179.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=231
RS_232,Existence of a national policy on public transport,179.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=232
RS_233,Existence of road safety audit for all new roads,179.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=233
RS_234,Existence of road safety audit for existing roads,179.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=234
RS_236,Existence of mandatory vehicle insurance,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=236
RS_237,Existence of a formal pre-hospital care system,174.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=237
RS_205,Definition of drink-driving by BAC,179.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=205
RS_246,Distribution of road traffic deaths by type of road user (%),710.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=246
RS_207,Blood Alcohol Concentration (BAC) limit for drivers,358.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=207
RS_212,Seat-belt wearing rate (%),716.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=212
RS_219,Applicability of national motorcycle helmet law to all occupants,537.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=219
RS_235,Type of driving tests for new drivers,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=235
RS_238,Existence of a universal access telephone number for pre-hospital care,179.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=238
RS_217,Maximum speed limits,358.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=217
ATLAS_SU_0000000532,Government unit for treatment,0.0,
ATLAS_SU_0000000533,Government unit for alcohol and drugs: Location,0.0,
ATLAS_SU_0000000534,Government unit for alcohol: Location,0.0,
ATLAS_SU_0000000535,Government unit for drugs: Location,0.0,
ATLAS_SU_0000000536,No government unit,0.0,
ATLAS_SU_0000000537,Government unit for mental health/substance use: Location,0.0,
RS_576,Gross national income per capita (Atlas method),177.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3355
MDG_0000000029,Prevalence of HIV among adults aged 15 to 49 (%),783.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=334
TOBACCO_0000000502,Year of survey of adults,0.0,
TOBACCO_0000000503,Representativeness of survey of adults,0.0,
TOBACCO_0000000504,Repeating interval for survey of adults (years),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1320
TOBACCO_0000000505,Year of survey of youth,386.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=366
TOBACCO_0000000506,Representativeness of youth survey,386.0,
TOBACCO_0000000507,Repeating interval for survey of youth (years),386.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=368
TOBACCO_0000000508,Most sold brand of cigarettes - taxes as a % of price - value added tax,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1220
TOBACCO_0000000509,Most sold brand of cigarettes - taxes as a % of price - other taxes,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1228
MDG_0000000030,Smear-positive tuberculosis case-detection rate (%),363.0,
MDG_0000000031,Smear-positive tuberculosis treatment-success rate (%),3026.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=332
WHS5_512,Population using solid fuels (%),593.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=318
WHS2_513,Age-standardized mortality rate by cause (per 100 000 population) - Communicable,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=78
WHS2_514,Distribution of causes of death among children aged <5 years (%) - Prematurity,2192.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=89
WHS2_515,Distribution of causes of death among children aged <5 years (%) - Neonatal sepsis,2192.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=89
WHS2_516,Distribution of causes of death among children aged <5 years (%) - Congenital anomalies,2192.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=89
WHS6_517,Number of pharmaceutical personnel,250.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=319
WHS6_518,Number of environment and public health workers,107.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=321
WHS6_519,Density of pharmaceutical personnel (per 10 000 population),250.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=320
WHS6_520,Density of environment and public health workers (per 10 000 population),105.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=322
MDG_0000000032,Maternal mortality ratio (per 100 000 live births) - Country reported estimates,169.0,
WHS3_522,Number of reported cases of tuberculosis,12.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=333
WHS2_523,Distribution of causes of death among children aged <5 years (%) - Birth asphyxia,2192.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=89
TOBACCO_0000000524,Most sold brand of bidis - taxes as a % of price - value added tax,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1229
TOBACCO_0000000525,Most sold brand of bidis - taxes as a % of price - other taxes,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1230
NUTRITION_564,Children aged <5 years wasted for age (%),1898.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=302
NUTRITION_565,Prevalence of adults aged &#8805; 15 years who are pre-obese (%) (BMI 25.0-29.99),0.0,
NUTRITION_566,Prevalence of adults aged &#8805; 15 years who are overweight (%) (BMI ? 25.0),0.0,
NUTRITION_567,Prevalence of adults aged &#8805; 15 years who are in normal range (%) (BMI 18.5-24.99),0.0,
NUTRITION_568,Prevalence of adults aged &#8805; 15 years who are underweight (%) (BMI <18.5),0.0,
NUTRITION_569,Continued breastfeeding at 1 year (%),0.0,
NUTRITION_570,Early initiation of breastfeeding (%),129.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=337
NUTRITION_571,Exclusive breastfeeding under 4 months (%),0.0,
NUTRITION_573,Children ever breastfed (%),0.0,
NUTRITION_572,Continued breastfeeding at 2 years (%),0.0,
NUTRITION_574,Duration of any breastfeeding,0.0,
NUTRITION_575,Duration of exclusive breastfeeding,0.0,
NUTRITION_576,"Introduction of solid, semi-solid or soft foods and breast milk (%)",0.0,
NUTRITION_577,Bottle feeding rate 0-11.9 months (%),0.0,
NUTRITION_578,Bottle feeding rate 0-23.9 months (%),0.0,
NUTRITION_579,Exclusive breastfeeding under 6 months (%),253.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=130
WHS4_543,BCG immunization coverage among 1-year-olds (%),5807.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2442
WHS4_544,Polio (Pol3) immunization coverage among 1-year-olds (%),7045.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2443
SA_0000001398,"Alcohol, consumption of pure alcohol by type of beverage (%)",772.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=462
SA_0000001399,Consumption by type of alcoholic beverage - market share (%),0.0,
SA_0000001400,"Alcohol, recorded per capita (15+) consumption (in litres of pure alcohol)",44642.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=462
SA_0000001401,"Alcohol, recorded per capita (15+) consumption (in litres of pure alcohol), three-year average",394.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=462
SA_0000001402,"Alcohol, estimate of five-year change in recorded per capita (15+) consumption 2006-2010",194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=463
SA_0000001403,"Alcohol, total (recorded 3 year average + unrecorded) per capita (15+) consumption (in litres of pure alcohol)",777.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=465
SA_0000001404,"Alcohol, drinkers only (recorded 3 year average + unrecorded) per capita (15+)consumption in litres of pure alcohol",1356.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=464
SA_0000001405,"Alcohol, tourist consumption (in litres of pure alcohol)",196.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2322
SA_0000001406,"Alcohol, unrecorded per capita (15+) consumption (in litres of pure alcohol)",581.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=466
MDG_0000000033,Antiretroviral therapy coverage among people with HIV infection eligible for ART according to 2010 guidelines (%),194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=12
MDG_0000000034,"Antiretroviral therapy coverage among people with advanced HIV infection (%), WHO 2006 guidelines",114.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=12
SA_0000001409,"Alcohol, abstainers lifetime (%)",591.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=460
SA_0000001410,"Abstainers (15-19 years), lifetime (%)",139.0,
SA_0000001411,"Alcohol, abstainers past 12 months (%)",579.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=456
SA_0000001412,"Abstainers (15-19 years), past 12 months (%)",38.0,
SA_0000001413,"Alcohol, consumers past 12 months (%)",579.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2325
SA_0000001414,"Alcohol, former drinkers (%)",579.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=457
SA_0000001415,"Alcohol, heavy episodic drinking (population) past 30 days (%)",579.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=459
SA_0000001416,"Alcohol, heavy episodic drinking (drinkers only) past 30 days (%)",582.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=458
SA_0000001417,"Alcohol, patterns of drinking score",193.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=461
SA_0000001418,"Age-standardized DALYs, alcohol use disorders, per 100,000",573.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2377
SA_0000001419,"Age-standardized DALYs, breast cancer, per 100,000",447.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2377
SA_0000001420,"Age-standardized DALYs, colon and rectum cancers, per 100,000",573.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2377
SA_0000001421,"Age-standardized DALYs, diabetes mellitus, per 100,000",573.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2377
SA_0000001422,"Age-standardized DALYs, drownings, per 100,000",573.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2377
SA_0000001423,"Age-standardized DALYs, falls, per 100,000",573.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2377
SA_0000001424,"Age-standardized DALYs, fires, per 100,000",573.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2377
SA_0000001425,"Age-standardized DALYs, ischaemic heart disease, per 100,000",573.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2377
SA_0000001426,"Age-standardized DALYs, liver cancer, per 100,000",570.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2377
SA_0000001427,"Age-standardized DALYs, liver cirrhosis, per 100,000",570.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2377
SA_0000001428,"Age-standardized DALYs, maternal conditions, per 100,000",0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2377
SA_0000001429,"Age-standardized DALYs, mouth and oropharynx cancer, per 100,000",573.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2377
SA_0000001430,"Age-standardized DALYs, oesophagus cancer, per 100,000",570.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2377
SA_0000001431,"Age-standardized DALYs, poisoning, per 100,000",573.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2377
SA_0000001432,"Age-standardized DALYs, prematurity and low birth rate, per 100,000",573.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2377
SA_0000001433,"Age-standardized DALYs, road traffic accidents, per 100,000",573.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2377
SA_0000001434,"Age-standardized DALYs, self-inflicted injury, per 100,000",573.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2377
SA_0000001435,"Age-standardized DALYs, other unintentional injuries, per 100,000",573.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2377
SA_0000001436,"Age-standardized DALYs, violence, per 100,000",573.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2377
SA_0000001437,"Age-standardized death rates, alcohol use disorders, per 100,000",714.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2378
SA_0000001438,"Age-standardized death rates, breast cancer, per 100,000",765.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2378
SA_0000001439,"Age-standardized death rates, colon and rectum cancers, per 100,000",762.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2378
SA_0000001440,"Age-standardized death rates, diabetes mellitus, per 100,000",573.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2378
SA_0000001441,"Age-standardized death rates, drownings, per 100,000",765.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2378
SA_0000001442,"Age-standardized death rates, falls, per 100,000",756.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2378
SA_0000001443,"Age-standardized death rates, fires, per 100,000",744.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2378
SA_0000001444,"Age-standardized death rates, ischaemic heart disease, per 100,000",573.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2378
SA_0000001445,"Age-standardized death rates, liver cancer, per 100,000",762.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2378
SA_0000001446,"Age-standardized death rates, liver cirrhosis, per 100,000",761.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2378
SA_0000001447,"Age-standardized death rates, maternal conditions, per 100,000",0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2378
SA_0000001448,"Age-standardized death rates, mouth and oropharynx cancer, per 100,000",763.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2378
SA_0000001449,"Age-standardized death rates, oesophagus cancer, per 100,000",758.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2378
SA_0000001450,"Age-standardized death rates, poisoning, per 100,000",731.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2378
SA_0000001451,"Age-standardized death rates, prematurity and low birth rate, per 100,000",558.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2378
SA_0000001452,"Age-standardized death rates, road traffic accidents, per 100,000",765.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2378
SA_0000001453,"Age-standardized death rates, self-inflicted injury, per 100,000",755.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2378
SA_0000001454,"Age-standardized death rates, other unintentional injuries, per 100,000",573.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2378
SA_0000001455,"Age-standardized death rates, violence, per 100,000",765.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2378
SA_0000001456,"Age-standardized death rates (15+ years), alcoholic liver disease, per 100,000",804.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1413
SA_0000001457,"Liver cirrhosis, age-standardized death rates (15+), per 100,000 population",1375.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1413
SA_0000001458,"Age-standardized death rates (15+ years), poisoning, per 100,000",1026.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1413
SA_0000001459,"Road traffic crashes, age-standardized death rates (15+), per 100,000 population",388.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1413
SA_0000001460,"Age-standardized death rates (15+ years), violence, per 100,000",1029.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1413
SA_0000001461,"Alcohol dependence (15+ ), 12-month prevalence (%) with 95%CI",579.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1389
SA_0000001462,"Alcohol use disorders (15+), 12 month prevalence (%) with 95%",579.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1388
SA_0000001463,"Alcoholic psychosis, incidence, per 100,000",331.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2328
SA_0000001464,"Cautions and arrests for drink-driving, per 100,000 population",480.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2329
SA_0000001465,"Hospital discharges, alcohol-related injuries and poisoning, per 100,000",321.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2330
SA_0000001466,"Hospital discharges, alcoholic liver disease, per 100,000",221.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2331
SA_0000001467,Perceived trend in alcohol-related harm and consequences,275.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2376
SA_0000001468,"Treatment admissions (inpatient), alcohol dependence, per 100,000",76.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2332
SA_0000001469,"Treatment admissions (inpatient), alcoholic psychosis, per 100,000",198.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2333
SA_0000001470,"Alcohol-related road traffic crashes, per 100,000 population",1033.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2334
SA_0000001471,Alcohol-related road traffic crashes (% of all traffic crashes),640.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2335
SA_0000001472,"Alcohol-related injury mortality, per 1,000",154.0,
SA_0000001473,"Alcohol-related disease mortality, per 100,000 (15+ years)",358.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2337
SA_0000001474,Alcoholic excise tax revenue as a per cent of government revenue,299.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2338
SA_0000001475,Annual revenues from alcohol excise tax in millions US$,655.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2316
SA_0000001476,Alcohol expenditure as a per cent of total household expenditure,477.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2339
SA_0000001477,Social costs of alcohol use in millions US$,54.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1394
HIV_0000000001,Estimated number of people (all ages) living with HIV,201.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2921
HIV_0000000002,Number of adults aged 15 and over living with HIV,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2921
HIV_0000000003,Number of women aged 15 and over living with HIV,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2921
HIV_0000000004,Number of children under 15 living with HIV,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2921
HIV_0000000005,HIV prevalence rate among adults (15-49),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=86
HIV_0000000006,Number of deaths due to HIV/AIDS,783.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2922
HIV_0000000007,"Testing and counselling facilities, reported number",144.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2925
HIV_0000000008,"Testing and counselling facilities, estimated number per 100 000 adult population",144.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2926
HIV_0000000009,Reported number of people receiving antiretroviral therapy,175.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2924
HIV_0000000010,"Reported number of people receiving antiretroviral therapy, month and year of report",0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2924
HIV_0000000011,Reported number of children receiving antiretroviral therapy,196.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2924
HIV_0000000012,"Reported number of children receiving antiretroviral therapy, month and year of report",290.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2924
HIV_0000000013,"Pregnant women tested for HIV, reported number",0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2927
HIV_0000000014,"Pregnant women tested for HIV, estimated coverage (%)",0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2929
HIV_0000000015,Number of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission,168.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2936
HIV_0000000016,"Number of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission, reporting period",0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2936
HIV_0000000017,"Number of people aged 15 years and over who received HIV testing and counselling, reported number",144.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2930
HIV_0000000018,"People aged 15 years and over who received HIV testing and counselling, estimated number per 1000 adult population",146.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2931
HIV_0000000019,"Number of people aged 15 years and over who received HIV testing and counselling, reporting period",144.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2931
HIV_0000000020,Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission,168.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4754
HIV_0000000021,Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods,168.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2933
HIV_0000000022,Estimated number of people eligible for antiretroviral therapy according to 2010 guidelines,194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2934
HIV_0000000023,Estimated number of children needing antiretroviral therapy based on WHO methods,196.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2935
HIV_0000000024,Estimated antiretroviral therapy coverage among children,196.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2966
SA_0000001502,Adopted written national policy on alcohol,197.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1396
SA_0000001503,Alcoholic beverage legally defined,194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2340
SA_0000001504,Alcohol use is banned,193.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1395
SA_0000001505,Surrogate alcohol consumption is a problem,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2342
SA_0000001506,National legislation to prevent illegal alcohol,388.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2341
NUTRITION_0,Prevalence of adults aged &#8805; 15 years who are moderately and severely thin (BMI <17.0),0.0,
NUTRITION_1,Prevalence of adults aged &#8805; 15 years who are severely thin (BMI <16.0),0.0,
NUTRITION_2,Prevalence of adults aged &#8805; 15 years who are mildly thin (BMI 17.0-18.49),0.0,
NUTRITION_3,Prevalence of adults aged &#8805; 15 years who are moderately thin (BMI 16.0-16.99),0.0,
LEAD_1,Percentage of the children under 15 years with blood lead levels above 5ug/dl,8.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1351
LEAD_2,Percentage of the children under 15 years with blood lead levels above 10ug/dl,8.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1351
LEAD_3,Percentage of the adults (15+ years) with blood lead levels above 5ug/dl,8.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1351
LEAD_4,Percentage of the adults (15+ years) with blood lead levels above 10ug/dl,8.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1351
LEAD_5,Lead attributable deaths,8.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2263
LEAD_6,Lead attributable DALYs ('000),8.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2263
LEAD_7,Lead attributable deaths per 100'000 capita,8.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2263
LEAD_8,Lead attributable DALYs per 100'000 capita,8.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2263
LEAD_9,Lead attributable DALYs ('000) in children under 5 years,8.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2263
LEAD_10,Lead attributable DALYs per 100'000 children under 5 years,8.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2263
SHS_1,Percentage of children under 15 years exposed to second-hand smoke,8.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2265
SHS_2,Percentage of women (15+ years) exposed to second-hand smoke,8.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2266
SHS_3,Percentage of men (15+ years) exposed to second-hand smoke,8.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2266
SHS_4,Second-hand smoke attributable deaths,8.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2266
SHS_5,Second-hand smoke attributable DALYs ('000),8.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2266
SHS_6,Second-hand smoke attributable deaths per 100'000 capita,8.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2266
SHS_7,Second-hand smoke attributable DALYs per 100'000 capita,8.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2266
SHS_8,Second-hand smoke attributable deaths ('000) in children under 5 years,8.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2266
SHS_9,Second-hand smoke  attributable deaths per 100'000 children under 5 years,8.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2266
SHS_10,Second-hand smoke attributable DALYs ('000) in children under 5 years,8.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2266
SHS_11,Second-hand smoke  attributable DALYs per 100'000 children under 5 years,8.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2266
WSH_1,"Water, sanitation and hygiene attributable deaths",165.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2260
WSH_2,"Water, sanitation and hygiene attributable deaths ('000) in children under 5 years",165.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2260
WSH_3,"Water, sanitation and hygiene attributable deaths per 100'000 capita",165.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2260
WSH_4,"Water, sanitation and hygiene  attributable deaths per 100'000 children under 5 years",165.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2260
WSH_5,"Water, sanitation and hygiene attributable DALYs ('000)",165.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2260
WSH_6,"Water, sanitation and hygiene attributable DALYs ('000) in children under 5 years",165.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2260
WSH_7,"Water, sanitation and hygiene attributable DALYs per 100'000 capita",165.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2260
WSH_8,"Water, sanitation and hygiene  attributable DALYs per 100'000 children under 5 years",165.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2260
AIR_1,Ambient air pollution attributable deaths,372.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2259
AIR_2,Ambient air pollution (Annual PM10 [ug/m3]),177.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1349
AIR_3,Percentage of the total population living in cities > 100'000 inhabitants,173.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2259
AIR_4,Ambient air pollution attributable deaths in children under 5 years,372.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2259
AIR_5,Ambient air pollution attributable deaths (per 100 000 population),194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2259
AIR_6,Ambient air pollution  attributable deaths per 100'000 children under 5 years,371.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2259
AIR_7,Ambient air pollution attributable DALYs ('000),173.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2259
AIR_8,Ambient air pollution attributable DALYs  in children under 5 years,173.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2259
AIR_9,Ambient air pollution attributable DALYs  (per 100 000 population),194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2259
AIR_10,Ambient air pollution  attributable DALYs per 100'000 children under 5 years,173.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2259
AIR_11,Household air pollution attributable deaths,1822.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2256
AIR_12,Household air pollution attributable deaths in children under 5 years,199.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2256
AIR_13,Household air pollution attributable deaths per 100'000 capita,199.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2256
AIR_14,Household air pollution  attributable deaths per 100'000 children under 5 years,199.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2256
AIR_15,Household air pollution attributable DALYs,191.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4491
AIR_16,Household air pollution attributable DALYs in children under 5 years,191.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2256
AIR_17,Household air pollution attributable DALYs (per 100 000 population),191.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4491
AIR_18,Household air pollution  attributable DALYs per 100'000 children under 5 years,191.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4491
AIR_19,Population using electricity as main cooking fuel (%),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2267
TB_1,Tuberculosis treatment coverage,3462.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1422
MENING_1,Number of suspected meningitis deaths reported,887.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2478
MENING_2,Number of suspected meningitis cases reported,97.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=49
TB_e_mort_exc_tbhiv_num,"Number of deaths due to tuberculosis, excluding HIV",3462.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1425
TB_e_prev_num,Number of prevalent tuberculosis cases,5062.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1472
TB_e_inc_num,Number of incident tuberculosis cases,3462.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1426
TB_e_inc_tbhiv_100k,Incidence of tuberculosis (per 100 000 population) (HIV-positive cases),3462.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=20
TB_e_inc_tbhiv_num,"Number of incident tuberculosis cases,  (HIV-positive cases)",3462.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1426
AIR_20,Population using LPG as main cooking fuel (%),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2267
AIR_21,Population using natural gas as main cooking fuel (%),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2267
AIR_22,Population using biogas as main cooking fuel (%),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2267
AIR_23,Population using kerosene as main cooking fuel (%),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2267
AIR_24,Population using clean fuels and technologies (sum of)(%),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2267
AIR_25,Population using coal as main cooking fuel (%),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2267
AIR_26,Population using charcoal as main cooking fuel (%),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2267
AIR_27,Population using wood as main cooking fuel (%),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2267
AIR_28,Population using dung as main cooking fuel (%),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2267
AIR_29,Population using crop waste as main cooking fuel (%),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2267
AIR_30,Population using solid fuels (sum of) (%),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2267
AIR_31,Population using others (non listed items) as main cooking fuel (%),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2267
AIR_32,Population not cooking (%),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2267
AIR_33,Missing information on cooking fuels (%),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2267
AIR_34,Total survey respondents,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2267
TB_tot_newrel,Tuberculosis - new and relapse cases,4236.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=333
TB_8_c_cdr,Case detection rate for all forms of tuberculosis,0.0,
SA_0000001507,Advertising restrictions on national television,579.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1408
SA_0000001508,Advertising restrictions on cable television,579.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1408
SA_0000001509,Advertising restrictions on national radio,579.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1408
SA_0000001510,Advertising restrictions on local radio,579.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1408
SA_0000001511,Advertising restrictions in print media,579.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1408
SA_0000001512,Advertising restrictions at cinemas,579.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1408
SA_0000001513,Advertising restrictions on billboards,579.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1408
SA_0000001514,Advertising restrictions at point-of-sale,579.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1408
SA_0000001515,Advertising restrictions on the internet,579.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1408
SA_0000001516,Restrictions on product placement on national television,579.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1409
SA_0000001517,Restrictions on product placement on cable television,579.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1409
SA_0000001518,Age limits on-premise service,579.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1400
SA_0000001519,Minimum legal drinking age,74.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2343
SA_0000001520,Legal blood alcohol concentration (BAC) limits,582.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1407
SA_0000001521,Random breath testing (RBT) use,193.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2344
SA_0000001522,Mandatory driver education for habitual offenders,0.0,
SA_0000001523,"Prices for alcoholic beverages (average, US$)",757.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2317
SA_0000001524,Trend in real price of alcoholic beverages relative to CPI over the past five years,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2346
SA_0000001525,Off-premise sales restrictions on days,579.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1402
SA_0000001526,Off-premise sales restrictions on hours,579.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1402
SA_0000001527,Off-premise sales restrictions on places,579.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1403
SA_0000001528,Off-premise sales restrictions on outlet density,579.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1403
SA_0000001529,Off-premise sales restrictions at specific events,579.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1404
SA_0000001530,Off-premise sales restrictions at petrol stations,579.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1406
SA_0000001531,On-premise sales restrictions on days,579.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1402
SA_0000001532,On-premise sales restrictions on hours,579.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1402
SA_0000001533,On-premise sales restrictions on places,579.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1403
SA_0000001534,On-premise sales restrictions on outlet density,579.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1403
SA_0000001535,On-premise sales restrictions at specific events,579.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1404
SA_0000001536,On-premise sales restrictions to intoxicated persons,579.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1405
SA_0000001537,Restrictions on sponsorship of sporting events,579.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1410
SA_0000001538,Restrictions on sponsorship of youth events,579.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1410
SA_0000001539,"Restrictions on sales promotion from producers (parties, events)",579.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1411
SA_0000001540,Restrictions on sales promotion from retailers (sales below cost),579.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1411
SA_0000001541,Restrictions on sales promotion from owners of pubs and bars (alcohol for free),579.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1411
SA_0000001542,Government monopoly on production,582.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1397
SA_0000001543,Government monopoly on retail sales,582.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1397
SA_0000001544,Licence required for production,582.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1398
SA_0000001545,Licence required for retail sales,582.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1398
SA_0000001546,Excise tax as a per cent of the retail price of alcoholic beverages,579.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2347
SA_0000001547,Excise duty (average) per hectolitre in Euros,571.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2318
SA_0000001548,Excise tax as a per cent of the total retail price for 1 litre of pure alcohol,74.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2348
SA_0000001549,Duty paid or excise stamp on alcohol container,580.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2349
SA_0000001550,Excise tax on alcoholic beverages,580.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1399
SA_0000001551,Value-added tax (VAT) on alcohol (%),193.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2350
SA_0000001552,"Value-added tax (VAT), (%)",0.0,
SA_0000001553,Restrictions on alcohol use in public places,1777.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2352
SA_0000001554,Health warning labels on alcohol advertising,192.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2353
SA_0000001555,Health warning labels on alcohol containers,192.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2354
SA_0000001651,Monitoring,157.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2362
SA_0000001653,"Treatment, services",153.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1412
SA_0000001652,"Interventions, projects, training",27.0,
SA_0000001647,Awareness activities,1807.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2355
SA_0000001648,"Information, education, prevention",27.0,
SA_0000001650,"Standard drink measures, in grams per unit",33.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2361
SA_0000001649,National drinking guidelines,33.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2358
SA_0000001676,Production in 1000s hectolitres,1832.0,
SA_0000001677,Imports in 1000s hectolitres,1512.0,
SA_0000001678,Sales of beer in 1000s hectolitres,1813.0,
SA_0000001679,Exports of beer (barley) in 1000s hectolitres,1626.0,
SA_0000001680,Perceived trend in production,83.0,
SA_0000001681,Perceived trend in imports,114.0,
SA_0000001682,Perceived trend in sales,91.0,
SA_0000001683,Perceived trend in exports,63.0,
SA_0000001654,"Surveys, research",26.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2366
SA_0000001655,Counselling,27.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2371
SA_0000001684,Sales of wine in 1000s hectolitres,623.0,
SA_0000001685,Sales of spirits in 1000s hectolitres,198.0,
SA_0000001686,Exports of wine (grape) in 1000s hectolitres,1283.0,
SA_0000001687,Exports of spirits in 1000s hectolitres,1178.0,
TB_new_sp,"New cases: Pulmonary, smear-positive",3462.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=333
TB_new_sn,New cases: pulmonary smear-negative,3246.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=333
TB_new_su,New cases: pulmonary smear unknown/not done,2557.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=333
TB_new_ep,New cases: extrapulmonary,3462.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=333
TB_new_oth,New cases: other,1236.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=333
TB_ret_rel,Relapse cases (pre-2013 definition),3462.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=333
TB_ret_taf,Retreatment cases: treatment after failure (pulmonary smear and/or culture positive),2011.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=333
TB_ret_tad,Retreatment cases: treatment after default (pulmonary smear and/or culture positive),2024.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=333
TB_ret_oth,Retreatment cases: other,2036.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=333
TB_newret_oth,Treatment history unknown,3462.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=333
MORT_100,Number of deaths,5.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3365
MORT_200,Deaths per 1 000 live births,5.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3366
MORT_300,Distribution of causes of death among children aged < 5 years (%),5.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=89
TB_c_lab_sm_100k,Laboratories providing tuberculosis diagnostic services using sputum smear microscopy (per 100 000 population),1572.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1369
TB_c_lab_cul_5m,Laboratories providing tuberculosis diagnostic services using culture (per 5 million population),1556.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1370
TB_c_lab_dst_5m,Laboratories providing drug susceptibility testing (DST) (per 5 million population),1548.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid= 2715
TB_sldst_avail,Second-line drug susceptibility testing (DST) available,1414.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1372
TB_nrl,National Reference Laboratory (NRL),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1373
TB_r_rgmn_new_initcont,Rifampicin used throughout treatment,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1357
TB_fdc_pcnt,% of patients treated with fixed-dose combinations (FDCs),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1358
TB_paed_form,Paediatric formulations procured for TB patients,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1359
TB_c_new_snep_tsr,Treatment success rate for new pulmonary smear-negative and extrapulmonary tuberculosis cases,1133.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1360
TB_c_ret_tsr,Treatment success rate: previously treated TB cases,4263.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4462
NCD_BMI_25A,"Prevalence of overweight among adults, BMI &GreaterEqual; 25 (age-standardized estimate) (%)",26116.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2390
NCD_BMI_25C,"Prevalence of overweight among adults, BMI &GreaterEqual; 25 (crude estimate) (%)",25956.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2390
NCD_BMI_30A,"Prevalence of obesity among adults, BMI &GreaterEqual; 30 (age-standardized estimate) (%)",26116.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2389
NCD_BMI_30C,"Prevalence of obesity among adults, BMI &GreaterEqual; 30 (crude estimate) (%)",25956.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2389
NCD_BMI_MEAN,Mean BMI (kg/m&#xb2;) (age-standardized estimate),26116.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2388
NCD_PAA,Insufficiently active (age-standardized estimate),612.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2381
NCD_PAC,Insufficiently active (crude estimate),615.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2381
CC_1,Climate change attributable deaths,8.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2391
CC_2,Climate change attributable DALYs ('000),8.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2391
CC_3,Climate change attributable deaths per 100'000 capita,8.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2391
CC_4,Climate change attributable DALYs per 100'000 capita,8.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2391
CC_5,Climate change attributable deaths ('000) in children under 5 years,8.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2391
CC_6,Climate change  attributable deaths per 100'000 children under 5 years,8.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2391
CC_7,Climate change attributable DALYs ('000) in children under 5 years,8.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2391
CC_8,Climate change  attributable DALYs per 100'000 children under 5 years,8.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2391
OCC_1,Occupational risk factors attributable deaths,8.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2392
OCC_2,Occupational risk factors attributable DALYs ('000),8.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2392
OCC_3,Occupational risk factors attributable deaths per 100'000 capita,8.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2392
OCC_4,Occupational risk factors attributable DALYs per 100'000 capita,8.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2392
TOTENV_1,Deaths attributable to the environment,1469.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4653
TOTENV_2,Age-standardized deaths attributable to the environment (per 100 000 population),776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4656
TOTENV_3,Disability-adjusted life years (DALYs) attributable to the environment,1459.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4654
TOTENV_4,Age-standardized DALYs attributable to the environment (per 100 000 population),776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4658
TOTENV_5,Deaths attributable to the environment (%),205.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4655
TOTENV_6,Disability-adjusted life years (DALYs) attributable to the environment (%),205.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4657
TOTENV_7,Total environment attributable deaths ('000) in children under 5 years,15.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2393
TOTENV_8,Total environment  attributable deaths per 100'000 children under 5 years,15.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2393
TOTENV_9,Total environment attributable DALYs ('000) in children under 5 years,15.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2393
TOTENV_10,Total environment  attributable DALYs per 100'000 children under 5 years,15.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2393
TOTENV_11,Deaths attributable to the environment in children under 5 years (%),15.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2393
TOTENV_12,DALYs attributable to the environment in children under 5 years (%),15.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2393
UV_1,UV radiation,191.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2395
UV_2,UV radiation attributable deaths,190.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2394
UV_3,UV radiation attributable DALYs ('000),190.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2394
UV_4,UV radiation attributable deaths per 100'000 capita,190.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2394
UV_5,UV radiation attributable DALYs per 100'000 capita,190.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2394
NCD_CCS_NCDUnit,"Existence of Unit, Branch, or Dept. in Ministry of Health with responsibility for NCDs",0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2396
NCD_CCS_CVDPlan,Existence of operational policy/strategy/action plan for cardiovascular diseases,582.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2397
NCD_CCS_CancerPlan,Existence of operational policy/strategy/action plan for cancer,582.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2398
NCD_CCS_DiabPlan,Existence of operational policy/strategy/action plan for diabetes,582.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2399
NCD_CCS_CRDPlan,Existence of operational policy/strategy/action plan for chronic respiratory diseases,582.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2400
NCD_CCS_AlcPlan,Existence of operational policy/strategy/action plan to reduce the harmful use of alcohol,582.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2401
NCD_CCS_DietPlan,Existence of operational policy/strategy/action plan to reduce unhealthy diet related to NCDs,582.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2402
NCD_CCS_PAPlan,Existence of operational policy/strategy/action plan to reduce physical inactivity,582.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2403
NCD_CCS_TobPlan,Existence of operational policy/strategy/action plan to decrease tobacco use,582.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2404
NCD_CCS_CancerReg,Existence and scope of cancer registry,0.0,
NCD_CCS_RFSurv,"Existence of risk factor surveillance for selected risk factors (harmful alcohol use, diet, physical inactivity, and tobacco use)",0.0,
NCD_CCS_DiabGuide,Availability and stage of implementation of guidelines/protocols/standards for the management of diabetes,0.0,
NCD_CCS_HypGuide,Availability and stage of implementation of guidelines/protocols/standards for the management of raised blood pressure / hypertension,0.0,
NCD_CCS_CervCy,General availability of cervical cytology at the primary health care level,194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2409
NCD_CCS_AceticAcid,General availability of acetic acid visualization at the primary health care level,0.0,
NCD_CCS_BowelCancer,General availability of colon cancer screening at the primary health care level,194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2411
NCD_CCS_BreastCancer,General availability of breast cancer screening (by palpation or mammogram) at the primary health care level,194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2412
NCD_CCS_DiabetesTest,"General availability of diabetes testing (by blood glucose measurement, OGTT, or HbA1c) at the primary health care level",194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2413
NCD_CCS_Electrocard,General availability of electrocardiogram at the primary health care level,0.0,
NCD_CCS_CholMsmt,General availability of total cholesterol measurement at the primary health care level,582.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2415
NCD_CCS_Spirom,General availability of peak flow measurement spirometry at the primary health care level,582.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2416
NCD_CCS_Insulin,General availability of insulin in the public health sector,582.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2417
NCD_CCS_Aspirin,General availability of aspirin (100 mg) in the public health sector,582.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2418
NCD_CCS_Metformin,General availability of metformin in the public health sector,582.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2419
NCD_CCS_Gliben,General availability of glibenclamide in the public health sector,0.0,
NCD_CCS_Thiazide,General availability of thiazide diuretics in the public health sector,582.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2421
NCD_CCS_ACE,General availability of ACE inhibitors in the public health sector,582.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2422
NCD_CCS_CCBlkrs,General availability of CC blockers in the public health sector,582.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2423
NCD_CCS_BetaBlkrs,General availability of beta blockers in the public health sector,0.0,
NCD_CCS_Tamox,General availability of tamoxifen in the public health sector,0.0,
NCD_CCS_Statins,General availability of statins in the public health sector,582.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2426
NCD_CCS_OralMorph,General availability of oral morphine in the public health sector,582.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2427
NCD_CCS_Nicotine,General availability of nicotine replacement therapy in the public health sector,388.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2428
NCD_CCS_Salb,General availability of salbutamol in the public health sector,0.0,
NCD_CCS_Prednis,General availability of prednisolone tabs in the public health sector,0.0,
NCD_CCS_Steroid,General availability of steroid inhalers in the public health sector,582.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2431
NCD_CCS_Hydrocort,General availability of hydrocortisone injections in the public health sector,0.0,
NCD_CCS_Ipratro,General availability of ipratropium bromide in the public health sector,0.0,
NCD_CCS_RetinalPho,General availability of retinal photocoagulation in the public health system,0.0,
NCD_CCS_RenalTherapy,General availability of renal replacement therapy (by dialysis or transplantation) in the public health system,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2435
NCD_CCS_RadioTherapy,General availability of radiotherapy in the public health system,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2436
NCD_CCS_Chemo,General availability of chemotherapy in the public health system,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2437
NCD_CCS_Collab,Existence of partnerships/collaborations for implementing key activities related to NCDs,0.0,
NCD_CCS_Taxes,Implementation of fiscal interventions to influence behaviour change,0.0,
NCD_CCS_Earmarking,Earmarking of taxes from fiscal interventions to influence behaviour change used to fund health promotion programmes or a health promotion foundation,0.0,
OCC_5,Occupational airborne particulates attributable deaths,8.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2392
OCC_6,Occupational airborne particulates attributable DALYs ('000),8.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2392
OCC_7,Occupational airborne particulates attributable deaths per 100'000 capita,8.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2392
OCC_8,Occupational airborne particulates attributable DALYs per 100'000 capita,8.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2392
OCC_9,Occupational carcinogens attributable deaths,8.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2392
OCC_10,Occupational carcinogens attributable DALYs ('000),8.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2392
OCC_11,Occupational carcinogens attributable deaths per 100'000 capita,8.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2392
OCC_12,Occupational carcinogens attributable DALYs per 100'000 capita,8.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2392
OCC_13,Occupational noise attributable DALYs ('000),8.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2392
OCC_14,Occupational noise attributable DALYs per 100'000 capita,8.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2392
OCC_15,Occupational ergonomic stressors attributable deaths,8.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2392
OCC_16,Occupational ergonomic stressors attributable DALYs ('000),8.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2392
OCC_17,Occupational ergonomic stressors attributable deaths per 100'000 capita,8.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2392
OCC_18,Occupational ergonomic stressors attributable DALYs per 100'000 capita,8.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2392
OCC_19,Occupational injuries attributable deaths,8.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2392
OCC_20,Occupational injuries attributable DALYs ('000),8.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2392
OCC_21,Occupational injuries attributable deaths per 100'000 capita,8.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2392
OCC_22,Occupational injuries attributable DALYs per 100'000 capita,8.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2392
HRH_01,Number of nursing personnel,1658.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=102
HRH_02,Number of physicians,1911.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=104
HRH_03,Number of midwifery personnel,1015.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=102
HRH_04,Number of pharmacists,1431.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=319
HRH_05,Number of pharmaceutical technicians/assistants,218.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=319
HRH_06,Number of community health workers,155.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=100
HRH_07,Number of traditional birth attendants,37.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=102
HRH_08,Number of radiographers,583.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=103
HRH_09,Number of other health workers,411.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=103
HRH_10,Number of dental technicians/assistants,225.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=101
HRH_11,Number of health management & support workers,249.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4545
HRH_12,Number of environment and public health workers,287.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=321
HRH_13,Number of laboratory scientists,149.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=103
HRH_14,Number of laboratory technicians/assistants,283.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=103
HRH_15,Number of dentists,1606.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=101
HRH_16,Number of traditional medicine practitioners,56.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=100
HRH_17,Number of medical assistants,380.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4547
HRH_18,Number of personal care workers,176.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4546
HRH_19,Number of pharmaceutical personnel,1136.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=319
HRH_20,Number of laboratory health workers,372.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4544
HRH_21,Number of dentistry personnel,1282.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=103
HRH_22,Number of community and traditional health workers,191.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4548
HRH_23,Number of other health workers,908.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=103
HRH_24,Number of nursing and midwifery personnel,1451.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=102
HRH_25,Pharmaceutical personnel density (per 1000 population),1042.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=320
HRH_26,Physicians density (per 1000 population),1386.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=112
HRH_27,Laboratory health workers density (per 1000 population),369.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4549
HRH_28,Dentistry personnel density (per 1000 population),1177.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=87
HRH_29,Community and traditional health workers density (per 1000 population),186.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4551
HRH_30,Other health workers density (per 1000 population),860.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=106
HRH_31,Environmental and public health workers density (per 1000 population),283.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=322
HRH_32,Health management & support workers density (per 1000 population),237.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4550
HRH_33,Nursing and midwifery personnel density (per 1000 population),1292.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=105
BP_01,Raised blood pressure (SBP>=140 OR DBP>=90 OR on medication) (crude estimate),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2385
BP_02,Raised blood pressure (SBP>=140 OR DBP>=90 OR on medication) (age-standardized estimate),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2385
BP_03,Raised blood pressure (SBP>=140 OR DBP>=90) (crude estimate),25338.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2386
BP_04,Raised blood pressure (SBP>=140 OR DBP>=90) (age-standardized estimate),25338.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2386
BP_05,Mean systolic blood pressure (crude estimate),11580.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2387
BP_06,Mean systolic blood pressure (age-standardized estimate),16072.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2387
CHOL_01,Raised total cholesterol (>= 5.0 mmol/L) (crude estimate),612.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2382
CHOL_02,Raised total cholesterol (>= 5.0 mmol/L) (age-standardized estimate),612.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2382
CHOL_03,Mean Total Cholesterol (age-standardized estimate),11582.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2384
CHOL_04,Mean Total Cholesterol (crude estimate),11580.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2384
RS_1845,Population,181.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3359
NCD_DTH_TOT,Total NCD Deaths (in thousands),2884.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=36
NCD_DTH_PER,"All NCDs, deaths per 100,000 (age-standardized estimate)",0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=36
NCD_CA,"Cancers, deaths per 100,000 (age-standardized estimate)",0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=36
NCD_CHRON,"Chronic respiratory diseases, deaths per 100,000 (age-standardized estimate)",0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=36
NCD_CARDIO,"Cardiovascular diseases and diabetes, deaths per 100,000 (age-standardized estimate)",0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=36
NCD_UNDER70,NCD deaths under age 70 (percent of all NCD deaths),2196.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4731
CHOL_05,Raised total cholesterol (&#8805; 6.2 mmol/L) (age-standardized estimate),612.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2383
CHOL_06,Raised total cholesterol (&#8805; 6.2 mmol/L) (crude estimate),612.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2383
WHOSIS_000014,Stillbirth rate (per 1000 total births),194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2444
NCD_GLUC_01,Mean fasting blood glucose (mmol/l) (age-standardized estimate),11582.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2380
NCD_GLUC_02,Mean fasting blood glucose (mmol/l) (crude estimate),11580.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2380
NCD_GLUC_03,Raised fasting blood glucose (>= 7.0 mmol/L or on medication) (crude estimate),21642.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2379
NCD_GLUC_04,Raised fasting blood glucose (>=7.0 mmol/L or on medication)(age-standardized estimate),21630.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2379
WHS6_100,Radiotherapy units (per 1 000 000 population),175.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2441
NCD_BMI_MEANC,Mean BMI (kg/m&#xb2;) (crude estimate),5.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2388
NTD_1,Number of new reported cases of Buruli ulcer,495.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2448
NTD_2,Dracunculiasis certification status of countries at the beginning of the year,194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2468
NTD_3,Annual incidence of dracunculiasis cases,4107.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2464
NTD_4,Number of new reported cases of human African trypanosomiasis (T.b. gambiense),648.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2466
NTD_5,Number of new reported cases of human African trypanosomiasis (T.b. rhodesiense),351.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2447
EQ_ANC,Coverage of antenatal care (4 visits),2446.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4434
EQ_DTP3,Coverage of DTP3 immunization,2827.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4432
EQ_KNHIV,Knowlege about sexual transmission of AIDS,4190.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4441
EQ_HIVPREV,HIV prevalence,314.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4444
EQ_INFANTMORT,Infant mortality per 1 000 live births,1978.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4716
EQ_MEAIMM,Coverage of measles immunization,2826.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4433
EQ_BMI30,Prevalence of obesity,1802.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4442
EQ_SBA,Coverage of skilled birth attendance,2881.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4714
EQ_STUNT,Prevalence of (moderate or severe) stunting in children,2180.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4712
EQ_TOBACCO,Prevalence of current cigarette smoking,2166.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4436
EQ_U5MORT,Under-five mortality per 1 000 live births,1978.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4717
EQ_URBPOP,Population living in urban areas (%),2101.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4455
EQ_WATER,Population using improved drinking-water sources (%),300.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=8
NTD_6,Status of elimination of trachoma as a public health problem,194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2470
NTD_7,"Population in areas that warrant treatment with antibiotics, facial cleanliness and environmental improvement for elimination of trachoma as a public health problem",330.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2471
NTD_8,Number of people who received treatment with antibiotics for trachoma,813.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2469
MENING_3,Number of meningitis epidemic districts,162.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2475
SA_0000001688,Total (recorded+unrecorded) alcohol per capita (15+) consumption,237.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4759
EQ_URBSLUM,Slum population in urban areas (% of total population),189.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2476
MDG_0000000005_AGE1519,"Contraceptive prevalence, among girls aged 15-19 (%)",89.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid= 2481
MDG_0000000006_AGE1519,"Unmet need for family planning, among girls aged 15-19 (%)",79.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2480
MDG_0000000025_AGE1519,"Births attended by skilled health personnel, among girls aged 15-19 (%)",84.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=25
WHS4_111_AGE1519,"Antenatal care coverage - at least one visit, among girls aged 15-19 (%)",86.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2479
HWWS_2,Handwashing with soap after cleaning child's stool (%),6.0,
HWWS_1,Handwashing with soap after using the toilet (%),9.0,
RSUD_1,"Point prevalence (%), alcohol use disorders, 15+ years",382.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2497
RSUD_2,"Point prevalence (%), drug use disorders, 15+ years",382.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2498
RSUD_3,"Age-standardized death rates, alcohol and drug use disorders, per 100 000",364.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2500
RSUD_4,"Age-standardized death rates, drug use disorders, per 100 000",0.0,
RSUD_5,"Age-standardized DALYs, alcohol and drug use disorders, per 100 000",382.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2502
RSUD_6,"Age-standardized DALYs, drug use disorders, per 100 000",0.0,
RSUD_7,Psychoactive substance causing entry into treatment,88.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2503
SA_0000001689,"Age-standardized DALYs, cerebrovascular disease, per 100,000",573.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2377
SA_0000001690,"Age-standardized death rates, cerebrovascular disease, per 100,000",573.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2378
RSUD_8,Epidemiological data collection system for substance use disorders,287.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2504
RSUD_9,Service delivery data collection system for substance use disorders,284.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2505
RSUD_10,National survey on substance use among children and adolescents,289.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2506
RSUD_11,Data on substance use disorders disseminated in national annual reports,286.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2507
RSUD_12,Substance use policy at the national level,145.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2508
RSUD_13,"Substance use policy at the national level, level of integration",145.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2509
RSUD_14,Policy documents on the pharmacological treatment of substance use disorders,140.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2510
RSUD_15,Guidelines on the pharmacological treatment of substance use disorders,139.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2511
RSUD_16,Legislative provision for treatment and rehabilitation of substance use disorders,143.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2512
RSUD_17,Legislative provision for compulsory treatment,144.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2513
RSUD_18,Drug courts,144.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2514
RSUD_19,Programmes diverting clients from the justice system towards treatment,141.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2515
RSUD_20,Confidentiality of health records on substance use disorders  protected by law,282.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2516
RSUD_21,Government unit for substance use disorder treatment,144.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2517
RSUD_22,Budget line for substance use disorder treatment,145.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2518
RSUD_23,Financing method for substance use disorder treatment,252.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2519
RSUD_24,"Treatment services for alcohol use disorders, free of charge",0.0,
RSUD_25,"Treatment services for drug use disorders, free of charge",0.0,
RSUD_26,Governement benefits for persons with substance use disorders,276.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2520
RSUD_27,"Government benefits for alcohol use disorders, subsidy or disability pension",110.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2521
RSUD_28,"Government benefits for drug use disorders, subsidy or disability pension",116.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2522
RSUD_29,Sector for inpatient detoxification of alcohol use disorders,122.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2523
RSUD_30,Sector for inpatient treatment of alcohol dependence,118.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2524
RSUD_31,Sector for outpatient treatment of alcohol dependence,116.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2525
RSUD_32,Sector for the treatment of alcohol-induced psychoses and other alcohol-induced psychiatric conditions,123.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2526
RSUD_33,Sector for residential long-term rehabilitation of alcohol use disorders,92.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2527
RSUD_34,Sector for inpatient detoxification of drug use disorders,125.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2528
RSUD_35,Sector for inpatient treatment of drug dependence,122.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2529
RSUD_36,Sector for outpatient treatment of drug dependence,119.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2530
RSUD_37,Sector for substitution maintenance therapy of opioid dependence,54.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2531
RSUD_38,Sector for residential long-term rehabilitation of drug use disorders,96.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2532
RSUD_39,Treatment system for substance use disorders,135.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2533
RSUD_40,"Treatment setting for substance use disorders, most common",266.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2534
AIR_2_1,Ambient air pollution in urban areas (Annual PM<sub>10</sub> [&#956;g/m<sup>3</sup>]),91.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1349
AIR_3_1,Percent of urban inhabitants living in cities covered by PM measurements,91.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2259
RSUD_41,Specialized treatment services for drug use disoders and HIV/AIDS,143.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2535
RSUD_42,Specialized treatment services for substance use disorders and TB,139.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2536
RSUD_43,Open access services for substance use disorders,545.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2537
RSUD_44,"Treatment slots for alcohol and drug use disorders, outpatient, per 10 000",57.0,
RSUD_45,"Beds for the treatment of substance use disorders, per 100 000",159.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2539
RSUD_46,"Length of stay for inpatient detoxification, days",177.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2540
RSUD_47,"Length of stay for inpatient short-term treatment, days",161.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2541
RSUD_48,"Length of stay for inpatient long-term residential treatment, days",118.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2542
CM_01,Number of under-five deaths (thousands),5531.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2712
CM_02,Number of infant deaths (thousands),5531.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2711
CM_03,Number of neonatal deaths (thousands),5531.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2714
NCD_UNDER60,NCD deaths under age 60 (percent of all NCD deaths),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=36
RSUD_49,Opioid agonist pharmacotherapy for the treatment of opioid dependence (detoxification or maintenance),143.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2543
RSUD_50,Timeframe of opioid agonist treatment,56.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2544
RSUD_51,Methadone used for the treatment of opioid dependence,143.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2545
RSUD_52,Methadone used for detoxification or maintenance,57.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2546
RSUD_53,Methadone formulation used for the treatment of opiod dependence,55.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2547
RSUD_54,Buprenorphine used for the treatment of opioid dependence,142.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2548
RSUD_55,Buprenorphine used for detoxification or maintenance,37.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2549
RSUD_56,Buprenorphine/naloxone used for the treatment of opioid dependence,142.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2550
RSUD_57,Buprenorphine/naloxone used for detoxification or maintenance,28.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2551
RSUD_58,Methadone provision in clinical and community-based settings,435.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2552
RSUD_59,Buprenorphine provision in clinical and community-based settings,288.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2553
RSUD_60,Buprenorphine/naloxone provision in clinical and community-based settings,240.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2554
RSUD_61,Supervision requirements for methadone administration,105.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2555
RSUD_62,Supervision requirements for buprenorphine administration,66.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2556
RSUD_63,Supervision requirements for buprenorphine/naloxone administration,54.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2557
RSUD_64,Prescription requirements for methadone,164.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2558
RSUD_65,Prescription requirements for buprenorphine,110.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2559
RSUD_66,Prescription requirements for buprenorphine/naloxone,79.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2560
RSUD_67,Commencement of treatment with opioid agonists,120.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2561
RSUD_68,Pharmacotherapy used for the management of alcohol withdrawal,1106.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2562
RSUD_69,Pharmacotherapy used for the management of benzodiazepine withdrawal,375.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2563
RSUD_70,Pharmacotherapy used for the management of cannabis withdrawal,250.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2564
RSUD_71,Essential list of medicines,143.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2565
RSUD_72,"Essential list of medicines, pharmacotherapy for substance use disorders",812.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2566
TOBACCO_0000000526,Anti-tobacco mass media campaigns,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2723
TOBACCO_0000000527,National tobacco control programmes,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2724
TOBACCO_0000000528,Survey age range,0.0,
TOBACCO_0000000529,Law mandates that health warnings appear on tobacco packages,0.0,
TOBACCO_0000000530,Health warnings on cigarette packaging must be placed at the top of the principal display areas of the package,0.0,
TOBACCO_0000000531,Health warnings on cigarette packaging do not remove or diminish the liability of the tobacco industry,0.0,
TOBACCO_0000000532,Health warnings on cigarette packaging law applys to products whether manufactured domestically imported AND for duty-free sale,0.0,
TOBACCO_0000000533,Health warnings on cigarette packaging must not be obscured in any way including by required markings such as tax stamps,0.0,
TOBACCO_0000000534,Health warnings on cigarette packaging law requires or establishes fines for violations,0.0,
TOBACCO_0000000535,Cigarette packaging and labelling must not use figurative or other signs including colors or numbers as substitutes for prohibited misleading terms and descriptors,0.0,
TOBACCO_0000000536,Cigarette packaging and labelling must not use descriptors depicting flavours,0.0,
TOBACCO_0000000537,Cigarette packaging and labelling must not display quantitative information on emission yields (such as tar nicotine and carbon monoxide) including when used as part of a brand name or trademark,0.0,
TOBACCO_0000000538,The quit line number must appear on cigarette packaging or labelling,0.0,
TOBACCO_0000000539,Plain packaging of cigarettes is mandatory (ie. the use of logos colours brand images or promotional information on packaging other than brand names and product names displayed in a standard colour and font style is prohibited),0.0,
TOBACCO_0000000540,Law mandates that health warnings appear on smokeless tobacco packages,0.0,
TOBACCO_0000000541,Health warnings on smokeless tobacco packaging must be placed at the top of the principal display areas of the package,0.0,
TOBACCO_0000000542,Health warnings on smokeless tobacco packaging do not remove or diminish the liability of the tobacco industry,0.0,
TOBACCO_0000000543,Health warnings on smokeless tobacco packaging law applys to products whether manufactured domestically imported AND for duty-free sale,0.0,
TOBACCO_0000000544,Health warnings on smokeless tobacco packaging must not be obscured in any way including by required markings such as tax stamps,0.0,
TOBACCO_0000000545,Health warnings on smokeless tobacco packaging law requires or establishes fines for violations,0.0,
TOBACCO_0000000546,Smokeless tobacco packaging and labelling must not use figurative or other signs including colors or numbers as substitutes for prohibited misleading terms and descriptors,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2743
TOBACCO_0000000547,Smokeless tobacco packaging and labelling must not use descriptors depicting flavours,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2744
TOBACCO_0000000548,Smokeless tobacco packaging and labelling must not display quantitative information on emission yields (such as tar nicotine and carbon monoxide) including when used as part of a brand name or trademark,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2745
TOBACCO_0000000549,The quit line number must appear on smokeless tobacco packaging or labelling,0.0,
TOBACCO_0000000550,Plain packaging of smokeless tobacco products is mandatory (ie. the use of logos colours brand images or promotional information on packaging other than brand names and product names displayed in a standard colour and font style is prohibited),0.0,
TOBACCO_0000000551,At least one national mass media campaign ran during the survey period,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2748
TOBACCO_0000000552,Campaign was part of a comprehensive tobacco control programme,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2749
TOBACCO_0000000553,Campaign was pre-tested,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2750
TOBACCO_0000000554,Formative research was conducted,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2751
TOBACCO_0000000555,Campaign utilized media planning,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2752
TOBACCO_0000000556,Earned media/public relations were used to promote the campaign,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2753
TOBACCO_0000000557,Process evaluation was employed to assess implementation,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2754
TOBACCO_0000000558,Outcome evaluation was employed to assess effectiveness,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2755
TOBACCO_0000000559,Ban on appearance of tobacco brands in TV and/or films (product placement),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2756
NUTRITION_2005,Proportion of children aged 6-23 months who receive a minimum acceptable diet,60.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4738
NUTRITION_2006,Minimum dietary diversity (%),0.0,
NUTRITION_2007,Minimum meal frequency (%),0.0,
TOBACCO_0000000560,Most sold brand of cigarettes - price in international dollars,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2757
TOBACCO_0000000561,Cheapest brand of cigarettes - price in international dollars,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2758
TOBACCO_0000000562,Most sold brand of bidis - price in international dollars,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2759
TOBACCO_0000000563,Tobacco excises increased over the survey period,0.0,
RSUD_73,Government unit for substance use disorder prevention,144.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2567
RSUD_74,Budget line for substance use disorder prevention,143.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2568
RSUD_75,Funding method for substance use disorder prevention,123.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2569
RSUD_76,"Prevention activities for substance use disorders, main focus",138.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2570
RSUD_77,Programmes for the prevention of substance use disorders for special populations,1305.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2571
RSUD_78,Screening and brief interventions for substance use and substance use disorders,282.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2572
RSUD_79,Harm reduction programmes for IDUs,946.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2573
RSUD_80,Health professionals mostly involved in treatment of substance use disorders,250.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2574
RSUD_81,Clinical supervision of health care staff,546.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2575
RSUD_82,Standards of care for health professionals,143.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2576
RSUD_83,"Standards of care for health professionals, maintenance",272.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2577
RSUD_84,"Standards of care for health professionals, human rights",68.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2578
RSUD_85,NGOs for alcohol use disorders,544.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2579
RSUD_86,NGOs for drug use disorders,550.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2580
RSUD_87,Self-help groups for substance use disorders,541.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2581
RSUD_88,Groups and agencies for the prevention of substance use disorders,1450.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2582
MH_1,Mental health policy,182.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2950
MH_2,Mental health plan,182.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2951
MH_3,Stand-alone mental health legislation,182.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2956
MH_4,Government expenditures on mental health as a percentage of total government expenditures on health (%),78.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2953
MH_5,Government expenditures on mental hospitals as a percentage of total government expenditures on mental health (%),46.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2957
MH_6,"Psychiatrists working in mental health sector (per 100,000)",305.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2954
MH_7,"Nurses working in mental health sector (per 100,000)",273.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2958
MH_8,"Social workers working in mental health sector (per 100,000)",247.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2959
MH_9,"Psychologists working in mental health sector (per 100,000)",267.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2960
MH_10,"Mental health outpatient facilities (per 100,000)",164.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2952
MH_11,"Mental health day treatment facilities (per 100,000)",153.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2961
MH_12,Age-standardized suicide rates (per 100 000 population),2203.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=78
MH_13,"Beds for mental health in general hospitals (per 100,000)",278.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2962
MH_14,"Community residential facilities (per 100,000)",131.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2963
MH_15,"Beds in community residential facilities (per 100,000)",209.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2964
MH_16,"Beds in mental hospitals (per 100,000)",388.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2965
RSUD_89,Opioid agonist pharmacotherapy for the treatment of opioid dependence (maintenance),145.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2718
MH_17,"Mental hospitals (per 100,000)",194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2955
MH_18,"Mental health units in general hospitals (per 100,000)",174.0,
WHS4_108,Children aged <5 years with ARI symptoms who took antibiotic treatment (%),135.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2973
WHOSIS_000015,Life expectancy at age 60 (years),9486.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2977
MALARIA001,Malaria - number of reported deaths,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2967
MALARIA002,Estimated number of malaria cases,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2971
MALARIA003,Estimated number of malaria deaths,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4650
DEVICES01,Total density per 100 000 population: Health posts,222.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3010
DEVICES02,Total density per 100 000 population: Health centres,219.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3011
DEVICES03,Total density per 100 000 population: District/rural hospitals,244.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3012
DEVICES04,Total density per 100 000 population: Provincial hospitals,251.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3013
DEVICES05,Total density per 100 000 population: Specialized hospitals,252.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3014
DEVICES06,Availability of national standards or recommended lists of medical devices,318.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3015
DEVICES07,Types of lists recommending health technology for high burden diseases,322.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3016
DEVICES08,Total density per million population: Magnetic Resonance Imaging,263.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3005
DEVICES09,Total density per million population: Computed tomography units,268.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3006
DEVICES10,Total density per million population: Positron Emission tomography,230.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3007
DEVICES11,Total density per million population: Gamma camera or Nuclear medicine,232.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3008
DEVICES12,Total density per million population: Linear Accelerator,331.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3003
DEVICES13,Type of nomenclature system,337.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2995
DEVICES14,Use of nomenclature system,204.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3017
DEVICES15,Health technology (medical device) national policy,341.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3018
DEVICES16,Unit in the Ministry of Health responsible for the management of medical devices,340.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3019
DEVICES17,Procurement of medical devices carried out at the national level,336.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3020
DEVICES18,Availability of national list of approved medical devices for procurement or reimbursement,340.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3021
DEVICES19,"National guidelines, policies or recommendations on the procurement of medical devices",335.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3022
DEVICES20,Availability of technical specifications of medical devices to support procurement or donations,331.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3002
DEVICES21,Total density per million population: Telecobalt Unit,327.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3004
DEVICES22,Total density per million population: Radiotherapy units,338.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2441
DEVICES23,Total density per million females aged from 50 to 69 years old: Mammography units,245.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3009
WHS4_2530,Postnatal care visit within two days of birth (%),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2972
SA_0000001691,Central coordinating entity for alcohol policy implementation,726.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2312
SA_0000001692,Framework of national alcohol policy,396.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2313
SA_0000001693,Level of adoption of national alcohol policy,260.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2315
SA_0000001694,Sectors represented in national alcohol policy,723.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1401
SA_0000001695,"Cautions and arrests for public drunkenness, per 100,000 population",255.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2321
SA_0000001696,Alcohol-related road traffic crashes with fatalities (% of all road traffic crashes with fatalities),492.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2314
WHS2_3070_all,"Age-standardized mortality rate by cause (ages 30-70, per 100 000 population) - All causes",0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=78
WHS2_3070_cancer,"Age-standardized mortality rate by cause (ages 30-70, per 100 000 population) - Cancer",0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=78
WHS2_3070_cdd,"Age-standardized mortality rate by cause (ages 30-70, per 100 000 population) - Cardiovasular disease and diabetes",0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=78
WHS2_3070_chronic,"Age-standardized mortality rate by cause (ages 30-70, per 100 000 population) - Chronic respiratory conditions",0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=78
WHS9_CBR,Crude birth rate (per 1000 population),204.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2978
WHS9_CDR,Crude death rate (per 1000 population),205.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=41
WHS9_CS,Cellular subscribers (per 100 population),805.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2974
WHS10_1,Most recent census (year),186.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3056
WHS10_2,Number of cause-of-death registration years available,193.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=83
WHS10_3,Number of national population surveys - child anthropometry,193.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=83
WHS10_4,Number of national population surveys - child mortality,193.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=83
WHS10_5,Number of national population surveys - maternal mortality,193.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=83
WHS10_6,Number of national population surveys -  HIV prevalence,193.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=83
WHS10_7,Number of national population surveys -  adult health,193.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=83
WHS10_8,Civil registration coverage of cause-of-death (%),497.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=84
WHS10_9,Ill-defined causes in cause-of-death registration (%),114.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3057
WHS10_10,International Statistical Classification of Diseases and Related Health Problems (ICD),118.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=83
HIV_0000000025,"Testing and counselling facilities, reporting period",144.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2931
MALARIA004,Number of under-five deaths from malaria,2200.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2967
anc1,Antenatal care coverage - at least one visit (in the two or three years preceding the survey) (%,6795.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=3324
bcgv,BCG immunization coverage among one-year-olds (%),7475.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=3325
cpmo,Contraceptive prevalence - modern methods (%),7487.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=3334
cpmt,Contraceptive prevalence - modern and traditional methods (%),7487.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=3333
dptv,DTP3 immunization coverage among one-year-olds (%),7475.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=3335
ebreast,Early initiation of breastfeeding (in the two or three years preceding the survey) (%),7486.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=3336
famplan,Family planning needs satisfied (%),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3321
full,Full immunization coverage among 1-year-olds (%),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3317
itnchild,Children aged <5 years sleeping under insecticide-treated nets (%),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3327
measlesv,Measles (MCV) immunization coverage among 1-year-olds (%),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3337
ort,Children aged < 5 years with diarrhoea receiving oral rehydration therapy and continued feeding (%),7477.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=3331
pneumcare,Children aged <5 years with ARI symptoms taken to facility (%),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3330
poliov,Polio immunization coverage among one-year-olds (%),7475.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=3339
sba,Births attended by skilled health personnel (in the two or three years preceding the survey) (%),6795.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=3343
stunt,Children aged <5 years stunted (%),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3328
uweight,Children aged <5 years underweight (%),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3329
vita,Children aged 6-59 months who received vitamin A supplementation (%),7469.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=3332
anc13,Antenatal care coverage - at least one visit (in the three years preceding the survey) (%),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3324
anc15,Antenatal care coverage - at least one visit (in the five years preceding the survey) (%),6795.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=3324
anc43,Antenatal care coverage - at least four visits (in the three years preceding the survey) (%),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3323
anc45,Antenatal care coverage - at least four visits (in the five years preceding the survey) (%),6795.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=3323
csection3,Births by caesarean section (in the three years preceding the survey) (%),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3326
csection5,Births by caesarean section (in the five years preceding the survey) (%),6812.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=3326
ebreast3,Early initiation of breastfeeding (in the three years preceding the survey) (%),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3336
ebreast5,Early initiation of breastfeeding (in the five years preceding the survey) (%),-1.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=3336
itnpreg,Pregnant women sleeping under insecticide-treated nets (%),-1.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3318
obese,"Prevalence of obesity in non-pregnant women aged 15 - 49 years, BMI >=  30 (%)",0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3319
pncall3,Postnatal care visit within two days of birth (in the three years preceding the survey) (%),576.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3340
pncall5,Postnatal care visit within two days of birth (in the five years preceding the survey) (%),-1.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3340
pnchome3,Postnatal care visit within two days of birth - born outside a health facility (in the three years preceding the survey) (%),480.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3341
pnchome5,Postnatal care visit within two days of birth - born outside a health facility (in the five years preceding the survey) (%),-1.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3341
sba3,Births attended by skilled health personnel (in the three years preceding the survey) (%),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3343
sba5,Births attended by skilled health personnel (in the five years preceding the survey) (%),-1.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=3343
stunt3,Stunting prevalence in children aged < 3 years (%),7469.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=3346
stunt5,Stunting prevalence in children aged < 5 years (%),7469.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=3328
uweight3,Underweight prevalence in children aged < 3 years (%),-1.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=3347
uweight5,Underweight prevalence in children aged < 5 years (%),7469.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=3329
asfr1,Adolescent fertility rate (per 1000 women aged 15-19 years),6795.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=3322
tfr,Total fertility rate (per woman),-1.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=3344
cmr,Child mortality rate (probability of dying between age 1 and age 5 per 1000 live births),0.0,
imr,Infant mortality rate (deaths per 1000 live births),7469.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=3342
nmr,Neonatal mortality rate (deaths per 1000 live births),7469.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4486
pnmr,Postneonatal mortality rate (probability of dying between age 30 days and 11 months per 1000 live births),0.0,
u5mr,Under-five mortality rate (deaths per 1000 live births),-1.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=3345
SA_0000001697,"Adopted written national policy on alcohol, year adopted",67.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1396
SA_0000001698,"Adopted written national policy on alcohol, year revised",65.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1396
SA_0000001699,Age limits off-premise sales,-1.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1400
SA_0000001700,Consumer information on alcohol and health at points of sale,29.0,
SA_0000001701,Educational programmes involving target groups in school curriculum,-1.0,
SA_0000001702,Brief interventions as health promotion/disease prevention,68.0,
SA_0000001703,Server training on a regular basis,68.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2360
SA_0000001704,Data collection on alcohol-related health indicators,181.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2362
SA_0000001705,System for monitoring alcohol-related harm,180.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2369
SA_0000001706,National treatment policy for alcohol use disorders,180.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1412
SA_0000001707,Persons with alcohol use disorders receiving treatment (%),181.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2370
SA_0000001708,Designation of alcohol tax revenues to health services,-1.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2363
SA_0000001709,National surveys on drink-driving,178.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2366
SA_0000001710,Public-funded alcohol research/monitoring programmes,178.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2364
SA_0000001711,"Public funds designated for alcohol research/monitoring programmes, in Euros",178.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2319
SA_0000001712,Community-based interventions/projects involving stakeholders,217.0,
SA_0000001713,Interventions/projects actively involving young people and civil society,216.0,
SA_0000001714,Training in screening and brief interventions for alcohol problems,216.0,
SA_0000001715,Counselling to children in families with alcohol problems,-1.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2371
SA_0000001716,Counselling to pregnant women with alcohol problems,215.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2372
SA_0000001717,Prevention/counselling at workplaces for those with alcohol problems,215.0,
MEDS201110200,Total Pharmaceutical Expenditure (millions US$),28.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2251
MEDS201120200C,Total Pharmaceutical Expenditure per capita (US$)rate),20.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2268
MEDS2011400C,Share of Total Pharmaceutical Expenditure in Total Health Expenditure (%),19.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2269
MEDS2011600C,Share of Public Pharmaceutical Expenditure in Total Pharmaceutical Expenditure (%),15.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2270
MEDS201170200C,Public Pharmaceutical Expenditure per capita (US$),21.0,
MEDS2020200C,Density of pharmacists (per 10 000 population),22.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2257
MEDS3010400,Presence of National Medicines Policy,45.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1414
MEDS3010700,Presence of National Medicines Policy implementation plan,38.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2273
MEDS3011000,Right of access to essential medicines,30.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2274
MEDS5010200,Existence of formal Medicines Regulatory Authority,42.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1415
MEDS5010700,Website of the formal Medicines Regulatory Authority,47.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2252
MEDS5020100,Market Authorization for all pharmaceutical products required,50.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2276
MEDS5021700S,Registration Fee pharmaceutical containing New Chemical Entity,36.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2279
MEDS5021800S,Registration Fee generic pharmaceutical product,34.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2280
MEDS5030200,Inspectors are allowed to inspect premises where pharmaceutical activities are performed,48.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2281
MEDS5050200,Pharmaceutical manufacturers must comply with Good Manufacturing Practices,40.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2283
MEDS5050900,Licensing private pharmacies obligatory,41.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2284
MEDS5060200,National Quality Control Laboratory exists,39.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2285
MEDS5070100,Legal provisions control promoting and advertising of prescription medicine,-1.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2287
MEDS5070300,Ban on Direct to Consumer Pharmaceutical Advertising,50.0,
MEDS5080100,Legal provisions exist requiring authorization for conducting Clinical Trials by the MRA,41.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2310
MEDS5090300,Annual consumption of Morphine (mg/capita),46.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2289
MEDS5100400,National pharmacovigilance centre linked to the MRA exists,37.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2291
MEDS6010102,Children <5 years receive free medicines,42.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2293
MEDS6010103,Pregnant women receive free medicines,41.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2294
MEDS6010201,All medicines included in the EML,38.0,
MEDS6010300,Social (health) fund is providing at least partial medicine coverage,40.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2296
MEDS6030100,System in place to monitor prices of medicines,49.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1417
MEDS6060100,Duties on imported active pharmaceutical ingredients,39.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2298
MEDS6060200,Duties on imported finished pharmaceutical products,40.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2299
MEDS6060300,Value Added Tax is levied on finished pharmaceuticals products,37.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2300
MEDS7010400,Public sector tender awards are publicly available,37.0,
MEDS7020900S,Availability of key medicines at the Central Medical Store in percentage (%),14.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2297
MEDS8010100,National Essential Medicine List exists,44.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2290
MEDS8010200,Standard Treatment Guidelines for common illnesses are made by Ministry of Health,37.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2286
MEDS8010500,National Standard Treatment Guidelines specific to paediatric conditions exist,38.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2308
MEDS8010800,National Medicines Information Center provides information on medicines,45.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2282
MEDS8011200,Existence of National strategy to contain antimicrobial resistance,42.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2277
MEDS8021201,Public sector,41.0,
MEDS8021202,Private sector,41.0,
MEDS8030400,Substitution of generic equivalents at the point of dispensing in public sector facilities is allowed,42.0,
MEDS8030500,Substitution of generic equivalents at the point of dispensing in private sector facilities is allowed,42.0,
MEDS3011302,For the pharmaceutical sector,10.0,
MEDS5020600,Number of registered pharmaceutical products,43.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2278
MEDS5100800,Number of reports submitted in the last two year by the pharmacovigilance centre,27.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2292
MEDS4020300,Market share of domestic manufacturers (%),21.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2261
MEDS2012100S,Market share of generic pharmaceuticals by value (%),13.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2272
NHABASIS,Basis for NHA estimate,86.0,
PerctestedANC,Women accessing antenatal care (ANC) services who were tested for syphilis (%),587.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3248
PercposANC,Antenatal care attendees who were positive for syphilis (%),703.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3249
PercposSW,Sex workers with active syphilis (%),-1.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3250
PercposMSM,Men who have sex with men (MSM) with active syphilis (%),-1.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3251
HIV_0000000026,Number of new HIV infections,-1.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4659
NCDMORT3070,"Probability (%) of dying between age 30 and exact age 70 from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease",3255.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3354
RS_239,Reported % of seriously injured patients transported by ambulance,-1.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3358
RS_240,Training in medical emergency - available for doctors,-1.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3356
RS_241,Training in medical emergency - available for nurses,-1.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3357
MALARIA005,Malaria incidence per 100 000 population,111.0,
WHS_PBR,Preterm birth rate (per 100 live births),-1.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4420
GBD_ASDR,Age-standardized death rates (per 100 000 population),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=78
MEDS1_01_01,Population,-1.0,
MEDS1_02_01,Life Expectancy M,0.0,
MEDS1_02_02,Life Expectancy F,0.0,
MEDS1_02_04,Under 5 Mortality,0.0,
MEDS1_02_03,Infant mortality,0.0,
MEDS1_01_03,GDP,-1.0,
MEDS1_01_05,Gross domestic product per capita,-1.0,
MEDS1_02_11,NCD mortality rate,0.0,
MEDS1_02_12,CVD and Diabetes  mortality rate,-1.0,
MEDS1_02_13,Cancer  mortality rate,-1.0,
MEDS1_02_15,TB mortality rate,0.0,
MEDS1_02_16,Malaria mortality rate,-1.0,
MEDS1_02_14,HIV mortality rate,0.0,
MEDS2_01_01_02,THE,0.0,
MEDS2_01_03_02,THE per capita,0.0,
MEDS2_01_04_02,Public Health Expenditure,0.0,
MEDS2_01_07_02,Public Health Expenditure per capita,0.0,
MEDS2_01_05,Public Health Expenditure as a % of Government Expenditure,0.0,
MEDS2_01_06,Public Health Expenditure of a % of THE,0.0,
MEDS,OOP as a % of THE,0.0,
MEDS2_01_08,Private Health Expenditure % of THE,0.0,
MEDS2_01_24,OOP as a % of Private Health Expenditure,0.0,
MEDS2_01_26,Premiums for private health plans as a % of private health expenditure,0.0,
MEDS2_01_10,Population covered by private health insurance,0.0,
MEDS2_01_09,Population covered by a public health service orr insurance plan,0.0,
MEDS2_01_11_02,Total pharmaceutical expenditure,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2251
MEDS2_01_14,Share of total pharmaceutical expenditure in total health expenditure (%),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2269
MEDS2_01_13,Share of total pharmaceutical expenditure in gross domestic product (%),0.0,
MEDS2_01_12_02,Total pharmaceutical expenditure per capita,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2268
MEDS2_01_15_02,Share of public pharmaceutical expenditures in total pharmaceutical expenditures (US$),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2270
MEDS2_01_18_02,Private TPE,0.0,
MEDS2_01_21,Market share of generic pharmaceuticals by value (%),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2272
MEDS2_02_01,Pharmacists,0.0,
MEDS2_02_02,Density of pharmacist (per 10.000),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2257
MEDS3_01_01,Presence of National Health Policy,0.0,
MEDS3_01_02,NHP Implementation plan exists,0.0,
MEDS3_01_04,Presence of national medicines policy,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1414
MEDS3_01_07,Presence of national medicines policy implementation plan,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2273
MEDS3_01_12_01,Pharmaceutical policy implementation is regularly monitored,0.0,
MEDS3_01_08,Presence of National Clinical Laboratory Policy,0.0,
MEDS3_01_09,NCLP implementation plan exists,0.0,
MEDS3_01_10,Right of access to essential medicines,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2274
MEDS3_01_13,Presence of national good governance policy,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2275
MEDS3_01_11,Official guidelines on medicine donations exist,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3368
MEDS3_01_14,Policy to manage conflict of interest issues,0.0,
MEDS3_01_15,Formal code of conduct for public officials,0.0,
MEDS3_01_16,Whistle Blowing mechanism,0.0,
MEDS4_01_02_01,Legal provision for granting patents on: Pharmaceuticals,0.0,
MEDS4_01_02_02,Legal provision for granting patents on: Laboratory Supplies,0.0,
MEDS4_01_02_03,Legal provision for granting patents on: Medical Supplies,0.0,
MEDS4_01_02_04,Legal provision for granting patents on: Medical Equipment,0.0,
MEDS4_01_04,TRIPS legislated through national legislation,0.0,
MEDS4_01_06,Trasitional period eligibility,0.0,
MEDS4_01_07_01,Compulsory Licensing,0.0,
MEDS4_01_07_02,Bolar exemption,0.0,
MEDS4_01_08,Parallel importing,0.0,
MEDS4_01_10,Legal provisions related to: Data exclusivity,0.0,
MEDS4_01_11,Legal provisions related to: Patent Extension,0.0,
MEDS4_01_12,Legal provisions for the linkage between patent status and market authorization,0.0,
MEDS4_02_01,Number of licensed pharmaceutical manufacturers,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3379
MEDS4_02_02_01,Manufacturing capacity: R&D new API,0.0,
MEDS4_02_02_02,Manufacturing capacity: Production API,0.0,
MEDS4_02_02_03,Manufacturing capacity: Production formulations,0.0,
MEDS4_02_02_04,Manufacturing capacity: Repackaging of finished dose forms,0.0,
MEDS4_02_03,Market share of domestic manufacturers by value (%),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2261
MEDS4_02_05,Market share of domestic manufactures by volume (%),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3388
MEDS5_01_01,Legal provisions for establishing MRA,0.0,
MEDS5_01_02,Formal medicines regulatory authority exists,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1415
MEDS5_01_04_01,MRA part of MoH,0.0,
MEDS5_01_04_02,MRA semi-autonomous,0.0,
MEDS5_01_07,Medicines regulatory authority has it own website,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2252
MEDS5_01_08,MRA receives external technical assistance,0.0,
MEDS5_01_09,MRA involved in harmonization / collaboration activities,0.0,
MEDS5_01_10,Assessment of medicines regulatory system conducted in last 5 years,0.0,
MEDS5_01_15,RA uses computerized information management system,0.0,
MEDS5_01_05_01,Function of MRA: Market Authorization,0.0,
MEDS5_01_05_02,Function of MRA: Inspection,0.0,
MEDS5_01_05_03,Function of MRA: Import Control,0.0,
MEDS5_01_05_04,Function of MRA: Licensing,0.0,
MEDS5_01_05_05,Function of MRA: Market control,0.0,
MEDS5_01_05_06,Function of MRA: Quality control,0.0,
MEDS5_01_05_07,Function of MRA: Advertising,0.0,
MEDS5_01_05_08,Function of MRA: Clinical trials,0.0,
MEDS5_01_05_09,Function of MRA: Pharmacovigilance,0.0,
MEDS5_01_11,Funding of MRA: Government,0.0,
MEDS5_01_12,Funding of MRA: Fees for service,0.0,
MEDS5_01_13,Funding of MRA: Other funding,0.0,
MEDS5_01_14,Funding of MRA: Revenues derived from RA kept in RA,0.0,
MEDS5_02_01,Market authorization for all pharmaceutical products is required,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2276
MEDS5_02_02,Mechnaisms for exceptions / waiver of registration,0.0,
MEDS5_02_03,Mutual recognition,0.0,
MEDS5_02_04,Public transparency of criteria for MA application assessment,0.0,
MEDS5_02_05,WHO prequalification programme information used for product registration,0.0,
MEDS5_02_06,Number of registered pharmaceuticals,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2278
MEDS5_02_07,List of pharmaceuticals with defined periodicity required to be publicly available,0.0,
MEDS5_02_08,Medicines registration includes INN,0.0,
MEDS5_02_09,Fee required for Marketing Authorization applications,0.0,
MEDS5_02_17,Fee for pharmaceuticals containing new chemical entity,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2279
MEDS5_02_18,Registration fee generic pharmaceutical product,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2280
MEDS5_03_01,Legal provisions for the appointment of government pharmaceutical officials,0.0,
MEDS5_03_02,Inspectors are allowed to inspect premises where pharmaceutical activities are performed,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2281
MEDS5_03_03_01,Inspection a pre-requisite for licensing of: Public,0.0,
MEDS5_03_03_02,Inspection a pre-requisite for licensing of: Private,0.0,
MEDS5_03_04,Inspection requirements the same for public and private facilities,0.0,
MEDS5_03_05_01,Local manufacturers - GMP compliance,0.0,
MEDS5_03_05_02,Private Wholesalers,0.0,
MEDS5_03_05_03,Retail distributors,0.0,
MEDS5_03_05_04,Public pharmacies and stores,0.0,
MEDS5_03_05_05,Pharmacies and dispensing points of health facilities,0.0,
MEDS5_04_01,Authorization to import medicines required,0.0,
MEDS5_04_02,Sampling of imported products for testing permitted,0.0,
MEDS5_04_03,Importation of medicines through authorized ports of entry,0.0,
MEDS5_04_04,Inspection of pharmaceutical products at authorized ports of entry permitted,0.0,
MEDS5_05_02,Pharmaceutical manufacturers must comply good manufacturing practices,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2283
MEDS5_05_01,Licensing required for: Manufacturers,0.0,
MEDS5_05_04,Licensing required for: Importers,0.0,
MEDS5_05_05,Licensing required for: Wholesalers,0.0,
MEDS5_05_09,Licensing private pharmacies obligatory,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2284
MEDS5_05_10,Licensing required for: public pharmacies,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3375
MEDS5_05_06,Wholesalers and distributors to comply with Good Distribution Practices,0.0,
MEDS5_05_08,Pharmacists to be registered,0.0,
MEDS5_05_03,Good Manufacturing Practices (GMP) published,0.0,
MEDS5_05_07,National Good Distribution Practice requirements published,0.0,
MEDS5_05_11,National Good Pharmacy Practice Guidelines published,0.0,
MEDS5_05_12,List of all licensed pharmaceutical facilities (publication legally required),0.0,
MEDS5_06_01,Legislation supports Pharmaceutical market regulation,0.0,
MEDS5_06_02,Quality control testing laboratory is available,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2285
MEDS5_06_02_01,Quality control laboratory is part of medication regulatory authority,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3380
MEDS5_06_02_02,Testing services contracted out by regulatory authority,0.0,
MEDS5_06_04_01,For quality monitoring in public sector (pharmacy stores and health facilities),0.0,
MEDS5_06_04_02,For quality monitoring in private sector (retail outlets),0.0,
MEDS5_06_04_03,When there are complaints / problems,0.0,
MEDS5_06_04_04,For product registration,0.0,
MEDS5_06_04_05,For public procurement prequalification,0.0,
MEDS5_06_04_06,For public program products prior to acceptance and/or distribution,0.0,
MEDS5_06_06,Number of quality control samples tested in past two years,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3381
MEDS5_06_07,Number of samples that failed the testing in two years,0.0,
MEDS5_07_01,Legal provisions control promoting and advertising of prescription medicine,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2287
MEDS5_07_03,Ban on direct to consumer pharmaceutical advertising,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2375
MEDS5_07_04,Pre-approval for medicines advertisements and promotional materials  required,0.0,
MEDS5_07_05,Guidelines for advertising and promotion of non-prescription medicines,0.0,
MEDS5_07_06,Code of conduct for advertising by MA holders exists and is publicly available,0.0,
MEDS5_07_06_01,Code of conduct applies to: Both,0.0,
MEDS5_07_06_02,Voluntary adherence to code,0.0,
MEDS5_07_06_03,Code contains formal process for complaints and sanctions,0.0,
MEDS5_07_06_04,Up to date list of complaints and sanctions publicly available,0.0,
MEDS5_08_01,Legal provisions exist requiring authorization for conducting clinical trials by the medical regulatory authority,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2310
MEDS5_08_02,Clinical Trials require ethics committee/institutional review board approval,0.0,
MEDS5_08_03,Registration of clinical trials in international/national/regional registry,0.0,
MEDS5_09_01_01,"Single convention on narcotic drugs, 1961",0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3382
MEDS5_09_01_02,"The 1972 protocol amending the single convention on narcotic drugs, 1961",0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3383
MEDS5_09_01_03,"Convention on psychotropic substances, 1971",0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3384
MEDS5_09_01_04,"United nations convention against the illicit traffic in narcotic drugs and psychotropic substances, 1988",0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3385
MEDS5_09_02,"Laws for the control of narcotic and psychotropic substances, and precursors exist",0.0,
MEDS5_09_03,Annual morphine consumption (mg/capita),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2289
MEDS5_10_01,PV activities legally established within MRA mandate,0.0,
MEDS5_10_02,MA holders required to continuously monitor safety of products and report to MRA,0.0,
MEDS5_10_03,Legal provisions for monitoring of ADR exist,0.0,
MEDS5_10_04,National pharmacovigilance center linked to the medicines regulatory authority,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2291
MEDS5_10_04_02,Number of reports submitted in the last two years by the national pharmacovigilance center,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2292
MEDS5_10_04_03,NPC publishes ADR bulletin,0.0,
MEDS5_10_07,No. of ADRs on database,0.0,
MEDS5_10_08,Number of reports of adverse drug reactions submitted in the last two years by the national pharmacovigilance center,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2292
MEDS5_10_09_01,No. of ADRs submitted to Uppsala database,0.0,
MEDS6_01_01_01,Patients who cannot afford them received free medicines,0.0,
MEDS6_01_01_02,Children under 5 receive free medicines,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2293
MEDS6_01_01_03,Pregnant women receive free medicines,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2294
MEDS6_01_01_04,Elderly  received free medicines,0.0,
MEDS6_01_02_01,All essential medicines are free,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2295
MEDS6_01_02_02,Free medicines for any non communicable diseases,0.0,
MEDS6_01_02_03,Free medicines for Malaria,0.0,
MEDS6_01_02_04,Free medicines for TB,0.0,
MEDS6_01_02_05,Free medicines for STD,0.0,
MEDS6_01_02_06,Free medicines for HIV,0.0,
MEDS6_01_02_07,Free vaccines for EPI,0.0,
MEDS6_01_03,National or social health insurance providing at least partial medicines coverage,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2296
MEDS6_01_03_01,Providing medicines that are on the Essential Medicines List for inpatients,0.0,
MEDS6_01_03_02,Providing medicines that are on the Essential Medicines List for outpatients,0.0,
MEDS6_01_04,Private health insurance schemes provide medicines coverage,0.0,
MEDS6_01_04_01,Private health insurance provides coverage for medicines which are on the EML,0.0,
MEDS6_02_01,Co-payments/ fee requirements for consultations,0.0,
MEDS6_02_02,Co-payments/ fee requirements for medicines,0.0,
MEDS6_03_01,Medicine pricing regulations,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1417
MEDS6_03_01_01,Pricing provisions aimed at: Manufacturers,0.0,
MEDS6_03_01_02,Pricing provisions aimed at: Wholesalers,0.0,
MEDS6_03_01_03,Pricing provisions aimed at: Retailers,0.0,
MEDS6_06_01,Duties on active pharmaceutical ingredients,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2298
MEDS6_06_02,Duties on finished pharmaceutical products,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2299
MEDS6_06_03,Value added taxes on pharmaceutical products,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2300
MEDS6_06_07,Duty rate on active pharmaceutical ingredients,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3369
MEDS6_06_08,Duty rate on finished pharmaceutical products,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3370
MEDS6_06_09,Value added taxes rate,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3371
MEDS6_02_03,Revenues from fees used to pay salaries of health workers,0.0,
MEDS7_01_01_01,Public sector procurement is decentralized,0.0,
MEDS7_01_01_02,Public sector procurement is decentralized and centralized,0.0,
MEDS7_01_02_01,Public sector procurement is the reponsibility of procurement agency that is part of MOH,0.0,
MEDS7_01_02_02,Public sector procurement is the reponsibility of procurement agency that is semi autonomous,0.0,
MEDS7_01_02_03,Public sector procurement is the reponsibility of procurement agency that is  autonomous,0.0,
MEDS7_01_02_04,A government procurement agency procures all public goods,0.0,
MEDS7_01_03,Public sector requests for tender documents are publicly available,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3386
MEDS7_01_04,Public sector awards are publicly available,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2311
MEDS7_01_05,Procurement is based on prequalification of suppliers,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3387
MEDS7_02_01,The government supply system department has a central medical store,0.0,
MEDS7_02_03,There are national guidelines on Good Distribution Practices,0.0,
MEDS7_02_04,There is a licensing authority that issues GDP licenses,0.0,
MEDS7_02_04_01,The licensing authority accredits public distribution facilities,0.0,
MEDS7_02_05,A list of GDP certified warehouses in the public sector exists,0.0,
MEDS7_02_06,A list of GDP certified distributors in the public sector exists,0.0,
MEDS7_02_09,Availability of key medicines at the central medical store,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2297
MEDS7_03_01,Legal provisions exist for licensing wholesales in private sector,0.0,
MEDS7_03_02,Legal provisions exist for licensing distributors in private sector,0.0,
MEDS7_03_03,A list of GDP certified wholsesalers in the private sector exists,0.0,
MEDS7_03_04,A list of GDP certified distributors in the private sector exists,0.0,
MEDS8_02_08_01,Core medical training includes: concept of EML,0.0,
MEDS8_02_08_02,Core medical training includes: Use for STGS,0.0,
MEDS8_02_08_03,Core medical training includes: Pharmacovigilance,0.0,
MEDS8_02_08_04,Core medical training includes: Problem based pharmacotherapy,0.0,
MEDS8_02_09,Mandatory continuing education that includes pharmaceutical issues is required for doctors,0.0,
MEDS8_02_10,Mandatory continuing education that includes pharmaceutical issues is required for nurses,0.0,
MEDS8_02_11,Mandatory continuing education that includes pharmaceutical issues is required for paramedical staff,0.0,
MEDS8_02_12_01,Public sector generic prescribing is obligatory,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2254
MEDS8_02_12_02,Private sector generic prescribing is obligatory,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2254
MEDS8_03_02_01,Core pharmacist training includes: EML,0.0,
MEDS8_03_02_02,Core pharmacist training includes: Use of  STG,0.0,
MEDS8_03_02_03,Core pharmacist training includes: drug information,0.0,
MEDS8_03_02_04,Core pharmacist training includes: clinical pharmacology,0.0,
MEDS8_03_02_05,Core pharmacist training includes: medicines supply management,0.0,
MEDS8_03_04,Generic substitution permitted in public sector,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2253
MEDS8_03_05,Generic substitution permitted in private sector,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2253
MEDS8_03_06,Antibiotics are sometimes sold OTC without prescription,0.0,
MEDS8_03_07,Injectables are sometimes sold OTC without prescription,0.0,
MEDS8_01_08,National medicines information center exists,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2282
MEDS8_01_09,Public education campaigns on rational medicine use topics have been conducted in previous two years,0.0,
MEDS8_01_10,A survey on rational medicine use has been conducted in the previous two years,0.0,
MEDS8_01_11,A national committee exists to monitor and promote rational use of medicines,0.0,
MEDS8_01_12,National strategy to contain antimicrobial resistance exists,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2277
MEDS8_01_18,Existence of a funded national intersectoral taskforce to coordinate the promotion of appropriate use of antimicrobials,0.0,
MEDS8_01_19,A national reference lab has responsibility for coordinating epidemiological surveillance of AMR,0.0,
MEDS8_02_01,Legal provisions exist to govern the licensing and prescribing practices of prescriber,0.0,
MEDS8_02_02,Legal provisions exist to restrict dispensing by prescribers,0.0,
MEDS8_02_03,Prescribers in the private sector dispense medicine,0.0,
MEDS8_02_04,Regulations require hospitals to organize/develop DTCs,0.0,
MEDS8_02_05,More than half of referral hospital have a DTC,0.0,
MEDS8_02_06,More than half of general hospitals have a DTC,0.0,
MEDS8_02_07,More than half of regions/provinces have a DTC,0.0,
MEDS8_02_13,Average number of medicines prescribed per patient contact in public health facilities,0.0,
MEDS8_02_15,Percentage of medicines in outpatient public health care facilities that are prescribed by INN name,0.0,
MEDS8_02_16,Percentage of patients in outpatient public health care facilities receiving antibiotics,0.0,
MEDS8_02_17,Percentage of patients in outpatient public health care facilities receiving injections,0.0,
MEDS8_02_19,Percentage of medicines adequately labelled in public health facilities,0.0,
MEDS8_02_23,Diarrhoea in children treated with ORS,0.0,
MEDS8_03_10_01,Nurses sometimes prescribe prescription-only medicines,0.0,
MEDS8_03_10_02,Pharmacists sometimes prescribe prescription-only medicines,0.0,
MEDS8_03_10_03,Paramedics sometimes prescribe prescription-only medicines,0.0,
MEDS8_03_10_04,Personnel with less than one month training sometimes prescribe prescription-only medicines,0.0,
MEDS8_03_01,Legal provisions exist to govern dispensing practices of pharmaceutical personnel,0.0,
MEDS8_01_01_01,Number of medicines on essential medicines list,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3389
MEDS8_01_01_02,Written process for selecting medicines on the EML,0.0,
MEDS8_01_01_03,Written process is publicly available,0.0,
MEDS8_01_01_04,Mechanism to align EML and STG,0.0,
MEDS8_01_02,Standard treatment guidelines for common illnesses produced by the ministry of health,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2286
MEDS8_01_03,STG specific to primary care exists,0.0,
MEDS8_01_04,STG specific to secondary care exists,0.0,
MEDS8_01_05,National standard treatment guidelines for children,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2308
MEDS8_01_06,% of public health facilities with copy EML (mean),0.0,
MEDS8_01_07,% of public health facilities with copy STG (mean),0.0,
MEDS8_01_14,EML includes formulations specific for children,0.0,
MEDS8_01_15,There are explicitly documented criteria for the selection of medicines on the EML,0.0,
MEDS8_01_16,There is a formal committee for the selection of products on the EML,0.0,
MEDS8_01_16_01,Conflict of interest declarations are required from members of national EML committee,0.0,
MEDS8_01_17,National medicines formulary exists,0.0,
MEDS8_02_14,% of medicines prescribed in outpatient public health care facilities that are on the EML,-1.0,
MEDS8_03_03,Mandatory continuing education that includes rational use of medicines is required for pharmacists,0.0,
MORT_500,Number of deaths,209508.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=36
MORT_400,Deaths per 100 000 population,5.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3367
CCO_1,Poverty headcount ratio at $1.25 a day (PPP) (% of population),-1.0,
CCO_2,Human development index rank,369.0,
CCO_3,Gender inequality index rank,340.0,
MEDS2_01_15_02_01,Share of public pharmaceutical expenditures in total pharmaceutical expenditures (%),-1.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2270
MEDS0_0_0,Generic,0.0,
MEDS8_01_12_01,AMR strategy has been updated in 2010 or later,-1.0,
MEDS8_01_01,Essential medicines list exists,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2290
NUTOVERWEIGHTPREV,Overweight prevalence,174.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=74
NUTOVERWEIGHTNUM,Overweight numbers (in millions),174.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=74
NUTSEVWASTINGPREV,Wasting prevalence,25.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3410
NUTSEVWASTINGNUM,Wasting  numbers (in thousands),25.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3410
NUTSTUNTINGPREV,Stunting prevalence,224.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=72
NUTSTUNTINGNUM,Stunting  numbers (in millions),224.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=72
NUTUNDERWEIGHTPREV,Underweight prevalence,174.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=27
NUTUNDERWEIGHTNUM,Underweight  numbers (in millions),174.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=27
NUTWASTINGPREV,Wasting prevalence,210.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=302
NUTWASTINGNUM,Wasting  numbers (in millions),210.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=302
RHR_IPV,Intimate partner violence prevalence among ever partnered women (%),102.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3745
RHR_NPSV,Non-partner sexual violence prevalence (%),29.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3686
ORGANPOP,Population (millions),0.0,
ORGANKIDNEYNUM,Kidney transplants (absolute number),0.0,
ORGANKIDNEYRATE,Kidney transplants (per million),0.0,
ORGANLIVERNUM,Liver transplants (absolute number),0.0,
ORGANLIVERRATE,Liver transplants (per million),0.0,
ORGANTOTALNUM,Total organs transplanted (absolute number),0.0,
ORGANTOTALRATE,Total organs transplanted (per million),0.0,
ORGANTOTALDECNUM,Total actual deceased donors (absolute number),0.0,
ORGANTOTALDECRATE,Total actual deceased donors (per million),0.0,
M_Group,Monitoring tobacco use and prevention policies,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=339
P_Group,Protecting people from tobacco smoke,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=341
O_Group,Offering help to quit tobacco use,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=343
W_Group,Warning about the dangers of tobacco,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1221
W-MM_Group,Anti-tobacco mass media campaigns,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2723
E_Group,"Enforcing bans on tobacco advertising, promotion and sponsorship",776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=373
R_Group,Raising taxes on tobacco,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=374
M_Est_tob_curr,"Current tobacco smoking, age-standardised",582.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=346
M_Est_tob_daily,"Daily tobacco smoking, age-standardised",582.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=347
M_Est_cig_curr,"Current cigarette smoking, age-standardised",582.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=348
M_Est_cig_daily,"Daily cigarette smoking, age-standardised",-1.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=356
M_svy_yr_adult,Year of latest adult prevalence survey,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=375
M_survey_title_adult,Name of survey of adults,-1.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4569
M_svy_national_adult,Representativeness of survey of adults,194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=345
M_svy_age_adult,Adult survey age range,-1.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2725
M_def_1_text_adult,Adult indicator 1 definition,194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4571
M_def_1_prev_adult,Adult indicator 1 rate,-1.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4572
M_def_2_text_adult,Adult indicator 2 definition,194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4571
M_def_2_prev_adult,Adult indicator 2 rate,582.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4572
M_smkless_svy_yr_adult,Year of survey of adults - smokeless,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=375
M_smkless_survey_title_adult,Name of survey of adults - smokeless,85.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4569
M_smkless_svy_national_adult,Representativeness of survey of adults - smokeless,85.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=345
M_smkless_age_range_adult,Adult survey age range - smokeless,85.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2725
M_smkless_def_text_adult,Adult smokeless tobacco use indicator definition,194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4571
M_smkless_prev_adult,Adult smokeless tobacco use indicator rate,563.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4572
M_svy_yr_youth,Year of survey of youth,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=375
M_survey_title_youth,Name of survey of youth,189.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4570
M_svy_national_youth,Representativeness of youth survey,189.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=345
M_svy_age_youth,Youth survey age range,189.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2725
M_def_1_text_youth,Youth indicator 1 definition,189.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4571
M_def_1_prev_youth,Youth indicator 1 rate,567.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4572
M_def_2_text_youth,Youth indicator 2 definition,157.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4571
M_def_2_prev_youth,Youth indicator 2 rate,471.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4572
M_smkless_svy_yr_youth,Year of survey of youth - smokeless,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=375
M_smkless_survey_title_youth,Name of survey of youth - smokeless,103.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4570
M_smkless_svy_national_youth,Representativeness of survey of youth - smokeless,103.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=345
M_smkless_age_range_youth,Youth survey age range - smokeless,103.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2725
M_smkless_def_text_youth,Youth smokeless tobacco use indicator definition,194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4571
M_smkless_prev_youth,Youth smokeless tobacco use indicator rate,582.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4572
P1_healthcare,National smoking ban in HEALTH-CARE FACILITIES,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1232
P2_education,National smoking ban in EDUCATIONAL FACILITIES EXCEPT UNIVERSITIES,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1233
P3_universities,National smoking ban in UNIVERSITIES,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1234
P4_govt,National smoking ban in GOVERNMENT FACILITIES,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1235
P5_indoor_off,National smoking ban in INDOOR OFFICES,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1236
P6_restaurants,National smoking ban in RESTAURANTS,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1329
P7_pubs,National smoking ban in PUBS AND BARS,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1238
P8_pub_transp,National smoking ban in PUBLIC TRANSPORT,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1239
P9_all_other,National smoking ban in ALL OTHER INDOOR PUBLIC PLACES,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1240
PC_sfe_compliance,Compliance with regulations on smoke-free environments (national legislation),776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1265
P_count_places_sf,National smoking ban: NUMBER OF PLACES SMOKE-FREE,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1312
P11_fines_any,National smoking ban: FINES FOR VIOLATIONS,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1324
P12_fines_establishment,National smoking ban: FINES ON THE ESTABLISHMENT,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1325
P13_fines_smoker,National smoking ban: FINES ON THE PATRON,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1326
P14_funds_for_enforce,National smoking ban: DEDICATED FUNDS FOR ENFORCEMENT,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1323
P15_complaints,National smoking ban: CITIZEN COMPLAINTS AND INVESTIGATIONS,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1322
P10_subnat_auth_exists,Subnational smoking bans - authority exists,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1241
P_subnat_complete_ban_exists,Comprehensive bans in place subnationally,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1242
O_Quitline,Access to a toll-free quit line,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1288
O_Avail_hosp,Treatment for tobacco dependence available in hospitals,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1243
O_Ins_hosp,Treatment for tobacco dependence in hospitals cost covered,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4573
O_Avail_hlthSPACEclin,Treatment for tobacco dependence available in health clinics or other primary care facilities,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1263
O_Avail_off_hlth_prof,Treatment for tobacco dependence available in offices of health professionals,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1262
O_Ins_off_hlth_prof,Treatment for tobacco dependence in offices of health professionals cost covered,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4573
O_Avail_community,Treatment for tobacco dependence available in the community,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1319
O_Ins_community,Treatment for tobacco dependence in the community cost covered,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4573
O_Avail_other,Treatment for tobacco dependence available in other settings,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1261
O_Ins_other,Treatment for tobacco dependence in other settings cost covered,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4573
O_NRT_sold,Nicotine replacement therapy - legally sold,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1309
O_NRT_where,Nicotine replacement therapy - place available,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1260
O_NRT_ins,Nicotine replacement therapy - cost covered,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4574
O_NRT_EML,Nicotine replacement therapy on the Essential Medicines List,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4575
O_Bup_sold,Bupropion - legally sold,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1259
O_Bup_where,Bupropion - place available,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1258
O_Bup_ins,Bupropion - cost covered,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4574
O_Varen_sold,Varenicline - legally sold,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1256
O_Varen_where,Varenicline - place available,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1257
O_Varen_ins,Varenicline - cost covered,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4574
W1_HW_law_A,Law mandates that health warnings appear on tobacco packages,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2726
W2_pc_front_back_A,Percentage of principal display area mandated to be covered by health warnings - front and back of cigarette packaging,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1314
W3_pc_front_A,Percentage of principal display area mandated to be covered by health warnings - front of cigarette packaging,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1266
W4_pc_back_A,Percentage of principal display area mandated to be covered by health warnings - back of cigarette packaging,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1252
W15_specific_hw_A,Does the law mandate specific health warnings on cigarette packaging?,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1251
W16_number_hw_A,How many health warnings are approved by the law for cigarette packaging?,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1250
W11_outside_pack_A,Do health warnings appear on each cigarette package and any outside packaging and labelling used in the retail sale?,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1249
W14_harm_effects_A,Do health warnings on cigarette packaging describe the harmful effects of tobacco use on health?,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1248
W6_font_A,"Does the law mandate font style, font size and colour of health warnings on cigarette packaging?",776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1247
W7_rotation_A,Are the health warnings on cigarette packaging rotating?,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1246
W8_princ_langs_A,Are the health warnings on cigarette packaging written in the principal language(s) of the country?,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1245
W10_graphic_A,Do the health warnings on cigarette packaging include a photograph or graphic?,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1244
W5_top_side_A,Health warnings on cigarette packaging must be placed at the top of the principal display areas of the package,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2727
W13_ind_liability_A,Health warnings on cigarette packaging do not remove or diminish the liability of the tobacco industry,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2728
W12_imports_dutyfree_A,Health warnings on cigarette packaging law applys to products whether manufactured domestically imported AND for duty-free sale,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2729
W9_no_obscure_A,Health warnings on cigarette packaging must not be obscured in any way including by required markings such as tax stamps,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2730
W17_fines_A,Health warnings on cigarette packaging law requires or establishes fines for violations,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2731
W18_misleading_terms_A,Ban on deceitful terms on cigarette packaging,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1255
W19_colours_numbers_A,Cigarette packaging and labelling must not use figurative or other signs including colors or numbers as substitutes for prohibited misleading terms and descriptors,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2732
W20_flavours_A,Cigarette packaging and labelling must not use descriptors depicting flavours,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2733
W21_emissions_A,Cigarette packaging and labelling must not display quantitative information on emission yields (such as tar nicotine and carbon monoxide) including when used as part of a brand name or trademark,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2734
W22_emissions_qual_A,Cigarette packaging and labelling must display qualitative information on relevant constituents and emissions,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4576
W23_emissions_front_back_A,Cigarette packaging and labelling must display qualitative information on constituents and emissions on one or more of the principal display areas,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4577
W24_exp_date_A,Cigarette packaging and labelling must not display expiry dates,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4578
W25_quitline_number_A,The quit line number must appear on cigarette packaging or labelling,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2735
W26_plainSPACEpackaging_A,Plain packaging of cigarettes is mandatory (ie. the use of logos colours brand images or promotional information on packaging other than brand names and product names displayed in a standard colour and font style is prohibited).,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2736
W27_smokeless_prod_ban,The sale of all smokeless tobacco products is completely banned,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4579
W1_HW_law_C,Law mandates that health warnings appear on smokeless tobacco packages,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2726
W2_pc_front_back_C,Percentage of principal display area mandated to be covered by health warnings - front and back of smokeless tobacco packaging,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1314
W3_pc_front_C,Percentage of principal display area mandated to be covered by health warnings - front of smokeless tobacco packaging,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1266
W4_pc_back_C,Percentage of principal display area mandated to be covered by health warnings - back of smokeless tobacco packaging,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1252
W15_specific_hw_C,Does the law mandate specific health warnings on smokeless tobacco packaging?,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1251
W16_number_hw_C,How many health warnings are approved by the law for smokeless tobacco packaging?,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1250
W11_outside_pack_C,Do health warnings appear on each smokeless tobacco package and any outside packaging and labelling used in the retail sale?,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1249
W14_harm_effects_C,Do health warnings on smokeless tobacco packaging describe the harmful effects of tobacco use on health?,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1248
W6_font_C,"Does the law mandate font style, font size and colour of health warnings on smokeless tobacco packaging?",776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1247
W7_rotation_C,Are the health warnings on smokeless tobacco packaging rotating?,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1246
W8_princ_langs_C,Are the health warnings on smokeless tobacco packaging written in the principal language(s) of the country?,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1245
W10_graphic_C,Do the health warnings on smokeless tobacco packaging include a photograph or graphic?,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1244
W5_top_side_C,Health warnings on smokeless tobacco packaging must be placed at the top of the principal display areas of the package,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2727
W13_ind_liability_C,Health warnings on smokeless tobacco packaging do not remove or diminish the liability of the tobacco industry,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2728
W12_imports_dutyfree_C,Health warnings on smokeless tobacco packaging law applys to products whether manufactured domestically imported AND for duty-free sale,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2729
W9_no_obscure_C,Health warnings on smokeless tobacco packaging must not be obscured in any way including by required markings such as tax stamps,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2730
W17_fines_C,Health warnings on smokeless tobacco packaging law requires or establishes fines for violations,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2731
W18_misleading_terms_C,Ban on deceitful terms on smokeless tobacco packaging,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1255
W19_colours_numbers_C,Smokeless tobacco packaging and labelling must not use figurative or other signs including colors or numbers as substitutes for prohibited misleading terms and descriptors,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2732
W20_flavours_C,Smokeless tobacco packaging and labelling must not use descriptors depicting flavours,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2733
W21_emissions_quant_C,Smokeless tobacco packaging and labelling must not display quantitative information on emission yields (such as tar nicotine and carbon monoxide) including when used as part of a brand name or trademark,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2734
W22_emissions_qual_C,Smokeless tobacco packaging and labelling must display qualitative information on relevant constituents and emissions,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4576
W23_emissions_front_back_C,Smokeless tobacco packaging and labelling must display qualitative information on constituents and emissions on one or more of the principal display areas,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4577
W24_exp_date_C,Smokeless tobacco packaging and labelling must not display expiry dates,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4578
W25_quitline_number_C,The quit line number must appear on smokeless tobacco packaging or labelling,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2735
W26_plainSPACEpackaging_C,Plain packaging of smokeless tobacco products is mandatory (ie. the use of logos colours brand images or promotional information on packaging other than brand names and product names displayed in a standard colour and font style is prohibited).,0.0,
Camp_nat,At least one national mass media campaign ran during the survey period,194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2748
Camp_gov_prog,Campaign was part of a comprehensive tobacco control programme,194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2749
Camp_mat_tested,Campaign was pre-tested,194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2750
Camp_aud_research,Formative research was conducted,194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2751
Camp_tv_radio,Campaign aired on television and/or radio,194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4580
Camp_media_planning,Campaign utilized media planning,194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2752
Camp_news,Earned media/public relations were used to promote the campaign,194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2753
Camp_airtime,Process evaluation was employed to assess implementation,194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2754
Camp_eval_impact,Outcome evaluation was employed to assess effectiveness,194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2755
E1_nat_tv_radio,Ban on advertising: National TV and radio,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1313
E2_intl_tv_radio,"Ban on advertising: International TV and radio (broadcast from abroad, including satellite)",776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1305
E3_nat_print,Ban on advertising: Local magazines and newspapers,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1307
E4_intl_print,Ban on advertising: International magazines and newspapers,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1304
E5_billboards,Ban on advertising: Billboards and outdoor advertising,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1292
E6_pt_of_sale,Ban on advertising: Point of sale,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1315
E7_internet,Ban on advertising: Internet,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1306
EC_direct_compliance,Compliance with bans on direct advertising,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1286
E9_free_distrib,Ban on free distribution of tobacco products in the mail or through other means,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1302
E10_promo_discounts,Ban on promotional discounts,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1316
E11_brand_stretching,Ban on non-tobacco goods AND services identified with tobacco brand names,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1310
E12_brand_sharing,Ban on brand name of non-tobacco products used for tobacco product,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1293
E13_brand_placement,Ban on appearance of tobacco brands in TV and/or films (product placement),776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2756
E14_prod_tv_films,Appearance of tobacco products in TV and/or films,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1291
E15_sponsored_events,Sponsored events,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1317
EC_indirect_compliance,Compliance with bans on promotion and sponsorship,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1295
E16_csr_promo_self,Ban on tobacco companies/tobacco industry publicizing their Corporate Social Responsibility activities,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4581
E17_csr_promo_others,Ban on entities other than tobacco companies/tobacco industry publicizing the Corporate Social Responsibility activities of the tobacco companies,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4582
E18_csr_anti_tobacco_media,"Ban on tobacco companies funding or making contributions (including in-kind contributions) to smoking prevention media campaigns, including those directed at youth",776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4583
E19_movies_anti_tob_ads,"Required anti-tobacco ads for any visual entertainment media product that depicts tobacco products, use or images",776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4585
E21_vending_machines,Complete ban on tobacco vending machines,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4586
E22_subnational_exists,"Subnational bans on tobacco advertising, promotion and sponsorship",776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1318
R_Curr_mp,Most sold brand of cigarettes - currency reported,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1321
R_Price_mp_estimate,Most sold brand of cigarettes - price in currency reported,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=377
R_Price_mp_ppp,Most sold brand of cigarettes - price in international dollars,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2757
R_Price_mp_usd,Most sold brand of cigarettes - price in US$ at official exchange rates,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=378
R_Curr_lowest_cost,Cheapest brand of cigarettes - currency reported,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1321
R_Price_lowest_estimate,Cheapest brand of cigarettes - price in currency reported,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=380
R_Price_lowest_ppp,Cheapest brand of cigarettes - price in international dollars,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2758
R_Price_lowest_usd,Cheapest brand of cigarettes - price in US$ at official exchange rates,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=381
R_Sp_excise_estimate,Most sold brand of cigarettes - taxes as a % of price - specific excise,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=385
R_Ad_val_estimate,Most sold brand of cigarettes - taxes as a % of price - ad valorem excise,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=386
R_imp_duty_estimate,Most sold brand of cigarettes - taxes as a % of price - import duties,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=387
R_VAT_estimate,Most sold brand of cigarettes - taxes as a % of price - value added tax,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1220
R_Other_estimate,Most sold brand of cigarettes - taxes as a % of price - other taxes,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1228
R_total_tax_estimate,Most sold brand of cigarettes - taxes as a % of price - total tax,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1223
R_excise_incr,Tobacco excises increased over the survey period,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2760
R_Curr_average,Average -  cigarette currency,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1321
R_Price_average_curr,Average -  cigarette price in currency,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4593
R_Price_average_ppp,Average -  cigarette price in international dollars,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4594
R_Price_average_usd,Average -  cigarette price in US$ at official exchange rates,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4595
R_Sp_excise_average,Average - taxes as a % of cigarette price - specific excise,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4598
R_Ad_val_average,Average - taxes as a % of cigarette price - ad valorem excise,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4596
R_imp_duty_average,Average - taxes as a % of cigarette price - import duties,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4597
R_VAT_average,Average - taxes as a % of cigarette price - value added tax,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4601
R_Other_average,Average - taxes as a % of cigarette price - other taxes,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4599
R_total_tax_average,Average - taxes as a % of cigarette price - total tax,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4600
Rev_type,Annual tax revenues - tobacco products included,194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4602
Rev_year,Annual tax revenues - year,194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4603
Rev_curr,Annual tax revenues - currency,194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1321
Rev_excise,Annual tax revenues - total excise (specific and ad valorem),194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4604
Rev_VAT,Annual tax revenues - value added tax (vat) and other sales taxes,194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4605
Rev_imp_other,Annual tax revenues - import duties and all other taxes (excluding corporate taxes on tobacco companies),194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4606
Rev_govt_total,Annual tax revenues - total revenues,194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4607
NTCP_govt_obj,Government objectives on tobacco control exist,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1303
NTCP_agcy,National agency for tobacco control exists,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1308
NTCP_FTE,Number of full-time equivalent staff in national agency,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1311
NTCP_govt_exp,Annual budget for tobacco control in currency reported,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1289
NTCP_curr,Reported currency,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1321
NTCP_budget_year,Budget year,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1290
NTCP_usd,Budget year,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1294
P16_subnat_complete_bans_exist,Comprehensive bans in place subnationally,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1242
EQ_UNDERWEIGHT,Prevalence of (moderate or severe) underweight in children,2169.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4713
EQ_OVERWEIGHT,Prevalence of (moderate or severe) overweight in children,2169.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4711
EQ_WATERIMPROVED,Households using an improved drinking-water source (%),2882.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4437
EQ_WATERPIPED,Households using a piped drinking-water source (%),1692.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4443
EQ_WATERPREMISES,Households using a piped onto premises drinking-water source (%),2872.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4438
EQ_HOUSENETS,Households that have a bednet for sleeping (%),1237.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4439
EQ_SLEPTNETS,Women that slept under a bednet last night (%),517.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4435
EQ_SOLIDFUELS,Households that use solid fuels for cooking (%),2119.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4440
EQ_SLUM,Proportion of urban residents living in a slum area,50.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2476
TB_newinc,Tuberculosis - new and relapse cases,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=333
NTD_YAWSEND,Status of yaws endemicity,194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3424
NTD_YAWSNUM,Number of cases of yaws reported,117.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3425
TB_c_newinc,Tuberculosis - new and relapse cases,3462.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=333
TB_hivtest_pct,TB patients with known HIV status (%),2858.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3428
TB_hivtest_pos_pct,Tested TB patients HIV-positive (%),2858.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3429
TB_hiv_cpt_pct,HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) (%),1102.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3430
TB_hiv_art_pct,HIV-positive TB patients on ART (antiretroviral therapy) (%),2858.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3431
TB_e_mdr_num,Estimated MDR-TB cases among notified pulmonary TB cases,196.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1364
TB_c_dst_rlt_new_pct,New cases tested for RR-/MDR-TB (%),2454.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1366
TB_c_dst_rlt_ret_pct,Previously treated cases tested for RR-/MDR-TB (%),2454.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1366
TB_mdr,Confirmed cases of MDR-TB,1262.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1367
TB_conf_mdr_tx_pct,Confirmed cases of MDR-TB started treatment for MDR-TB (%),629.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1368
TB_c_mdr_tsr,Treatment success rate for patients treated for MDR-TB (%),4263.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3432
TB_c_notified,Total number of notified TB cases,2387.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=333
O_Avail_hlth_clin,Treatment for tobacco dependence available in health clinics or other primary care facilities,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1263
O_Ins_hlth_clin,Treatment for tobacco dependence in health clinics or other primary care facilities cost covered,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4573
MORT_600,Projection of number of deaths,5.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=36
MORT_700,Projection of deaths per 100 000 population,,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3367
ITU_IDI,ICT Development Index (IDI),310.0,http://www.itu.int/en/ITU-D/Statistics/Documents/publications/mis2012/MIS2012_without_Annex_4.pdf
ITU_IDI_RANK,ICT Development Index (IDI) rank,310.0,http://www.itu.int/en/ITU-D/Statistics/Documents/publications/mis2012/MIS2012_without_Annex_4.pdf
ITU_ICT_1,Percentage of individuals using the Internet,189.0,
GHE_DALYNUM,Disability-adjusted life years (DALYs),5.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=158
GHE_DALYRATE,Disability-adjusted life years (DALYs) (per 100 000 population),5.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=156
GHE_YLDNUM,Years of healthy life lost due to disability (YLDs),5.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=160
GHE_YLDRATE,Years of healthy life lost due to disability (YLDs) (per 100 000 population),5.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4429
GHE_YLLNUM,Years of life lost from mortality (YLLs),5.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=159
GHE_YLLRATE,Years of life lost from mortality (YLLs) (per 100 000 population),5.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4427
ITU_ICT_2,Mobile-cellular telephone subscriptions per 100 inhabitants,173.0,
NTD_LEISHCEND,Status of endemicity of cutaneous leishmaniasis,193.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3761
NTD_LEISHVEND,Status of endemicity of visceral leishmaniasis,193.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3762
NTD_LEISHCNUM,Number of cases of cutaneous leishmaniasis reported,1070.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3760
NTD_LEISHVNUM,Number of cases of visceral leishmaniasis reported,976.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3759
SA_0000001736,Action Plan for implementation of alcohol policy,66.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2342
SA_0000001719,Advertising restrictions on social media,579.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1408
SA_0000001720,Restrictions on product placement in films/movies,579.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1409
SA_0000001721,Importance of measures for enhancing compliance with age limits,318.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2346
SA_0000001726,Penalties for drink driving,1544.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3781
SA_0000001727,Sobriety checkpoints,193.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2344
SA_0000001730,Price measures,956.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3784
SA_0000001732,New types of alcoholic beverages emerging,53.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3786
SA_0000001731,Level of taxation adjusted for inflation,579.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3785
SA_0000001733,"Consumer information about calories, additives, etc on containers",192.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3787
SA_0000001734,Number of standard alcoholic drinks displayed on containers,192.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3788
SA_0000001735,Alcohol content displayed on containers,192.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3789
SA_0000001722,Government support for community action,772.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2358
SA_0000001723,Community-based interventions involving stakeholders,53.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3778
SA_0000001724,National guidelines for implementing effective community-based interventions,53.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3779
SA_0000001725,National alcohol policy specifically involves young people activities,53.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3780
SA_0000001728,Detection of marketing infringements,193.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3782
SA_0000001729,Penalties for marketing infringements,193.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3783
PerctreatedANC,Antenatal care attendees positive for syphilis who received treatment (%),326.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3777
EMFSTANDARD,Existence of standards,246.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4483
EMFSTATUS,Legislative status,224.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4987
EMFSAR,Specific absorption rate (SAR) (W/kg),183.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4725
EMFLIMITS,Limit values,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4722
NTD_2_YEAR_CERTIFIED,Year country was certified,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2468
NTD_DRACASES,Dracunculiasis cases,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2468
AIR_2_2,Ambient air pollution  in urban areas (Annual PM<sub>2.5</sub> [&#956;g/m<sup>3</sup>]),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1349
AIR_35,Joint effects of air pollution attributable deaths,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3793
AIR_36,Joint effects of air pollution attributable deaths in children under 5 years,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3793
AIR_37,Joint effects of air pollution attributable deaths  per 100'000 capita,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3793
AIR_38,Joint effects of air pollution attributable deaths per 100'000 children under 5 years,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3793
NHAGGHEGDP,General government expenditure on health as percentage of gross domestic product,0.0,
NHAOOPSTHE,Out-of-Pocket expenditure on health as percentage of total health expenditure??,0.0,
NHAPREPAIDTHE,Prepaid plans as percentage of total health expenditure?,0.0,
IHR01,Legislation,1206.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4407
IHR02,Coordination,1206.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4408
IHR03,Surveillance,1206.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4409
IHR04,Response,1206.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4410
IHR05,Preparedness,1206.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4411
IHR06,Risk communication,1206.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4412
IHR07,Human resources,1206.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4413
IHR08,Laboratory,1206.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4414
IHR09,Points of entry,1206.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4415
IHR10,Zoonosis,1206.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4416
IHR11,Food safety,1206.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4417
IHR12,Chemical,1206.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4418
IHR13,Radionuclear,1206.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4419
EMFPOWERFREQUENCY,Power frequency (Hz),61.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4726
carep,Children aged < 5 years with pneumonia symptoms taken to a health facility (%),7469.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=3330
fps,Demand for family planning satisfied - modern and traditional methods (%),7487.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=3321
fullv,Full immunization coverage among one-year-olds (%),7475.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=3317
itnch,Children aged < 5 years sleeping under insecticide-treated nets (%),7469.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=3327
itnwm,Pregnant women sleeping under insecticide-treated nets (%),6795.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=3318
mslv,Measles immunization coverage among one-year-olds (%),7475.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=3337
obesewm,"Obesity prevalence in non-pregnant women aged 15-49 years, BMI >= 30 (%)",6795.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=3319
anc4,Antenatal care coverage - at least four visits (in the two or three years preceding the survey) (%),6795.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=3323
csection,Births by caesarean section (in the two or three years preceding the survey) (%),6811.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=3326
pncall,Postnatal care visit within two days of birth (in the x years preceding the survey) (%),1888.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3340
pnchome,Postnatal care visit within two days of birth - born outside a health facility (in the x years preceding the survey) (%),1253.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3341
SA_0000001737,"Alcohol, regional per capita (15+) consumption (in litres of pure alcohol)",42.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=465
SA_0000001739,"Alcohol, heavy episodic drinking (population) past 30 days (%), age-standardized with 95%CI",579.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=459
SA_0000001740,Alcohol-attributable Years of Life Lost (YLL) score,194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2376
SA_0000001741,"Alcohol-attributable fractions (15+), liver cirrhosis deaths (%)",388.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2332
SA_0000001742,"Alcohol-attributable fractions (15+), road traffic crash deaths (%)",388.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2332
SA_0000001743,"Alcohol-attributable fractions, all-cause deaths (%)",582.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2332
SA_0000001744,"Alcohol, regional prevalence of alcohol dependence (%)",7.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1389
SA_0000001745,"Alcohol, regional prevalence of alcohol use disorders (%)",7.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1388
SA_0000001746,"Alcohol, total  (recorded + unrecorded) per capita (15+) consumption with 95%CI, projections to 2025",582.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4402
SA_0000001747,"Alcohol, recorded per capita (15+) consumption (in litres of pure alcohol), three-year average with 95%CI",199.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=462
SA_0000001748,"Alcohol, unrecorded per capita (15+) consumption (in litres of pure alcohol) with 95%CI",194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=466
SA_0000001749,"Alcohol, total (recorded 3 year average + unrecorded) per capita (15+) consumption (in litres of pure alcohol) with 95%CI",582.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=465
SA_0000001751,"Alcohol, average daily intake in grams among drinkers with 95%CI",579.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4403
SA_0000001752,"Alcohol, total (recorded + unrecorded) per capita (15+) consumption, projected estimates for 2016",195.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4759
SA_0000001753,"Alcohol use disorders (15+), 12 month prevalence (%), age standardized, with 95%CI",579.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1388
SA_0000001754,"Alcohol, harmful use (15+), 12 month prevalence (%) with 95%CI",579.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4404
SA_0000001755,"15-19 years old heavy episodic drinkers (population), % with 95%CI",581.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=459
SA_0000001756,"15-19 years old heavy episodic drinkers (drinkers only), %",388.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=458
SA_0000001757,"15-19 years old abstainers, lifetime (%)",388.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=460
SA_0000001758,15-19 years old former drinkers (%),388.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=457
SA_0000001759,"15-19 years old, current drinkers (%)",388.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2325
EMFLIMITELECTRIC,Electric field (kV/m),32.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4722
EMFLIMITMAGNETIC,Magnetic flux density (microT),108.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4723
EMFLIMITELECTRIC1800,Electric field limit at 1800 MHz (V/m),0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4722
EMFLIMITELECTRIC900,Electric field limit at 900 MHz (V/m),0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4722
EMFLIMITPOWERDENSITY1800,Power density limit at 1800 MHz (W/m^2),0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4724
EMFLIMITPOWERDENSITY900,Power density limit at 900 MHz (W/m^2),0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4724
NTD_ONCHEMO,Estimated number of individuals in the country requiring preventive chemotherapy for onchocerciasis,152.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4421
NTD_ONCTREAT,Reported number of individuals treated for onchocerciasis,415.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4423
NTD_ONCHSTATUS,Status of endemicity of onchocerciasis,38.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4424
DEATHSTOTAL,Deaths total,580.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2260
DEATHS04Y,"Deaths, children aged under 5 years",580.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2260
DALYSTOTAL,Disability-adjusted life years (DALYs) total (000s),580.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2260
DALYS04Y000,"Disability-adjusted life years (DALYs), children aged under 5 years (000s)",580.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2260
DEATHSPER100000,Deaths per 100 000 population,580.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2260
DALYSPER100000,Disability-adjusted life years (DALYs) per 100 000 population,580.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2260
WHS7_150,Out-of-pocket expenditure as a percentage of total expenditure on health,4015.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4445
NCD_CCS_NCDGuide,Existence of evidence-based national guidelines/protocols/standards for the management of major NCDs through a primary care approach,582.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4478
NCD_CCS_MultisecNCDPlan,"Existence of at least one operational multisectoral national policy, strategy or action plan that integrates several noncommunicable diseases and shared risk factors in conformity with the global/regional noncommunicable disease action plans 2013?2020",0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4480
NCD_CCS_SurvMonRep9NCD,Existence of an NCD surveillance and monitoring system in place to enable reporting against the nine global NCD targets,194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4481
NCD_CCS_CancerRegNational,Existence of population-based cancer registry,582.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4479
NCD_CCS_NCDUnit_Operational,"Existence of an Operational Unit, Branch, or Dept. in Ministry of Health with responsibility for NCDs",582.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2396
SA_0000001761,National guidelines for the prevention and reduction of alcohol-related harm in schools,53.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4447
SA_0000001762,National guidelines for alcohol problem prevention and counselling at workplaces,53.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4448
SA_0000001763,Workplace representatives nationally involved to prevent and address alcohol-related harm,53.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4449
SA_0000001764,Server training,194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2360
SA_0000001765,Legal obligation for schools to include alcohol use prevention,53.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4450
SA_0000001766,Legal obligation for schools to interact with parents regarding education and well-being,53.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4451
SA_0000001767,Legislation on alcohol testing at workplaces,53.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4452
SA_0000001768,Standard drink defined,194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2361
SA_0000001769,National sytems for monitoring alcohol consumption and harms,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2369
SA_0000001770,Regular reports from national monitoring systems,194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2362
SA_0000001771,Comprehensive and regular reporting of alcohol situation,52.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4453
SA_0000001772,Clinical guidelines for brief interventions,53.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4454
SA_0000001773,National surveys on adult alcohol consumption,194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4456
SA_0000001774,National surveys on youth alcohol consumption,193.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4457
SA_0000001775,National surveys on heavy espisodic drinking,53.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2366
SA_0000001776,Data collection on Foetal Alcohol Syndome,53.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2364
SA_0000001777,Data collected on harm from alcohol at workplace,53.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2319
SA_0000001778,New types of alcoholic beverages emerging,0.0,
TB_c_mdr_tx,Cases started on MDR-TB treatment,2454.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1368
TB_new_clindx,"New or unknown treatment history cases: Pulmonary, clinically diagnosed",3462.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=333
TB_new_labconf,"New or unknown treatment history cases: Pulmonary, bacteriologically confirmed",3462.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=333
TB_new_snsuoth,"New cases: Pulmonary, smear-negative/unknown/not done and other new cases",3462.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=333
TB_ret_nrel,"Previously treated  cases, excluding relapse",3462.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=333
TB_ret_rel_clindx,"Relapse cases: Pulmonary, clinically diagnosed",3462.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=333
TB_ret_rel_ep,Relapse cases: extrapulmonary,3462.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=333
TB_ret_rel_labconf,"Relapse cases: Pulmonary, bacteriologically confirmed",3462.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=333
TB_rr_mdr,Confirmed cases of RR-/MDR-TB,2454.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1367
TB_c_new_tsr,Treatment success rate: new TB cases,4263.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4462
TB_c_tbhiv_tsr,Treatment success rate: HIV-positive TB cases,4263.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4462
TB_c_xdr_tsr,Treatment success rate: XDR-TB cases,4263.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3432
TB_new_snuoth,TB_new_snuoth,0.0,
NTD_BEJELSTATUS,Status of bejel endemicity,194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4458
NTD_BEJELNUM,Number of cases of bejel reported,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4459
NTD_PINTASTATUS,Status of pinta endemicity,194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4460
NTD_PINTANUM,Number of cases of pinta reported,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4461
SA_0000001760,15-19 years old total alcohol consumption in litres of pure alcohol,582.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=465
VIOLENCE_EXTENTIMP_CHILDHOMEVISIT,Child maltreatment: Extent of implementation of home-visiting programmes,132.0,
VIOLENCE_EXTENTIMP_YOUTHLIFESKILLS,Youth violence: Extent of implementation of life-skills and social development programmes,132.0,
VIOLENCE_EXTENTIMP_PARTNERVIOLPREVENTION,Intimate partner violence: Extent of implementation  of dating violence prevention programmes,132.0,
VIOLENCE_EXTENTIMP_ELDERCAREGIVER,Elder abuse: Extent of implementation  of caregiver-support programmes,132.0,
VIOLENCE_EXTENTIMP_ALLTYPES,Extent of implementation of  mental health services for victims of all types of violence,132.0,
VIOLENCE_EXTENTIMP_CHILDPROTECTION,Extent of implementation of child protection services,132.0,
VIOLENCE_EXTENTIMP_VICTIMSMEDICOLEGAL,Extent of implementation of medico-legal services for victims of sexual violence,132.0,
VIOLENCE_CHILD_PHYSICAL,Lifetime prevalence of child physical abuse (%),1.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4466
VIOLENCE_CHILD_EMOTIONAL,Lifetime prevalence of child emotional abuse (%),1.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4467
VIOLENCE_CHILD_SEXUAL,Lifetime prevalence of child sexual abuse (%),2.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4468
VIOLENCE_CHILD_NEGLECT,Lifetime prevalence of child physical neglect (%),1.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4469
VIOLENCE_HOMICIDENUM,Estimates of number of homicides,194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4464
VIOLENCE_HOMICIDERATE,Estimates of rates of homicides per 100 000 population,2850.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4465
HIV_ARTCOVERAGE,Estimated antiretroviral therapy coverage among people living with HIV (%),175.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4755
LEPTO_MORTALITY,Estimated leptospirosis deaths (per 100 000 population),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4649
LEPTO_MORBIDITY,Estimated leptospirosis incidence (per 100 000 population),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4648
cci,Composite coverage index (%),0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4489
ors,Children aged < 5 years with diarrhoea receiving oral rehydration salts (%),5.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4490
overwgt3,Overweight prevalence in children aged <three years (%),303.0,
overwgt5,Overweight prevalence in children aged <five years (%),571.0,
wast3,Wasting prevalence in children aged < 3 years (%),5.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4487
wast5,Wasting prevalence in children aged < 5 years (%),5.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4488
NCD_PAC_ADO,Insufficiently active (crude estimate),615.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4482
NTD_LEISHCNUM_IM,Number of imported cases of cutaneous leishmaniasis reported,264.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4485
NTD_LEISHVNUM_IM,Number of imported cases of visceral leishmaniasis reported,276.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4484
DEVICES00,Total density per 100 000 population: Hospitals,137.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3361
IR_INSECTICIDERESISTANCE_PREV,Number of insecticide classes to which resistance was reported,-1.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4557
IR_PYRETHROID_PRESENCE,Pyrethroid resistance reported for at least one site,1545.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4558
IR_ORGANOCHLORINE_PRESENCE,Organochlorine resistance reported for at least one site,-1.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4559
IR_CARBAMATE_PRESENCE,Carbamate resistance reported for at least one site,1545.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4560
IR_ORGANOPHOSPHATE_PRESENCE,Organophosphate resistance reported for at least one site,-1.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4561
IR_PYRETHROID_EXTENT,Percentage of sites for which pyrethroid resistance was reported,1442.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4562
IR_ORGANOCHLORINE_EXTENT,Percentage of sites for which organochlorine resistance was reported,-1.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4563
IR_CARBAMATE_EXTENT,Percentage of sites for which carbamate resistance was reported,1415.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4564
IR_ORGANOPHOSPHATE_EXTENT,Percentage of sites for which organophosphate resistance was reported,1413.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4565
SA_0000001779,Level of enforcement of BAC limits,0.0,
AIR_40,Household air pollution attributable DALYs,-1.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4491
NCD_CCS_UrineAlbumin,General availability of urine testing for albumin,582.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4553
NCD_CCS_Bronchodilators,General availability of bronchodilators in the public health sector,-1.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4554
PREVANEMIA,Prevalence of anaemia in women of reproductive age (%),-1.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4552
HRH_40,Biomedical engineers density (per 10 000 population),-1.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4584
SA_0000001750,Average daily intake in grams of alcohol among drinkers,-1.0,
SA_0000001780,"15-years old any alcoholic beverage consumed at least once in lifetime, (%)",-1.0,
SA_0000001781,"15-years old any alcoholic beverage consumed in past 12 months, (%)",432.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4555
SA_0000001782,"15-years old first drink at 13 years or younger, (%)",216.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4555
SA_0000001783,"15-years old any alcoholic beverage consumed in past 30 days, (%)",444.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4555
SA_0000001784,"15-years old, any alcoholic beverage consumed at least once a week, (%)",146.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4555
SA_0000001785,"15-years old ever got drunk in the past 30 days, (%)",0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4555
SA_0000001786,"13-15-years old any alcoholic beverage consumed in past 30 days, (%)",192.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4556
SA_0000001787,"13-15-years old first drink before age 14, (%)",114.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4556
CaseCS,Congenital syphilis number of reported cases,163.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4492
RateCS,Congenital syphilis rate per 100 000 live births,220.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4493
MH_19,"Mental hospital admissions (per 100,000)",0.0,
MH_20,"Outpatient visits (per 100,000)",0.0,
MH_21,"Total workforce in mental health sector (per 100,000)",0.0,
MH_22,"Occupational therapists in mental health sector (per 100,000)",0.0,
MH_23,"Other non-specialized doctors in mental health sector (per 100,000)",0.0,
MH_24,"Mental health units in general hospitals admissions (per 100,000)",0.0,
MH_25,Stand-alone policy or plan for mental health,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2950
SA_0000001718,Action Plan for implementation of alcohol policy,0.0,
SA_0000001738,Regional alcohol per capita (15+) consumption- total,0.0,
SA_0000001788,"Alcohol-related road traffic crashes with fatalities, per 100,000  population",358.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4566
VIOLENCE_PHYSICAL_FIGHTING,"Physical fighting, past 12 months (%)",0.0,
VIOLENCE_BULLIED,"Bullied, past 30 days (%)",0.0,
W1_HW_law_B,Law mandates that health warnings appear on other smoked tobacco packages,-1.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2726
W2_pc_front_back_B,Percentage of principal display area mandated to be covered by health warnings - front and back of other smoked tobacco packaging,5.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1314
W3_pc_front_B,Percentage of principal display area mandated to be covered by health warnings - front of other smoked tobacco packaging,5.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1266
W4_pc_back_B,Percentage of principal display area mandated to be covered by health warnings - back of other smoked tobacco packaging,-1.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1252
W15_specific_hw_B,Does the law mandate specific health warnings on other smoked tobacco packaging?,-1.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1251
W16_number_hw_B,How many health warnings are approved by the law for other smoked tobacco packaging?,5.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1250
W11_outside_pack_B,Do health warnings appear on each other smoked tobacco package and any outside packaging and labelling used in the retail sale?,-1.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1249
W14_harm_effects_B,Do health warnings on other smoked tobacco packaging describe the harmful effects of tobacco use on health?,5.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1248
W6_font_B,"Does the law mandate font style, font size and colour of health warnings on other smoked tobacco packaging?",5.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1247
W7_rotation_B,Are the health warnings on other smoked tobacco packaging rotating?,-1.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1246
W8_princ_langs_B,Are the health warnings on other smoked tobacco packaging written in the principal language(s) of the country?,5.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1245
W10_graphic_B,Do the health warnings on other smoked tobacco packaging include a photograph or graphic?,-1.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1244
W5_top_side_B,Health warnings on other smoked tobacco packaging must be placed at the top of the principal display areas of the package,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2727
W13_ind_liability_B,Health warnings on other smoked tobacco packaging do not remove or diminish the liability of the tobacco industry,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2728
W12_imports_dutyfree_B,Health warnings on other smoked tobacco packaging law applys to products whether manufactured domestically imported AND for duty-free sale,-1.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2729
W9_no_obscure_B,Health warnings on other smoked tobacco packaging must not be obscured in any way including by required markings such as tax stamps,5.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2730
W17_fines_B,Health warnings on other smoked tobacco packaging law requires or establishes fines for violations,-1.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2731
W18_misleading_terms_B,Ban on deceitful terms on other smoked tobacco packaging,-1.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1255
W19_Bolours_numbers_B,Other smoked tobacco packaging and labelling must not use figurative or other signs including colors or numbers as substitutes for prohibited misleading terms and descriptors,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2732
W20_flavours_B,Other smoked tobacco packaging and labelling must not use descriptors depicting flavours,-1.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2733
W21_emissions_quant_B,Other smoked tobacco packaging and labelling must not display quantitative information on emission yields (such as tar nicotine and carbon monoxide) including when used as part of a brand name or trademark,-1.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2734
W22_emissions_qual_B,Other smoked tobacco packaging and labelling must display qualitative information on relevant constituents and emissions,-1.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4576
W23_emissions_front_back_B,Other smoked tobacco packaging and labelling must display qualitative information on constituents and emissions on one or more of the principal display areas,5.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4577
W24_exp_date_B,Other smoked tobacco packaging and labelling must not display expiry dates,-1.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4578
W25_quitline_number_B,The quit line number must appear on other smoked tobacco packaging or labelling,5.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2735
E26_direct_ad_fines,Law requires fines for violations of direct advertising bans,-1.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4567
E27_indirect_ad_fines,Law requires fines for violations of indirect advertising bans,-1.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4568
E24_internet_sales_ban,Ban on internet sales of tobacco products,5.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4587
E25_ban_display_pt_of_sale,Ban on display of tobacco products at points of sale,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4588
E23_subnat_complete_bans_exist,"Subnational advertising, promotion and sponsorship bans - at least one jurisdiction has a comprehensive ban in place",-1.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4589
R_Curr_premium_cost,Premium brand of cigarettes - currency reported,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1321
R_Price_premium_estimate,Premium brand of cigarettes - price in currency reported,-1.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4590
R_Price_premium_ppp,Premium brand of cigarettes - price in international dollars,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4591
R_Price_premium_usd,Premium brand of cigarettes - price in US$ at official exchange rates,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4592
R_excise_type,Tax structure: Type of excise tax applied,194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4615
R_excise_uniform_varied,Tax structure: Uniform excise tax,194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4609
R_excise_specific_reliance,Tax structure: Greater reliance on specific tax in mixed excise regime,194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4610
R_excise_min_specific,Tax structure: Minimum specific tax applied in ad valorem or mixed excise regime,194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4616
R_excise_retail_price_base,Tax structure: Retail price used as base of ad valorem component in ad valorem or mixed excise regime (or retail price exclusive of VAT),194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4617
R_afford_less,Affordability: Cigarettes are less affordable in 2014 compared to 2008,194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4614
R_afford_tax_auto_adjust,Affordability: Specific tax component automatically adjusted for inflation (or other),194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4611
R_admin_tax_stamps,Tax administration: Tax stamps applied on tobacco products,194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4612
R_admin_duty_free_limited,Tax administration: Bans or limits on duty free imports by travellers,194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4619
R_admin_duty_free_allowance,"Tax administration: If duty free imports are limited, duty free allowance (number of cigarette sticks)",194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4618
P1_compliance,Compliance of ban on smoking in HEALTH-CARE FACILITIES,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1265
P2_compliance,Compliance of ban on smoking in EDUCATIONAL FACILITIES EXCEPT UNIVERSITIES,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1265
P3_compliance,Compliance of ban on smoking in UNIVERSITIES,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1265
P4_compliance,Compliance of ban on smoking in GOVERNMENT FACILITIES,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1265
P5_compliance,Compliance of ban on smoking in INDOOR OFFICES,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1265
P6_compliance,Compliance of ban on smoking in RESTAURANTS,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1265
P7_compliance,Compliance of ban on smoking in PUBS AND BARS,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1265
P8_compliance,Compliance of ban on smoking in PUBLIC TRANSPORT,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1265
E1_compliance,Compliance of ban on advertising on national TV and radio,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1286
E3_compliance,Compliance of ban on advertising on local magazines and newspapers,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1286
E5_compliance,Compliance of ban on advertising on billboards and outdoor advertising,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1286
E6_compliance,Compliance of ban on advertising at point of sale,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1286
E9_compliance,Compliance of ban on free distribution of tobacco products in the mail or through other means,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1295
E10_compliance,Compliance of ban on promotional discounts,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1295
E11_compliance,Compliance of ban on non-tobacco goods AND services identified with tobacco brand names,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1295
E12_compliance,Compliance of ban on brand name of non-tobacco products used for tobacco product,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1295
E13_compliance,Compliance of ban on appearance of tobacco brands in TV and/or films (product placement),776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1295
E14_compliance,Compliance of ban on appearance of tobacco products in TV and/or films,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1295
E15_compliance,Compliance of ban on sponsored events,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1295
W19_colours_numbers_B,Other smoked tobacco packaging and labelling must not use figurative or other signs including colors or numbers as substitutes for prohibited misleading terms and descriptors,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2743
W21_emissions_B,Other smoked tobacco packaging and labelling must not display quantitative information on emission yields (such as tar nicotine and carbon monoxide) including when used as part of a brand name or trademark,0.0,
R_excise_proportion,Tax structure: Excise tax proportion of price,194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4608
R_afford_gdp,"Affordability: % of GDP per capita required to purchase 100 packs of most sold brand (the higher the %, the less affordable)",194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4613
R_afford_price_dispersion,Affordability: Price dispersion: share of cheapest brand price in premium brand price (the higher the % the smaller the gap),194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4621
W26_plain_packaging_A,Plain packaging of cigarettes is mandatory (ie. the use of logos colours brand images or promotional information on packaging other than brand names and product names displayed in a standard colour and font style is prohibited).,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2736
W26_plain_packaging_C,Plain packaging of smokeless tobacco products is mandatory (ie. the use of logos colours brand images or promotional information on packaging other than brand names and product names displayed in a standard colour and font style is prohibited).,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2736
W26_plain_packaging_B,Plain packaging of other smoked tobacco products is mandatory (ie. the use of logos colours brand images or promotional information on packaging other than brand names and product names displayed in a standard colour and font style is prohibited).,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2736
MORT_MATERNALNUM,Number of maternal deaths,585.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4622
RS_223_BIS,Law requires helmet to be fastened,179.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4651
SUNBEDEXIST,Existence of national regulation,45.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4625
SUNBEDEXISTYEAR,Year of national implementation of regulation,24.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4631
RS_242,Vehicle standards,1253.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4652
SUNBEDREG_ACCESS,Access restrictions,125.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4626
SUNBEDREG_CONTROL,Restriction and inspection of facilities,75.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4627
SUNBEDREG_INFO,Information requirements,75.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4628
SUNBEDREG_TRAINING,Training requirements,50.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4630
SUNBEDREG_SAFETY,Safety requirements,50.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4629
HRH_41,Number of licensed qualified surgeons actively working,156.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4663
HRH_42,Number of licensed qualified obstetricians actively working,162.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4662
HRH_43,Number of licensed qualified anaesthesiologists actively working,160.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4661
LEPTO_YLD,Years of healthy life lost to disability (YLDs) due to leptospirosis,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4646
LEPTO_YLD100K,Years of healthy life lost to disability (YLDs) (per 100 000 population) due to leptospirosis,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4647
LEPTO_YLL,Years of life lost (YLLs) due to leptospirosis,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4644
LEPTO_YLL100K,Years of life lost (YLLs)  (per 100 000 population) due to leptospirosis,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4645
LEPTO_DALY,Disability-adjusted life years (DALYs) due to leptospirosis,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4642
LEPTO_DALY100K,Disability-adjusted life years (DALYs) (per 100 000 population) due to leptospirosis,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4643
EQ_ADOBIRTH,"Adolescent birth rate (births per 1,000 women aged 15 to 19)",1666.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4709
EQ_ITN,Households with at least one ITN for sleeping (%),854.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4439
EQ_U5SLEPTNETS,Children under five who slept under a bednet the previous night (%),703.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4439
EQ_ITNUNDER5,Children under five who slept under an ITN the previous night (%),677.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4439
EQ_CONTRACEPTIVE,Contraceptive prevalence rate among women married or in union,5.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4715
EQ_HANDWASHING,Households with soap and water at a handwashing facility (%),0.0,
EQ_CONDOMUSE,People who identify the use of condoms as a way to avoid AIDS (%),5.0,
EQ_DIRTFLOOR,Households with dirt floor (%),0.0,
EQ_OPENDEFECATION,Population not using any sanitation facility (open defecation) (%),5.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4710
MALARIA_15081,IPT 3rd dose,0.0,
EQ_OVERWEIGHTADULT,Prevalence of overweight and obesity,5.0,
SDGAIRBOD,Mortality rate attributed to household and ambient air pollution (per 100 000 population),190.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3793
SDGHIV,New HIV infections (per 1000 uninfected population),201.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4752
SDGMALARIA,Malaria incidence (per 1 000 population at risk),566.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4670
SDGPM25,Concentrations of fine particulate matter (PM2.5),632.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4674
SDGPOISON,Mortality rate attributed to unintentional poisoning (per 100 000 population),2850.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4666
SDGPOLLUTINGFUELS,Proportion of population with primary reliance on clean fuels and technologies (%),1125.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4673
SDGROADAGE,Age-standardized road traffic  mortality (per 100 000 population),0.0,
SDGTOBACCO,Age-standardized prevalence of current tobacco smoking among persons aged 15 years and older,480.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=346
SDGWSHBOD,Mortality rate attributed to exposure to unsafe WASH services (per 100 000 population),232.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4675
SDGNTDTREATMENT,Reported number of people requiring interventions against NTDs,1407.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4671
SDGOOP,Out-of-pocket expenditure as a percentage of total expenditure on health,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4445
SDGSAB,Proportion of births attended by skilled health personnel (%),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=25
SDGFP,Married or in-union women of reproductive age who have their need for family planning satisfied with modern methods (%),126.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4668
SDGABR,Adolescent birth rate (births per 1 000 women aged 15-19),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3322
CCO_WHS9_85,Literacy rate among adults aged >= 15 years (%),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=77
LEADCONTROL,Legally binding lead controls,194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4676
LEADCONTROLEGISLATION,Name of legislation for lead controls,0.0,
LEADCONTROLEGISLATIONDESC,Description of legislation for lead controls,0.0,
SDGCONFLICT,Estimated direct deaths from major conflicts (per 100 000 population),190.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3367
SDGDISASTER,Average death rate due to natural disasters (per 100 000 population),190.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4665
SDGSUICIDE,Crude suicide rates (per 100 000 population),3270.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4664
SDGSHP,Skilled health professionals density (per 10 000 population),268.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4667
SDGIHR,Average of 13 International Health Regulations core capacity scores,1158.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4672
EMFLIMITPOWERDENSITY,Power density (W/m^2),130.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4724
EMFLIMITELECTRICRADIO,Electric field limit (V/m),0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4722
WHOSIS_000007,Healthy life expectancy (HALE) at age 60 (years),2856.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=66
NTD_RAB2,Reported number of human rabies deaths,970.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4677
NTD_TRA5,Number of people operated for trachomatous trichiasis,264.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4679
NCD_CCS_MultisecComm,"Existence of a national multisectoral commission, agency or mechanism for NCDs",388.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4678
NCD_CCS_NCDIndicators,Existence of a set of national NCD indicators and has set time-bound national targets for these indicators,194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4681
NCD_CCS_integNCDplan,"Existence of an operational, multisectoral national NCD policy, strategy or action plan that integrates several NCDs and their risk factors",582.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4680
NCD_CCS_Mkting,Existence of any policies on marketing of foods to children,388.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4682
NCD_CCS_SaltPol,Existence of any policies to reduce population salt consumption,388.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4683
NCD_CCS_SatFat,Existence of national policies on saturated fatty acids / trans-fats,388.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4684
NCD_CCS_dietpaaware,Implementation of diet and/or physical activity public awareness program,194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4685
EMFLIMITELECTRICRF,Electric field (V/m),128.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4722
EMFLIMITELECTRICLF,Electric field (kV/m),62.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4722
NCD_CCS_diabtest,"General availability of diabetes testing (by blood glucose measurement, OGTT) at the primary health care level",582.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2413
NCD_CCS_HbA1c,General availability of diabetes testing (by HbA1c) at the primary health care level,582.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4688
NCD_CCS_DiabetesReg,Existence of a diabetes registry,388.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4686
NCD_CCS_PM3_Surv,Has a STEPS survey or a comprehensive health examination survey every 5 years,388.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4687
NCD_CCS_breastcancerscreening,Existence of national screening program for breast cancer,388.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4689
NCD_CCS_cervicalcancerscreening,Existence of national screening program for cervical cancer,388.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4690
NCD_CCS_cervicalcancermethod,Most widely used screening method in national cervical cancer screening program,388.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4691
NCD_CCS_cervicalcancerpgmtype,Type of national cervical cancer screening program,388.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4692
NCD_CCS_cervicalcancerpgmcvg,Coverage of national cervical cancer screening program (%),388.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4693
NCD_CCS_hpv,Existence of national HPV vaccination programme,388.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4694
NCD_CCS_photocoag,General availability of retinal photocoagulation in the public health system,388.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4695
NCD_CCS_dialysis,General availability of dialysis in the public health system,388.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4696
NCD_CCS_renaltrans,General availability of renal replacement by transplantation in the public health system,388.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4697
NCD_CCS_coronary,General availability of coronary bypass or stenting in the public health system,388.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4698
NCD_CCS_thrombolytic,General availability of thrombolytic therapy in the public health system,388.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4699
NCD_CCS_palliative_prim,General availability of palliative care in primary health care in the public health system,388.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4700
NCD_CCS_palliative_home,General availability of palliative care in community or home-based care in the public health system,388.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4701
NCD_CCS_riskstrat,Availability of cardiovascular risk stratification in 50% or more primary health care facilities,388.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4702
NCD_CCS_stroke,Provision for care of acute stroke and rehabilitation in more than 50% of public sector health facilities,388.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4703
NCD_CCS_rheum,Provision for secondary prevention of rheumatic fever and rheumatic heart disease in more than 50% of public sector health facilities,194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4704
NCD_CCS_betablockers,General availability of beta blockers in the public health sector,388.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4705
NCD_CCS_sulphonylurea,General availability of sulphonylurea(s) in the public health sector,388.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4706
AIR_41,Ambient air pollution attributable deaths,3492.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2259
AIR_42,"Ambient air pollution attributable deaths (per 100 000 population, age-standardized)",194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2259
AIR_43,Ambient air pollution attributable DALYs,3492.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2259
AIR_44,DALYs attributable to ambient air pollution (age-standardized),194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2259
SDGAIRBODA,Age-standardized mortality rate attributed to household and ambient air pollution (per 100 000 population),190.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=3793
AIR_45,Ambient air pollution attributable YLLs,3492.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2259
AIR_46,YLLs attributable to ambient air pollution (age-standardized),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2259
AIR_50,"Ambient air pollution attributable deaths (per 100 000 population, age-standardized)",194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2259
TB_e_rr_in_notified_pulm,Estimated MDR/RR-TB cases among notified pulmonary TB cases,3462.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1364
OA_DMFT,"Decayed, missing, or filled teeth",0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=3812
CATARACTSURGICAL,Cataract surgical coverage of adults aged 50 and over (%),102.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4729
CATARACTSURGICALEFFECTIVE,Effective cataract surgical coverage of adults aged 50 and over (%),90.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4730
MORTADO,Adolescent mortality rate (per 100 000 population),255.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4751
SG_REG_BRTH,Proportion of children under 5 years of age whose births have been registered with a civil authority,0.0,
SE_G23_MATH,Proportion of children in grades 2/3 achieving at least a minimum proficiency level in mathematics (%),75.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4742
SE_G23_RDG,Proportion of children in grades 2/3 achieving at least a minimum proficiency level in reading (%),75.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4742
SE_LSC_MATH,Proportion of children at the end of lower secondary achieving at least a minimum proficiency level in mathematics (%),300.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4742
SE_LSC_RDNG,Proportion of children at the end of lower secondary achieving at least a minimum proficiency level in reading (%),177.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4742
SE_PRM_MATH,Proportion of children at the end of primary achieving at least a minimum proficiency level in mathematics (%),258.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4742
SE_PRM_RDNG,Proportion of children at the end of primary achieving at least a minimum proficiency level in reading (%),240.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4742
VC_VAW_SXVLN,Proportion of young women and men aged 18-29 years who experienced sexual violence by age 18 (%),39.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4746
SG_REG_CENSUS,Proportion of countries that have conducted at least one population and housing census in the last 10 years (%),15.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4743
SG_REG_CENSUSN,Number of countries that have conducted at least one population and housing census in the last 10 years,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4743
UNICEF_PNCMOTHER,Women age 15-49 years who received a health check within 2 days after delivery of their most recent live birth in the last 2 years (%),99.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4734
UNICEF_NEWBORN,Proportion of newborns who have postnatal contact with a health provider within 2 days of delivery (%),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4735
UNICEF_PNCNEWBORN,Proportion of newborns who have postnatal contact with a health provider within 2 days of delivery (%),91.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4735
UNICEF_ORS,Children aged <5 years with diarrhoea receiving ORS (%),357.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4736
UNICEF_PNEUMONIACARE,Children aged < 5 years with pneumonia symptoms taken to a healthcare provider (%),0.0,
MALARIA_ITNPOP,Population sleeping under a bed net(%),0.0,
MALARIA_ITNPREG,Pregnant women sleeping under insecticide-treated nets the previous night (%),0.0,
SI_POV_DAY1,Proportion of population below the international poverty line of US$1.90 per day (%),948.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4744
SI_POV_EMP1,Employed population below the international poverty line of US$1.90 per day (the working poor) (%),0.0,
SE_DEV_ONTRK,"Children aged 36-59 months who are developmentally on track in at least three of the following domains: literacy-numeracy, physical development, social-emotional development and learning (%)",60.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4748
SE_PRE_PARTN,Participation rate in organized learning (one year before the official primary entry age) (%),1638.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4745
SP_DYN_MRBF15,Proportion of women aged 20-24 years who were married or in a union by age 15 (%),124.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4749
SP_DYN_MRBF18,Proportion of women aged 20-24 years who were married or in a union by age 18 (%),124.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4749
SH_STA_FGMS,Proportion of girls and women aged 15-49 years who have undergone female genital mutilation/cutting (FMG/C) (%),232.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4747
GB_XPD_RSDV,Research and development (R&amp;D) expenditure as a proportion of GDP,0.0,0
HSS_UHCLEGISLATION,Countries that have passed legislation on Universal Health Coverage (UHC),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4740
HSS_COMPREHENSIVEHEALTHPOLICY,Countries that have a comprehensive national health sector policy/ strategy/ plan with goals and targets updated within the last 5 years,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4732
HSS_MONITORPROGRESS,Countries that have monitored the progress of their national health policy/strategy/plan regularly,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4733
SDGODA,"Total net official development assistance to medical research and basic health sectors per capita (constant 2014 US$), by recipient",143.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4739
SDGCODCOMPLETENESS,Completeness of cause-of-death data (%),127.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=84
GOE_Q001,National universal health coverage strategy,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4760
GOE_Q002,strategy refers to the use of ICT to support UHC,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4761
GOE_Q003,National eHealth strategy,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4762
GOE_Q004,National eHealth strategy refers to objectives of UHC,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4763
GOE_Q006,National  health information system (HIS) policy or strategy,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4764
GOE_Q007,Public funding for eHealth,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4765
GOE_Q008,Private funding for eHealth,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4766
GOE_Q009,Donor/ non-public development funding for eHealth,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4767
GOE_Q010,Public-private partnerships for eHealth,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4768
GOE_Q011,Strategy implementation funding available for eHealth,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4769
GOE_Q012,Proportion of public funding,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4770
GOE_Q013,Proportion of private funding,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4770
GOE_Q014,Proportion of donor/non public development funding,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4770
GOE_Q015,Proportion ofpublic private partnerships funding,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4770
GOE_Q017,Government-supported health internet sites provide information in multiple languages,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4771
GOE_Q018,Tertiary institutions provide students of health sciences with training on eHealth,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4772
GOE_Q022,Institutions offer in-service training to health professionals on ICT for health,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4773
GOE_Q028,mHealth programmes are sponsored by government,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4774
GOE_Q030_1,Regulating mobile devices and software,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4775
GOE_Q030_2,Promoting standards and interoperability,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4775
GOE_Q030_3,Providing guidance on privacy and security,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4775
GOE_Q030_4,Providing oversight and enforcement of data ownership,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4775
GOE_Q030_5,Promoting the development and adoption of mHealth,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4775
GOE_Q031,"Regulatory oversight of mobile apps for quality, safety and reliability",0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4776
GOE_Q032,Providing incentives and guidance for innovation research and evaluation of health,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4777
GOE_Q047,Government-sponsored mHealth programmes are being evaluated,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4778
GOE_Q057,Capacity,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4779
GOE_Q058,Infrastructure,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4779
GOE_Q059,Funding,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4779
GOE_Q060,Effectiveness,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4779
GOE_Q061,Cost-effectiveness,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4779
GOE_Q062,Demand,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4779
GOE_Q063,Legal,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4779
GOE_Q064,Policy,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4779
GOE_Q065,Priorities,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4779
GOE_Q069,Country has telehealth policy or strategy,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4780
GOE_Q070,Strategy includes objectives as to how telehealth contributes to UHC,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4781
GOE_Q081,Evaluation of any government-sponsored telehealth programmes,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4782
GOE_Q103,eLearning is used in pre-service education to teach health sciences students,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4783
GOE_Q104_1,Reducing cost of delivering content,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4784
GOE_Q104_2,Improving access to content and experts,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4784
GOE_Q104_3,Enabling access to education where learning facilities are limited,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4784
GOE_Q109,Pre-service eLearning programmes have been evaluated,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4785
GOE_Q118,eLearning used for in-service training of health professionals,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4786
GOE_Q119_1,Reducing cost of delivering content,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4787
GOE_Q119_2,Improving access to content and experts,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4787
GOE_Q119_3,Enabling access to education where learning facilities are limited,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4787
GOE_Q120,eLearning courses accredited by continuing medical education or professional licensing bodies,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4788
GOE_Q122,eLearning programmes for in-service training of health professionals have been evaluated,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4789
GOE_Q131,Lack of capacity,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4790
GOE_Q132,Lack of infrastructure,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4790
GOE_Q133,Lack of funding,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4790
GOE_Q134,Not possible to gain a health sciences degree entirely through eLearning,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4790
GOE_Q135,Lack of evidence that eLearning is effective,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4790
GOE_Q136,Lack of evidence over cost-effectiveness,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4790
GOE_Q137,Lack of demand for eLearning programmes,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4790
GOE_Q138,Lack of suitable courses available,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4790
GOE_Q139,Insitutional educational policy does not include eLearning as an approach to teaching health sciences,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4790
GOE_Q140,Competing educational priorities,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4790
GOE_Q144,Country has national EHR,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4791
GOE_Q146,Country has specific legislation governing the use of national EHR system,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4792
GOE_Q153,Lack of capacity,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4793
GOE_Q154,Lack of infrastructure,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4793
GOE_Q155,Lack of funding,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4793
GOE_Q156,lack of evidence showing effectiveness of EHR,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4793
GOE_Q157,Lack of evidence showing cost-effectiveness or EHR,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4793
GOE_Q158,Lack of demand by health professionals and patients,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4793
GOE_Q159,Lack of legislation or regulations covering use of EHR,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4793
GOE_Q160,National strategy does not promote the adoption of EHR,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4793
GOE_Q161,Lack of national or international standards for interoperability of EHR,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4793
GOE_Q162,Competing health system priorities,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4793
GOE_Q168,"to define medical jurisdiction, liability or reimbursement of eHealth services such as telehealth",0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4794
GOE_Q169,"to address patient safety and quality of care based on data quality, data transmission standards, or clinical competency criteria",0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4808
GOE_Q170,to protect privacy of personally identifiable data of individuals irrespective of whether it is paper or digital format,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4809
GOE_Q171,to protect the privacy of individuals' health-related  data held in electronic format as an EHR,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4810
GOE_Q172,which governs the sharing of digital data between health professionals in other health services in the same country through the use of an EHR,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4811
GOE_Q173,which governs the sharing of digital data between health professionals  in health services in other countries through the use of an EHR,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4812
GOE_Q174,which allows for the sharing of personal and health data between research entities,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4813
GOE_Q175,which allows individuals electronic access to their own health-related data when held in an EHR,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4814
GOE_Q176,which allows individuals to demand that their own data be corrected  when held in an EHR if it is known to be inaccurate,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4815
GOE_Q177,which allows individuals to demand the deletion of health-related data from their EHR,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4816
GOE_Q178,Individuals have the legal right to specify which health-related data from their EHR can be shared with health professionals of their choice,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4817
GOE_Q181,Country has national policy or strategy on the use of social media by government organizations,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4795
GOE_Q182,Policy or strategy makes specific reference tothe use of social media in the health domain,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4796
GOE_Q196,Country has  national policy or strategy regulating the use of big data in the health sector,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4797
GOE_Q197,Country has national policy or strategy regulating the use of big data by private companies,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4798
GOE_Q198,Effective standards and best practices for data capture not fully established,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4799
GOE_Q199,Insufficient incentives for data sharing,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4799
GOE_Q200,Capacity building required for new skills,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4799
GOE_Q201,Privacy and security laws need to be in place,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4799
GOE_Q202,Research into new analytical methods needs occur to meet the challenges of working with big data,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4799
GOE_Q203,Lack of integration between various health services,0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4799
NUTRITION_WH_2,Children aged <5 years wasted <br> (% weight-for-height <-2 SD),-1.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=302
NUTRITION_WH2,Children aged <5 years overweight <br> (% weight-for-height >+2 SD),680.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=74
NUTRITION_HA_2,Children aged <5 years stunted <br> (% height-for-age <-2 SD),798.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=72
NUTRITION_WA_2,Children aged <5 years underweight <br> (% weight-for-age <-2 SD) (%),818.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=27
MALARIA_HOUSEHOLDITNIRS,Households with at least one insecticide-treated net (ITNs) or indoor residual spraying (IRS)(%),99.0,
AMR_GI_001,Status of countries enrolled in GLASS,0.0,
AMR_GI_002,Status of National coordination center establishment,0.0,
AMR_GI_003,Status of National plans to implement and strengthen antimicrobial surveillance,0.0,
SA_0000001789,Alcohol-related crimes (% of all crimes),249.0,
SUNBEDEXISTSUBNATIONAL,Existence of subnational regulation,46.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4625
RSUD_100,Government unit/official responsible for prevention for substance use,194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2517
RSUD_110,Ministry/office that takes primary responsibility for prevention for substance use,388.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2553
RSUD_120,Five years change in international cooperation for prevention for substance use,350.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2542
RSUD_130,Government unit/official responsible for treatment of substance use disorders,194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2517
RSUD_140,Ministry/office that takes primary responsibility for treatment of substance use disorders,388.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2553
RSUD_150,Involvement of representatives of affected or targeted populations in the development and formulation of policies and strategies for treatment of substance use disorders,1940.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2549
RSUD_160,Involvement of representatives of affected or targeted populations in the development and implementation of national programmes for treatment of substance use disorders,1940.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2554
RSUD_170,Involvement of representatives of affected or targeted populations in the development and formulation of policies and strategies for prevention for alcohol and drugs,1940.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2549
RSUD_180,Involvement of representatives of affected or targeted populations in the development and implementation of national programmes for prevention for alcohol and drugs,1940.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2554
RSUD_190,Five years change in international cooperation for treatment of substance use disorders,388.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2542
RSUD_200,Confidentiality of people in treatment for substance use disorders,388.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2516
RSUD_210,Voluntary treatment for people with alcohol use disorders in the criminal justice system,388.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2515
RSUD_220,Voluntary treatment for people with drug use disorders in the criminal justice system,388.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2515
RSUD_230,Compulsory treatment for people with alcohol use disorders in the criminal justice system,388.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2513
RSUD_240,Compulsory treatment for people with drug use disorders in the criminal justice system,388.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2513
RSUD_250,Five-year change in government resources for prevention for substance use,388.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2540
RSUD_260,Five-year change in government resources for treatment of substance use disorders,388.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2540
RSUD_270,Financing methods for treatment for alcohol use disorders,970.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2519
RSUD_280,Financing methods for treatment for drug use disorders,804.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2519
RSUD_290,Hypothecated taxes to be spent on prevention and treatment for substance use disorders,388.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2575
RSUD_300,Government benefits for people with alcohol use disorders,388.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2521
RSUD_310,Government benefits for people with drug use disorders,388.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2521
RSUD_320,Main sector for treatment for alcohol use disorders,970.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2524
RSUD_330,Main sector for treatment for drug use disorders,1164.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2524
RSUD_340,Treatment programmes for children and adolescents with alcohol use disorders,582.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2528
RSUD_350,Treatment programmes for children and adolescents with drug use disorders,582.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2528
RSUD_360,Specialized treatment facilities for substance use disorders,582.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2525
RSUD_370,Specialized treatment facilities for alcohol use disorders,582.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2525
RSUD_380,Specialized treatment facilities for drug use disorders,582.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2525
RSUD_390,Self-help groups,970.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2581
RSUD_400,Main substance at treatment entry,582.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2503
RSUD_410,Reported treatment coverage for substance dependence,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2527
RSUD_420,Guidelines on pharmacological treatment for substance use disorders,194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2511
RSUD_430,Pharmacotherapy with methadone,388.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2566
RSUD_440,Pharmacotherapy with buprenorphine,388.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2566
RSUD_450,Pharmacotherapy with buprenorphine/naloxone,388.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2566
RSUD_460,Access restrictions to maintenance treatment,582.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2532
RSUD_470,Timeframe for maintenance treatment of opioid dependence,194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2531
RSUD_480,Registration of medications for alcohol dependence and withdrawal,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2551
RSUD_490,Registration of medications for opioid dependence,1164.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2548
RSUD_500,Registration of medications for opioid withdrawal,582.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2548
RSUD_510,Registration of naloxone for injection for opioid overdose,194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2548
RSUD_520,Availability of naloxone,194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2550
RSUD_530,Screening and brief intervention for substance use in primary health care,388.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2572
RSUD_540,Screening and brief intervention for substance use in antenatal services,388.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2572
RSUD_550,Recommendations for screening and brief interventions for substance use in primary health care,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2522
RSUD_560,Recommendations for screening and brief interventions for substance use in antenatal services,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2522
RSUD_570,Groups and agencies involved in prevention programs,2522.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2582
RSUD_580,Prevention programmes for alcohol,1552.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2569
RSUD_590,Prevention programmes for specific populations for alcohol,2716.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2571
RSUD_600,Prevention programmes for drugs,1552.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2569
RSUD_610,Prevention programmes for specific populations for drugs,2716.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2571
RSUD_620,"HIV, Hepatitis counselling and treatment availability in specialized facilities and services",970.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2535
RSUD_630,Programmes readily available,970.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2573
RSUD_640,Standards of treatment and care for public specialized treatment facilities,194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2578
RSUD_650,Special treatment programmes for gambling disorder,582.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2556
RSUD_660,Treatment programmes for women with alcohol use disorders,582.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2528
RSUD_670,Treatment programmes for women with drug use disorders,582.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2528
RSUD_680,Special housing services for alcohol use disorders,582.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2536
RSUD_690,Special housing services for drug use disorders,582.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2536
RSUD_700,Employment services for alcohol use disorders,582.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2536
RSUD_710,Employment services for drug use disorders,582.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2536
RSUD_720,Open access interventions for alcohol,582.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2537
RSUD_730,Open access interventions for drugs,582.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2537
RSUD_740,Health professionals providing treatment for alcohol and drug use disorders,1940.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2574
RSUD_750,Standards of care for professionals providing treatment for alcohol and drug use disorders,1940.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2576
RSUD_760,Educational attainment in prevention,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2509
RSUD_770,Postgraduate training programme in prevention,1358.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2577
RSUD_780,Continuing professional development in prevention,1552.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2557
RSUD_790,Educational attainment in treatment,776.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2509
RSUD_800,Postgraduate training programme in treatment,1358.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2577
RSUD_810,Continuing professional development in treatment,1552.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2557
RSUD_820,Epidemiological data collection for substance use,194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2504
RSUD_830,Service delivery data collection for substance use,194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2526
RSUD_840,Regular reports on epidemiological and service delivery data for substance use,388.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2507
RSUD_850,System of monitoring alcohol involvement in forensic pathology,388.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4803
RSUD_860,System of monitoring drugs involvement in forensic pathology,388.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4803
RSUD_870,Epidemiological data collection system for substance use among children and adolescents,388.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2570
RSUD_880,Epidemiological data collection system for substance use among children and adolescents,388.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2570
RSUD_890,Treatment programmes for children and adolescents with alcohol use disorders,582.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2528
RSUD_900,Treatment programmes for children and adolescents with drug use disorders,582.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2528
AIR_90,"Ambient air pollution attributable DALYs  (per 100 000 population, age-standardized)",194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2259
AIR_51,Household air pollution attributable mortality rate (attributable deaths per 100 000 population),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2256
AIR_52,"Household air pollution attributable mortality rate (attributable deaths per 100 000 population, age-standardized)",0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2256
MCV2,Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%),2132.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4756
PCV3,Pneumoccocal conjugate vaccines (PCV3) immunization coverage among 1-year-olds (%),753.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4757
ROTAC,Rotavirus vaccines completed dose (RotaC) immunization coverage among 1-year-olds (%),495.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4758
E14b_movies_anti_tob_ads,"Requirement to present prescribed anti-tobacco ads before, during or after the broadcasting or showing of any visual entertainment media product that depicts tobacco products, use or images",0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4585
E15a_sponsorship,Complete ban on sponsorship,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1317
E15b_sponsor_contribution,"Ban on any form of contribution (financial or other support) to any event, activity or individual",0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1317
E15c_sponsor_publicity,"Banning the publicity of financial or other sponsorship or support by the tobacco industry of events, activities, individuals",0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1317
E15d_csr_ban,Ban on Corporate Social Responsibility activities (CSR),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1317
TOTENV_70,Total environment attributable deaths in children under 5 years,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2393
TOTENV_90,Total environment attributable DALYs  in children under 5 years,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2393
WSH_WATER_SAFELY_MANAGED,Population using safely managed drinking-water services (%),2459.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4819
WSH_WATER_BASIC,Population using at least basic drinking-water services (%),8616.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4818
WSH_SANITATION_SAFELY_MANAGED,Population using safely managed sanitation services (%),2941.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4820
WSH_SANITATION_BASIC,Population using at least basic sanitation services (%),8569.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4821
WSH_HYGIENE_BASIC,Population with basic handwashing facilities at home (%),2184.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4822
ANEMIAU5,Prevalence of anaemia in children under 5 years (%),5211.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4801
ANEMIANPW,Prevalence of anaemia in non-pregnant women (%),5211.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4552
ANEMIAPW,Prevalence of anaemia in pregnant women (%),5211.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4552
CHILDMORT5TO14,Mortality rate for 5-14 year-olds (probability of dying per 1000 children aged 5-14 years),5238.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4802
NCD_BMI_18A,"Prevalence of underweight among adults, BMI < 18 (age-standardized estimate) (%)",25956.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4804
NCD_BMI_18C,"Prevalence of underweight among adults, BMI < 18 (crude estimate) (%)",25956.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4804
NCD_BMI_PLUS1A,"Prevalence of overweight among children and adolescents, BMI > +1 standard deviations above the median (age-standardized estimate) (%)",0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4806
NCD_BMI_PLUS1C,"Prevalence of overweight among children and adolescents, BMI > +1 standard deviations above the median (crude estimate) (%)",77868.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4806
NCD_BMI_PLUS2C,"Prevalence of obesity among children and adolescents, BMI > +2 standard deviations above the median (crude estimate) (%)",77868.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4807
NCD_BMI_PLUS2A,"Prevalence of obesity among children and adolescents, BMI > +2 standard deviations above the median (age-standardized estimate) (%)",0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4807
NCD_BMI_MINUS2A,"Prevalence of thinness among children and adolescents, BMI < -2 standard deviations below the median (age-standardized estimate) (%)",0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4805
NCD_BMI_MINUS2C,"Prevalence of thinness among children and adolescents, BMI < -2 standard deviations below the median (crude estimate) (%)",77868.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4805
UHC_DATA_AVAIL_CODE,Data availability for UHC index of essential service coverage (ranking),183.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4832
UHC_INDEX_REPORTED,UHC index of essential service coverage (%),190.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4834
UHC_INDEX_ACTUAL,Index of Essential Service Coverage (Actual),0.0,
UHC_AVAILABILITY_SCORE,Data availability for UHC index of essential service coverage (%),183.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4833
FINPROTECTION_CATA_TOT_10_POP,Population with household expenditures on health greater than 10% of total household expenditure or income (SDG 3.8.2) (%),542.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4844
FINPROTECTION_CATA_TOT_25_POP,Population with household expenditures on health greater than 25% of total household expenditure or income  ( SDG indicator 3.8.2) (%),542.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4845
FINPROTECTION_IMP_NP190_POP,Population  pushed below the $1.90 a day  poverty line by household  health expenditures (%),504.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4838
FINPROTECTION_IMP_NP310_POP,Population  pushed below the $3.10 a day  poverty line by household  health expenditures (%),504.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4841
FINPROTECTION_P1_190_POP,Changes in poverty gap due to health expenditure at the $1.90 a-day poverty line (in 2011 PPs),0.0,
FINPROTECTION_P1_310_POP,Changes in poverty gap due to health expenditure at the $3.10 a-day poverty line (in 2011 PPs),0.0,
UHC_TB_DT,Tuberculosis detection and treatment,0.0,
UHC_NCD_NONELEVBP,Prevalence of non-elevated blood pressure (%),0.0,
UHC_NCD_FPG,Mean fasting plasma glucose,0.0,
UHC_HRHSURGEONDENSITY,Surgeons (per 100 000),0.0,
UHC_TOBACCONO,Prevalence of non-use of tobacco,0.0,
UHC_IHR,Compliance with international health regulations,988.0,http://apps.who.int/gho/indicators/?id=4824
GDO_q1x1,Inclusion of dementia in ministry portfolio,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5001
GDO_q1x1x1,"Inclusion of dementia in a branch of government [health, ageing, social services, mental health, noncommunicable disease]",21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5002
GDO_q1x2,Existence of dementia representative in ministry,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5003
GDO_q2x1,Existence of dementia national plan,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5005
GDO_q2x1x2,Availability of funding for dementia national plan,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5007
GDO_q2x1x3,Targets for monitoring implementation of dementia national plan,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5009
GDO_q2x2,Dementia integrated into other national plan,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5010
GDO_Q2x2x1_MENTAL,Identification of other plans in which dementia is integrated (Mental health),21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5011
GDO_Q2x2x1_AGE,Identification of other plans in which dementia is integrated (Ageing),21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5011
GDO_Q2x2x1_NCD,Identification of other plans in which dementia is integrated (NCD),21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5011
GDO_Q2x2x1_DISAB,Identification of other plans in which dementia is integrated (Disability),21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5011
GDO_q2x2x1_other,Identification of other plans in which dementia is integrated (Other),21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5011
GDO_q2x3,Existence of dementia sub-national plan(s),21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5012
GDO_q2x3x1_1,Percentage of sub-national regions covered by dementia plan,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5013
GDO_q2x4_1,Inclusion of human rights as a guiding principle of the dementia plan,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5015
GDO_q2x4_2,Inclusion of equity as a guiding principle of the dementia plan,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5016
GDO_q2x4_3,Inclusion of empowerment as a guiding principle of the dementia plan,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5017
GDO_q2x4_4,Inclusion of multisectoral collaboration as a guiding principles of the dementia plan,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5018
GDO_q2x4_5,Inclusion of universal health coverage as a guiding principle of the dementia plan,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5019
GDO_q2x5_1,Inclusion of dementia-friendly communities as a specific action of the dementia plan,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5021
GDO_q2x5_2,Inclusion of dementia risk reduction as a specific action of the dementia plan,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5022
GDO_q2x5_3,"Inclusion of dementia diagnosis, care and support as a specific action of the dementia plan",21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5023
GDO_q2x5_4,Inclusion of dementia workforce training as a specific action of the dementia plan,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5024
GDO_q2x5_5,Inclusion of support for dementia carers and families as a specific action of the dementia plan,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5025
GDO_q2x5_6,Inclusion of improved information system as a specific action of the dementia plan,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5026
GDO_q2x5_7,Inclusion of research and innovation as a specific action of the dementia plan,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5027
GDO_q3x1,Existence of dementia legislation,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5029
GDO_q3x1x1_1,Implementation level [national/subnational] of dementia legislation,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5030
GDO_q3x2,Existence of other laws that apply to the rights of people with dementia,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5031
GDO_q3x3a_1,Existence of legislation for supported decision making for people with dementia,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5033
GDO_q3x3a_2,Existence of legislation to file appeals protecting the rights of people with dementia,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5035
GDO_q3x3a_3,Existence of legislation to promote community-based services for people with dementia,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5036
GDO_q3x3a_4,Existence of legislation to promote monitoring of human rights conditions of people with dementia in facilities where they reside,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5037
GDO_q3x4_1,Existence of legislation for advanced care directives for people with dementia,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5039
GDO_q3x4_2,Existence of legislation to end discrimination against people with dementia,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5040
GDO_q3x4_3,Existence of legislation to end discrimination against carers of people with dementia,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5041
GDO_q3x3b_1,Existence of legislation to end coercieve practices for people with dementia,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5034
GDO_q4x1,Existence of dementia standards/ guidelines/ protocols,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5043
GDO_q4x1x1_SQ001,Implementation level of dementia standards/ guidelines/ protocols (National),21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5044
GDO_q4x1x1_SQ002,Implementation level of dementia standards/ guidelines/ protocols (Sub-national),21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5044
GDO_q4x1x2,Existence of approved government dementia standards/ guidelines/ protocols,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5045
GDO_q4x2_1,Existence of standards/ guidelines/ protocols for prevention and risk reduction of dementia,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5047
GDO_q4x2_2,Existence of standards/ guidelines/ protocols for diagnosis of dementia,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5048
GDO_q4x2_3,Existence of standards/ guidelines/ protocols for management of dementia,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5049
GDO_q4x2_4,Existence of standards/ guidelines/ protocols for other post-diagnostic supports of people with dementia,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5050
GDO_q4x3x4_1,"Existence of standards/ guidelines/ protocols for advance care directives, power of attorney or guardianship for people with dementia",21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5051
GDO_q4x3x4_2,Existence of standards/ guidelines/ protocols for palliative and end-of-life care for people with dementia,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5052
GDO_q4x3x4_3,Existence of standards/ guidelines/ protocols of care in nursing & residential care facilities for people with dementia,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5053
GDO_q4x3x4_4,Existence of standards/ guidelines/ protocols of care in hospital for people with dementia,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5054
GDO_q4x2_5,Existence of standards/ guidelines/ protocols for treatment and support of carers and families of people with dementia,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5055
GDO_q5x1,Availability of mechanisms to coordinate dementia care across sectors,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5057
GDO_q5x1x1_1,Identification of different sectors in dementia care coordination  (Health),21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5058
GDO_q5x1x1_2,Identification of different sectors in dementia care coordination (Social),21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5058
GDO_q5x1x1_3,Identification of different sectors in dementia care coordination (Education),21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5058
GDO_q5x1x1_4,Identification of different sectors in dementia care coordination (Employment),21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5058
GDO_q5x1x1_5,Identification of different sectors in dementia care coordination (Justice),21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5058
GDO_q5x1x1_6,Identification of different sectors in dementia care coordination (Housing),21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5058
GDO_q5x1x1_7,Identification of different sectors in dementia care coordination (Civil society),21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5058
GDO_q5x1x1_8,Identification of different sectors in dementia care coordination (Private sector),21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5058
GDO_q5x1x1_other,Identification of different sectors in dementia care coordination (Other),21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5058
GDO_q5x1x2,Implementation level [national/subnational] of dementia care coordination,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5059
GDO_q5x1x3,Presence of formal agreement/joint plan for dementia care coordination,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5060
GDO_q5x2,Availability of dementia care coordination standards/ guidelines/ protocols,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5061
GDO_,EXISTING GHO INDICATOR Number of Personal care workers (Health workforce),0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5074
GDO_q6x1_2,"Number of neurologists (per 100,000)",21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5068
GDO_q6x1_3,"Number of geriatricians or psychogeriatricians (per 100,000)",21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5069
GDO_q6x2_1,Inclusion of basic dementia competencies in training of physicians,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5076
GDO_q6x2_2,Inclusion of basic dementia competencies in training of specialists,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5077
GDO_q6x2_3,Inclusion of basic dementia competencies in training of nurses,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5078
GDO_q6x2_4,Inclusion of basic dementia competencies in training of pharmaceutical personnel,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5079
GDO_q6x2_5,Inclusion of basic dementia competencies in training of social workers,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5080
GDO_q6x2_6,Inclusion of basic dementia competencies in training of personal support workers,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5081
GDO_q7x1_AVAIL,Availability of dementia diagnostic rate,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5083
GDO_q8x1,Existence of community-based health or social care services for dementia,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5091
GDO_q8x2_1,Availability of diagnostic services in community for dementia,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5092
GDO_q8x3_1,"Accessibility of diagnostic services in community for dementia [Capital/capital and main cities/capital, main cities, rural areas]",21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5093
GDO_q8x4_1,"Majority provider of diagnostic services in community for dementia [public, private]",21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5094
GDO_q8x2_2,Availability of behaviour and psychological management in community for dementia,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5095
GDO_q8x3_2,"Accessibility of behaviour and psychological management in community for dementia [Capital/capital and main cities/capital, main cities, rural areas]",21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5096
GDO_q8x4_2,"Majority provider of behaviour and psychological management in community for dementia [public, private]",21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5097
GDO_q8x5_2,Estimated number of people receiving behaviour and psychological management services in community for dementia,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5098
GDO_q8x2_3,Availability of psychosocial and rehabilitation services in community for dementia,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5099
GDO_q8x3_3,"Accessibility of psychosocial and rehabilitation services in community for dementia [Capital/capital and main cities/capital, main cities, rural areas]",21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5100
GDO_q8x4_3,"Majority provider of psychosocial and rehabilitation services in community for dementia [public, private]",21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5101
GDO_q8x5_3,Estimated number of people receiving psychosocial and rehabilitation services in community for dementia,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5102
GDO_q8x2_4,Availability of activities of daily living suppport services in community for dementia,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5103
GDO_q8x3_4,"Accessibility of activities of daily living support services in community for dementia [Capital/capital and main cities/capital, main cities, rural areas]",21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5104
GDO_q8x4_4,"Majority provider of activities of daily living support services in community for dementia [public, private]",21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5105
GDO_q8x5_4,Estimated number of people receiving activities of daily living support services in community for dementia,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5106
GDO_q8x2_5,Availability of palliative and end-of-life care services in community for dementia,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5107
GDO_q8x3_5,"Accessibility of palliative and end-of-life care services in community for dementia [Capital/capital and main cities/capital, main cities, rural areas]",21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5108
GDO_q8x4_5,"Majority provider of palliative and end-of-life care services in community for dementia [public, private]",21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5109
GDO_q8x5_5,Estimated number of people receiving palliative and end-of-life care services in community for dementia,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5110
GDO_q8x2_6,Availability of social and financial protection for dementia,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5111
GDO_q8x3_6,"Accessibility of social and financial protection for dementia [Capital/capital and main cities/capital, main cities, rural areas]",21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5112
GDO_q8x4_6,"Majority provider of social and financial protection for dementia [public, private]",21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5113
GDO_q8x5_6,Estimated number of people with dementia receiving social and financial protection for dementia,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5114
GDO_q9_1,Dementia care facilities [hospitals],21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5116
GDO_q9x1_1,EXISTING GHO INDICATOR Density of hospitals (per 100 000 population),0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5117
GDO_q9x1_2,EXISTING GHO INDICATOR Hospital beds (per 10 000 population) (Health systems),0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5118
GDO_q9x1_3,"Dementia-specific hospital beds (per 10,000 population)",21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5119
GDO_q9x1_4,"Geriatric-specific hospital beds (per 10,000 population)",21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5120
GDO_q9x1_5,"Total dementia hospital admissions (per 100,000)",21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5121
GDO_q9x1_7,Estimated percentage of hospitals following national dementia standards,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5123
GDO_q9_2,Care facilities [long-term care],21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5124
GDO_q9x2_1,"Density of residential long-term care facilities (per 100,000 population)",21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5125
GDO_q9x2_2,Residential long-term care beds (per 10 000 population),21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5126
GDO_q9x2_3,"Dementia-specific residential long-term care beds (per 10,000 population)",21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5127
GDO_q9x2_4,Estimated number of people with dementia living in residential long-term care,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5128
GDO_q9x2_5,Estimated percentage of residential long-term care facilities following national dementia standards,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5129
GDO_q9_3,Care facilities [hospice centres],21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5130
GDO_q9x3_1,"Density of hospice centres (per 100,000 population)",21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5131
GDO_q9x3_2,Hospice centre beds (per 10 000 population),21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5132
GDO_q9x3_3,"Dementia-specific hospice care beds (per 10,000 population)",21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5133
GDO_q9_4,Adult day centres,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5134
GDO_q9x4_1,"Density of adult day centres (per 100,000 population)",21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5135
GDO_q9x4_2,"Adult day centre places (per 10,000 population)",21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5136
GDO_q9x4_3,"Dementia-specific adult day centre places (per 10,000 population)",21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5137
GDO_q9_5,Outpatient health centres,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5138
GDO_q9x5_1,"Density of outpatient health centres (per 100,000 population)",21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5139
GDO_q9x5_2,Estimated number of people with dementia receiving services at outpatient health centre,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5140
GDO_q9_6,Outpatient social centres,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5141
GDO_q9x6_1,"Density of outpatient social centres (per 100,000 population)",21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5142
GDO_q9x6_2,Estimated number of people with dementia receiving services at outpatient social centre,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5143
GDO_q10x1,National regulator approval of anti-dementia medication,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5145
GDO_q10x1x1,Availability of generic anti-dementia medication,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5146
GDO_q10x1x2,Availability of at least one anti-dementia medication approved for on-label use reimbursement,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5147
GDO_q10x2_1AVAIL,Availability of atleast one adult hygiene products for people with dementia,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5149
GDO_q10x2_TECH,Availability of  atleast one assistive technology for people with dementia,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5150
GDO_q10x2_HOSUE,Availability of atleast one housing adjustment for people with dementia,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5151
GDO_q11x1,Existence of dementia national nongovernmental organization,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5153
GDO_q11x2x1,Dementia nongovernmental organization equipped with office,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5155
GDO_q11x2x2_1,Dementia nongovernmental organization office branches (Sub-national),21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5156
GDO_q11x2x2_2,Dementia nongovernmental organization office branches (Local),21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5156
GDO_q11x2x2_3,Dementia nongovernmental organization office branches (National only),21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5156
GDO_q11x2x3,Dementia nongovernmental organization staff primarily salaried/volunteer,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5157
GDO_q11x2x5,Provision of governmental funding to dementia nongovernmental organization for activities/services,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5159
GDO_q11x2x6,Dementia nongovernmental organization's involvement in policy development,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5160
GDO_q12x1,Existence of dementia carer support services,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5162
GDO_q12x1x1,Implementation level [national/subnational] of dementia carer support services,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5163
GDO_q12x1x2,Existence of dedicated resources for dementia carer support services,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5164
GDO_q12x1x3,Existence of implementation plan for dementia carer support services,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5165
GDO_q12x2_1,Existence of dementia carer training and education,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5167
GDO_q12x2x1x1_1,"Accessibility of dementia carer training and education [Capital/capital and main cities/capital, main cities, rural areas]",21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5168
GDO_q12x2x1x1_1PUB,Majority provider of dementia carer training and education (Public sector),21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5169
GDO_q12x2x1x1_1PRV,Majority provider of dementia carer training and education (Private sector),21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5169
GDO_q12x2x1x1_1NGO,Majority provider of dementia carer training and education (NGO),21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5169
GDO_q12x2x1x3,Estimated number of dementia carers receiving training and education,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5170
GDO_q12x2_2,Existence of psycho-social supports for dementia carers,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5171
GDO_q12x2x1x1_2,"Accessibility of psycho-social supports for dementia carers [Capital/capital and main cities/capital, main cities, rural areas]",21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5172
GDO_q12x2x1x1_2PUB,Majority provider of psycho-social supports for dementia carers (Public sector),21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5173
GDO_q12x2x1x1_2PRV,Majority provider of psycho-social supports for dementia carers (Private sector),21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5173
GDO_q12x2x1x1_2NGO,Majority provider of psycho-social supports for dementia carers (NGO),21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5173
GDO_q12x2x2x3,Estimated number of dementia carers receiving psycho-social supports,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5174
GDO_q12x2_3,Existence of respite care for dementia carers,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5175
GDO_q12x2x1x1_3,"Accessibility of respite care for dementia carers [Capital/capital and main cities/capital, main cities, rural areas]",21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5176
GDO_q12x2x1x1_3PUB,Majority provider of respite care for dementia carers (Public sector),21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5177
GDO_q12x2x1x1_3PRV,Majority provider of respite care for dementia carers (Private sector),21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5177
GDO_q12x2x1x1_3NGO,Majority provider of respite care for dementia carers (NGO),21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5177
GDO_q12x2x3x3,Estimated number of dementia carers receiving respite care,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5178
GDO_q12x2_4,Existence of information on legal rights for dementia carers,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5179
GDO_q12x2x1x1_4,"Accessibility of information on legal rights for dementia carers [Capital/capital and main cities/capital, main cities, rural areas]",21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5180
GDO_q12x2x1x1_4PUB,Majority provider of information  on legal rights for dementia carers (Public sector),21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5181
GDO_q12x2x1x1_4PRV,Majority provider of information on legal rights for dementia carers (Private sector),21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5181
GDO_q12x2x1x1_4NGO,Majority provider of information on legal rights for dementia carers (NGO),21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5181
GDO_q12x2x4x3,Estimated number of dementia carers receiving information on legal rights,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5182
GDO_q12x2_5,Existence of financial benefits/social protection for dementia carers,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5183
GDO_q12x2x1x1_5,"Accessibility of financial benefits/social protection for dementia carers [Capital/capital and main cities/capital, main cities, rural areas]",21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5184
GDO_q12x2x1x1_5PUB,Majority provider of information  on financial benefits/social protection for dementia carers (Public sector),21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5185
GDO_q12x2x1x1_5PRV,Majority provider of information on financial benefits/social protection for dementia carers (Private sector),21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5185
GDO_q12x2x1x1_5NGO,Majority provider of information on financial benefits/social protection for dementia carers (NGO),21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5185
GDO_q12x2x5x3,Estimated number of dementia carers receiving financial benefits/social protection,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5186
GDO_q13x1,Existence of at least one functioning dementia awareness campaign,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5188
GDO_q13x1x1,Implementation level [national/subnational] of dementia awareness campaign,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5189
GDO_q13x3,Existence of at least one functioning risk reduction campaign,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5197
GDO_q13x3x1,Implementation level [national/subnational] of dementia risk reduction campaign,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5198
GDO_q14x1,Availability of dementia-friendly initiatives that improve accessibility,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5207
GDO_q14x2_1,Existence of dementia-friendly initiative to improve accessibility of public spaces,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5209
GDO_q14x2_2,Existence of dementia-friendly initiative to improve accessibility of public transportation,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5210
GDO_q14x2_3,Existence of dementia-friendly initiative for assistance with home modification,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5211
GDO_q14x2_4,Existence of dementia-friendly initiative with assistive technology for loss of capacity,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5212
GDO_q14x2_5,Existence of dementia-friendly initiative supporting community places for older people,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5213
GDO_q14x2_6,Existence of dementia-friendly initiative supporting social opportunities,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5214
GDO_q15x1,Inclusion of dementia training and education for non-health workers,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5216
GDO_q15x2_1,Existence of dementia training for volunteers,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5217
GDO_q15x2_2,Existence of dementia training for police and fire services,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5219
GDO_q15x2_3,Existence of dementia training for first responders,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5221
GDO_q15x2_4,Existence of dementia training for legal professionals,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5223
GDO_q15x2_5,Existence of dementia training for community workers,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5225
GDO_q15x2_6,Existence of dementia training for school children,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5227
GDO_q15x2_7,Existence of dementia training for financial service staff,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5229
GDO_q15x2_8,Existence of dementia training for retail and hospitality staff,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5231
GDO_q16x1,Routine monitoring of people with dementia,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5234
GDO_q16x1x1_1,Data sources used to routinely monitor people with dementia (Clinical records),21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5235
GDO_q16x1x1_2,Data sources used to routinely monitor people with dementia (Household surveys),21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5235
GDO_q16x1x1_3,Data sources used to routinely monitor people with dementia (Administrative data),21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5235
GDO_q16x1x1_4,Data sources used to routinely monitor people with dementia (Facility survey or records),21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5235
GDO_q16x1x1_other,Data sources used to routinely monitor people with dementia (Other),21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5235
GDO_q16x1x2_1,Electronic availability of data sources used to routinely monitor people with dementia,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5236
GDO_q16x1x2_2,Data used to routinely monitor people with dementia can be disaggregated,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5237
GDO_q16x2_1,Availability of routine hospital admissions records for people with dementia for monitoring purposes,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5239
GDO_q16x2_2,Availability of routine outpatient visit records for people with dementia for monitoring purposes,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5240
GDO_q16x2_3,Availability of routine outpatient intervention and treatment records for people with dementia for monitoring purposes,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5241
GDO_q16x2_4,Availability of routine pharmaceutical records for people with dementia for monitoring purposes,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5242
GDO_q16x2_5,Availability of routine antipsychotic prescription records for people with dementia for monitoring purposes,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5243
GDO_q16x3,Availability and status of dementia reporting in the past two years,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5245
GDO_q17x1,Existence of a current dementia research plan/programme,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5247
GDO_q17x1x1,Implementation level [national/subnational] of dementia research plan/programme,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5248
GDO_q17x2,Dementia integrated into other national research plan/programme,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5250
GDO_q17x2x1_1,Identification of other research plans in which dementia is integrated (Mental health),21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5251
GDO_q17x2x1_2,Identification of other research plans in which dementia is integrated (Ageing),21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5251
GDO_q17x2x1_3,Identification of other research plans in which dementia is integrated (Neuro or neurodegenerative disease),21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5251
GDO_q17x2x1_4,Identification of other research plans in which dementia is integrated (NCD),21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5251
GDO_q17x2x2,Implementation level [national/subnational] of research plan in which dementia is integrated,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5252
GDO_q18x1_1,EXISTING GHO INDICATOR (SDG 9.5.1) Gross domestic R&D expenditure on health (health GERD) as a % of gross domestic product (GDP),0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5255
GDO_q18x2,Availability of funding for dementia-specific research plan/programme,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5256
GDO_q18x2x1_1,"Total expenditure on dementia research (local currency, self-report)",21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5257
GDO_q18x2x3_1,"Total expenditure on dementia basic research (local currency, self-report)",21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5260
GDO_q18x2x3_2,"Total expenditure on dementia clinical/translational research (local currency, self-report)",21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5261
GDO_q18x2x3_3,"Total expenditure on dementia implementation research (local currency, self-report)",21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5262
GDO_q19x2,Number of people with dementia involved in research routinely monitored,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5265
GDO_q19x3,Availability of investigational pharmaceutical trials for dementia,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5268
GDO_q19x3x1_1,Number of investigational pharmaceutical trials for dementia,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5269
WSH_SANITATION_OD,Population practising open defecation (%),8691.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4823
TB_effective_treatment_coverage,Tuberculosis effective treatment coverage (%),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4835
TB_treatment_coverage,xxx,0.0,
FINPROTECTION_CATA_ESTIMATE_AVAILABLE,Availability of estimates on large  health expenditures as a share of total expenditure or income,542.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4844
FINPROTECTION_IMPOV_ESTIMATE_AVAILABLE,Availability of estimates on impoverishment due to out-of-pocket health expenditures,542.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4838
FINPROTECTION_IMP_PG_190_STD,"Increase in poverty gap due to household  health expenditures, expressed as a proportion of the $1.90 a-day poverty line (%)",504.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4839
FINPROTECTION_IMP_PG_190,"Increase in poverty gap  due to household  health expenditures at the $1.90 a day poverty line, in cents of international dollars",504.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4840
FINPROTECTION_IMP_PG_310_STD,"Increase in poverty gap due to household  health expenditures, expressed as a proportion of the 3.10 a-day poverty line (%)",504.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4842
FINPROTECTION_IMP_PG_310,"Increase in poverty gap  due to household  health expenditures at the $3.10a day poverty line, in cents of international dollars",504.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4843
FINPROTECTION_CATA_TOT_10_LEVEL_SH,Total population with household expenditures on health greater than 10% of total household expenditure or income (SDG 3.8.2) (%),84.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4844
FINPROTECTION_CATA_TOT_10_LEVEL_MILLION,Total population with household expenditures on health greater than 10% of total household expenditure or income (SDG 3.8.2) (millions),84.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4844
FINPROTECTION_CATA_TOT_25_LEVEL_SH,Total population with household expenditures on health greater than 25% of total household expenditure or income  ( SDG indicator 3.8.2) (%),84.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4845
FINPROTECTION_CATA_TOT_25_LEVEL_MILLION,Total population with household expenditures on health greater than 25% of total household expenditure or income  ( SDG indicator 3.8.2) (millions),84.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4845
FINPROTECTION_IMP_NP_190_LEVEL_SH,Total population  pushed below the $1.90 a day  poverty line by household  health expenditures (%),84.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4838
FINPROTECTION_IMP_NP_190_LEVEL_MILLION,Total population  pushed below the $1.90 a day  poverty line by household  health expenditures (millions),84.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4838
FINPROTECTION_IMP_NP_310_LEVEL_SH,Total population  pushed below the $3.10 a day  poverty line by household  health expenditures (%),84.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4841
FINPROTECTION_IMP_NP_310_LEVEL_MILLION,Total population  pushed below the $3.10 a day  poverty line by household  health expenditures (millions),84.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4841
GDO_q20,Total number of published dementia research output,21.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5270
GHED_CHEGDP_SHA2011,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),3280.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4950
GHED_CHE_pc_US_SHA2011,Current health expenditure (CHE) per capita in US$,3280.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4951
GHED_CHE_pc_PPP_SHA2011,Current health expenditure (CHE) per capita in PPP int$,3104.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4952
GHED_GGHE-DCHE_SHA2011,Domestic general government health expenditure (GGHE-D) as percentage of current health expenditure (CHE) (%),3104.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4953
GHED_PVT-DCHE_SHA2011,Domestic private health expenditure (PVT-D) as percentage of current health expenditure (CHE) (%),3104.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4954
GHED_EXTCHE_SHA2011,External health expenditure (EXT) as percentage of current health expenditure (CHE) (%),3104.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4955
GHED_GGHE-DGGE_SHA2011,Domestic general government health expenditure (GGHE-D) as percentage of general government expenditure (GGE) (%),3115.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4956
GHED_GGHE-DGDP_SHA2011,Domestic general government health expenditure (GGHE-D) as percentage of gross domestic product (GDP) (%),3104.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4957
GHED_EXT-GEXT_SHA2011,External health expenditure channelled through government (EXT-G) as percentage of external health expenditure (EXT) (%),0.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4958
GHED_GGHE-D_pc_US_SHA2011,Domestic general government health expenditure (GGHE-D) per capita in US$,3104.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4959
GHED_GGHE-D_pc_PPP_SHA2011,Domestic general government health expenditure (GGHE-D) per capita in PPP int$,3104.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4960
GHED_PVT-D_pc_US_SHA2011,Domestic private health expenditure (PVT-D) per capita in US$,3104.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4961
GHED_PVT-D_pc_PPP_SHA2011,Domestic private health expenditure (PVT-D) per capita in PPP int$,3104.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4962
GHED_EXT_pc_US_SHA2011,External health expenditure (EXT) per capita in US$,3104.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4963
GHED_EXT_pc_PPP_SHA2011,External health expenditure (EXT) per capita in PPP int$,3104.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4964
GHED_OOPSCHE_SHA2011,Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%),3104.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4965
GHED_OOP_pc_US_SHA2011,Out-of-pocket expenditure (OOP) per capita in US$,3104.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4966
GHED_OOP_pc_PPP_SHA2011,Out-of-pocket expenditure (OOP) per capita in PPP int$,3104.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4967
AMRGLASS_COORD01,Functioning national AMR surveillance plan,18.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4968
AMRGLASS_COORD02,Establishment of National Coordination Centre (NCC),18.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4969
AMRGLASS_COORD03,Nomination of National Focal Point (NFP),12.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4970
AMRGLASS_COORD04,Establishment of national reference laboratory (NRL),12.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4971
AMRGLASS_SURVL01,Number of national surveillance sites in each country providing data to GLASS: hospital category,24.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4972
AMRGLASS_SURVL02,Number of National surveillance sites in each country providing data to GLASS: outpatient facility category,24.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4973
AMRGLASS_SURVL03,Number of local clinical laboratories in each country performing AST to support national AMR surveillance sites,24.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4974
AMRGLASS_QA01,EQA provided to the national reference laboratory (NRL),12.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4975
AMRGLASS_QA02,EQA provided for bacterial identification and AST,12.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4976
AMRGLASS_QA03,EQA provided to local laboratories participating in GLASS,18.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4977
AMRGLASS_QA04,GLASS pathogens testing covered by EQA,18.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4978
AMRGLASS_QA05,Types of AST standards followed by countries,24.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4979
cci2030,Composite coverage index (%),6795.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4489
fpsmo,Demand for family planning satisfied - modern methods (%),7469.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=3813
GDO_q35,Estimated population-based prevalence of depression,183.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=5281
SDGHIV1524,New HIV infections among adults 15-24 years old (per 1000 uninfected population),0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4752
SDGODA02,"Official development assistance for medical research and basic health sectors as a percentage of GNI (%), by donor country",0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1473
SDGODA01,"Total net official development assistance to medical research and basic health sectors per capita (US$), by recipient country",147.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4739
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),201.0,http://apps.who.int/gho/data/node.wrapper.imr?x-id=4985
SDG_SH_DTH_RNCOM,"Number of deaths attributed to non-communicable diseases, by type of disease and sex",0.0,
SDG_SH_STA_SCIDEN,"Number of deaths attributed to suicide, total and by sex",0.0,
SA_0000001400_ARCHIVED,"Alcohol, recorded per capita (15+) consumption (in litres of pure alcohol)",43233.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=462
NUTRITION_WH_3,Children aged <5 years severely wasted <br> (% weight-for-height <-3 SD),0.0,
AIR_60,Household and ambient air pollution attributable DALYs ('000),0.0,
AIR_61,Household and ambient air pollution attributable DALYs (per 100 000 capita),0.0,
AIR_62,"Household and ambient air pollution attributable DALYs (per 100 000 capita, age-standardized)",0.0,
AIR_63,Household and ambient air pollution attributable DALYs in children under 5 years ('000),0.0,
NCD_CCS_targets,Existence of a set of time-bound national targets based on WHO guidance,388.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4980
NCD_CCS_paaware,Implementation of physical activity public awareness program,388.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4981
NCD_CCS_oralhealthplan,Existence of operational policy/strategy/action plan for oral health,194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4982
NCD_CCS_rheumreg,Existence of a register of patients who had rheumatic fever and rheumatic heart disease,194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4983
NCD_CCS_rheumfollowup,Has systems for follow-up/recall to deliver long-term penicillin prophylaxis to patients with rheumatic fever and rheumatic heart disease,194.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4984
TB_e_inc_num_014,Number of incident tuberculosis cases in children aged 0 - 14,0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=1426
M_Est_tob_daily_crude,"Daily tobacco smoking, crude adjusted",0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=360
M_Est_cig_daily_crude,"Daily cigarette smoking, crude adjusted",0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=363
M_Est_tob_curr_crude,"Current tobacco smoking, crude adjusted",0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=358
M_Est_cig_curr_crude,"Current cigarette smoking, crude adjusted",0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=361
AIR_39,"Household air pollution attributable DALYs (per 100 000, age-standardized)",0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4491
SG_DMK_SRCR_FN_ZS,"Proportion of women aged 15-49 years who make their own informed decisions regarding sexual relations, contraceptive use and reproductive health care (%)",0.0,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=4986
E14a_prod_tv_films,Ban on appearance of tobacco products in TV and/or films,0.0,
E19_indirect_ad_fines,Law requires fines for violations of indirect advertising bans,0.0,
E20_subnational_exists,"Subnational laws or regulations exist banning some or all types of tobacco advertising, promotion and sponsorship",0.0,
E22_internet_sales_ban,Ban on internet sales of tobacco products,0.0,
E6b_ban_display_pt_of_sale,Ban on display of tobacco products at points of sale,0.0,
E8_direct_ad_fines,Law requires fines for violations of direct advertising bans,0.0,
WSH_09,"Water, sanitation and population attributable fractions",,http://apps.who.int/gho/indicatorregistry/App_Main/view_indicator.aspx?iid=2260
